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Cilia and flagella are evolutionarily conserved microtubule-based cellular organelles with 
multiple important functions in animal development and physiology. Broadly, cilia can 
be classified into two categories: motile cilia that beat to direct fluid flow and immotile 
sensory cilia that serve as platforms for signal reception. Motile ciliary dysfunction is the 
pathological basis for a class of diseases known as primary ciliary dyskinesia. Therefore, 
understanding the development, form and function of motile cilia has a direct effect on 
human health and therapeutics. A major lacuna in the field of ciliary biology has been the 
absence of a detailed functional screen for ciliary genes at the vertebrate organismal 
level. 
Our group previously discovered that the Forkhead domain containing 
transcription factor Foxj1 is the master regulator of motile cilia differentiation in 
vertebrates. Foxj1 activity is not only critical but is also sufficient for motile cilia 
formation. Given the importance of Foxj1 in motile ciliogenesis and the fact that there are 
currently no genome-wide organism based screens for ciliary genes, we embarked on the 
identification and functional characterization of the targets of Foxj1 in the structure and 
function of motile cilia using the zebrafish as a model system. 
We first identified the targets of Foxj1 by performing a whole genome microarray 
analysis upon overexpression of Foxj1. By using several validation tools, we show that 
the identified list of direct and indirect targets of Foxj1, called as Foxj1-induced genes 
(FIGs), contain novel motile ciliary genes. Further, I carried out a thorough, large-scale 
knockdown of FIGs in zebrafish embryos using morpholinos. I knocked down 50 




related phenotypes in 31 out of the 50 selected candidates, thereby yielding a hit rate of 
62% based on discernable phenotypes in zebrafish embryos. Hence, this collection of 
FIGs contains several novel ciliary genes and is a valuable tool in advancing our 
understanding of ciliary biology and further, aiding in the quest to find genes whose 
mutations would lead to ciliary dysfunction.  
In chapter 6, I have reported the characterization of a novel Leucine-rich repeat encoding 
gene-lrrc9. From the list of FIGs, I evaluated the role of genes encoding Leucine-rich 
repeats in the context of motile cilia. Through a morpholino-based knockdown screen, I 
identified that loss of Lrrc9 had a profound consequence on ciliary structure and function. 
Loss of lrrc9 led to the development of several phenotypes in the zebrafish embryo, 
similar to that occurring due to ciliary dysfunction. Surprisingly, I observed a dramatic 
shortening of motile cilia along with perturbed axonemal ultrastructure upon loss of 
Lrrc9. This is in contrast to two other known Lrr proteins-Lrrc6 and Lrrc50, whose loss 
does not produce any ciliary shortening. Thus, in this thesis, I have reported for the first 
time, the characterization of a Leucine-rich repeat gene - lrrc9, whose knockdown led to 
significant ciliary shortening. 
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This thesis is organized into seven chapters. Chapter 1 introduces the motile cilium, its 
structure and function, as well as consequences of altered function. Through this chapter, 
I have highlighted the importance of studying motile cilia as well as make a case for the 
need to identify its constituents.   
Chapter 2 introduces the role of leucine-rich repeat (LRR) containing proteins in human 
health and disease. I have emphasized the relevance of studying these proteins through 
examples of genetic conditions arising from mutations in LRR encoding genes.  
The hypothesis and objectives of this thesis are described in Chapter 3.  
Chapter 4 comprises the materials and methodology used for the experiments described 
in this thesis. 
Chapter 5 essentially builds up from chapter 1 and reports the results obtained. 
Chapter 6 builds up from chapter 2 and reports the results from the characterization of a 
novel lrr-encoding gene – lrrc9, followed by conclusions and future work in chapter 7. 
Supplementary material is organized into appendices. 
 
 
 Motile cilia in health and disease 
 
1 




 “The elements that unite are single cells, each on the point of death; but by their union a 
rejuvenated individual is formed, which constitutes a link in the eternal process of Life.” 
F. R. Lillie 
 
There is no doubt that the act of fertilization sustains the continuity of life, and 
underlying this process, is a remarkable organelle- the motile cilium. The continuity of 
life depends to a large measure on the proper functioning of this fascinating organelle in 
the male and female reproductive systems.  
What is a motile cilium? How does an organelle accomplish this remarkable feat 
of motility? What are the secrets yet to be discovered about it? In this chapter, structure 
and functions of motile cilia will be summarized, and the stage set for the work done in 
this thesis. 
Cilia and flagella are microtubule-based cellular organelles that project from the 
surface of several cell types [1]. They perform functions that are crucial to the survival as 
well as the homeostasis of an organism [1, 2]. Additionally, the microstructure and 
organization of cilia and flagella are highly conserved evolutionarily, from unicellular 
Chlamydomonas to humans; highlighting their crucial role in the life of an organism [3, 
4].  
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The history of observing cilium dates back to 1675, when Antonie van 
Leeuwenhoek first used a microscope, developed by him, to describe the “little legs” of 
protozoa [5]. Hence, from the time of the invention of the first microscope, cilia 
serendipitously have been one of the first cellular organelles to be described. However, it 
was not until 1786 that the term “cilium” meaning “an eyelash” (in Latin) was coined by 
Otto Muller [6]. In over 300 years that have passed, an enormous deal of information has 
been amassed about its distribution, form and functions. Even so, the field of ciliary 
biology is at a point where there are more questions than answers. What light has been 
shed by years of research on the mysteries of this organelle? Details of the structure and 
function of motile cilia, obtained by consolidating pioneering studies form the highlight 
of the following sections.    
 
1.2 Structure of a cilium 
Superficially, the cilium may appear as a membranous extension of the plasma 
membrane. However, its architecture is distinct and complex as revealed by electron 
microscopy. At the core of each cilium is the axoneme, an axial structure consisting of 
the microtubule cytoskeleton with associated proteins. The axoneme is ensheathed by a 
membrane called the ciliary membrane, which in turn is continuous with the plasma 
membrane (figure 1.1). Axonemal microtubules are extensions from a cytoplasmic 
structure, the basal body that is derived from the mother centrioles (figure 1.1). The basal 
body anchors to the apical cell membrane during ciliogenesis (the process of generating a 
new cilium) and provides a template for the outgrowth of the axoneme [1].  
 




Figure 1.1: Structure of a cilium.  
The axoneme consisting of microtubular doublets extends from the apical basal body and 
projects outwards.  
 
In the axoneme, microtubules are arranged in a striking pattern. As illustrated in 
figure 1.2, two distinct configurations of the microtubule arrangement have been 
observed [1]: 
• 9+2: in this configuration, the axoneme consists of nine doublets of microtubules 
arranged around a central pair of microtubules.  
• 9+0: in this configuration, the axoneme is devoid of the central pair of 
microtubules. 




Figure 1.2: Ultrastructure and types of cilia. 
There are two types of cilia with distinct axonemal architectural features as seen in this 
cross section through the axonemes. Primary cilia (A) lack the central pair of 
microtubules and present with 9+0 arrangement. In contrast, motile cilium (B) possesses 
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the central pair and has a 9+2 arrangement of axonemes. Additional features present in a 
motile cilium are indicated in the illustration. 
 
1.3 Types of cilia 
Based on ultrastructural and functional observations of cilia, two distinct types have been 
recognized: immotile and motile cilia [1]. Structurally, axonemes of immotile or primary 
cilia present a 9+0 arrangement due to the absence of a central pair. In addition, primary 
cilia are devoid of proteins required for motility, namely the dyneins and other associated 
proteins [1]. In general, motile cilia possess a central pair or the 9+2 arrangement and 
contain proteins that confer motility (Figure 1.2). However, exceptions to this rule are 
known. For example, motile cilia in a transient embryonic structure- the node in medaka 
fish lacks the central pair of microtubules [7]. Likewise, Kerstin Feistel and Martin Blum 
reported the existence of 9+4 arrangement for motile cilia in the notochord of rabbit 
embryos [8].  
Primary cilia (with 9+0 arrangement) are short and usually present as a single 
cilium on several differentiated cells of tissues like muscles, kidney tubule epithelial 
cells, neurons and fibroblasts to name a few. Studies on the primary cilia suggest a 
dedicated role in sensory perception like mechanosensation, chemosensation, 
photosensation, control of cell cycle, and in conducting various signals like hedgehog, 
Wnt, to name a few [9, 10]. Thus, primary cilia are crucial for the development and 
physiology of an animal through these critical regulators.  
On the other hand, motile cilia are longer and can beat. They are present on 
various protozoans and several invertebrate larvae that utilize ciliary beating for 
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locomotion. In vertebrates, motile cilia are restricted to certain groups of cells and tissues 
such as the respiratory tract, the spinal canal, the sperm cell, and in the oviduct of the 
female reproductive system. Also, there is considerable diversity in the occurrence of 
motile cilia in these tissues. For instance, cells of the respiratory tract contain multiple 
cilia per cell, while each sperm cell contains only a single flagellum. Similarly, there is 
diversity in ciliary length in different tissues. For example, respiratory epithelial cilium is 
much shorter than the long flagellum of the sperm. Though genetic analysis has 
uncovered several mediators of length control, definitive answers about regulation of 
ciliary length are still missing [11]. The functions of motile cilia have been dealt with in 
section 1.6. 
The traditional view has been that primary cilia are important for sensing signals 
while motile cilia provide functions involving motion. However, this classification has 
attracted severe scientific criticism in the wake of accumulating evidence which confirms 
that motile cilia can sense cues in addition to their role in motility (section 1.6) [12]. 
Hence, the conventional distinction is no longer valid, and further, functions of motile 
cilia are likely to be more complex than previously thought.  
Let me address the next question: how is a cilium constructed?  
 
1.4 Building the cilium: Intraflagellar transport 
Consider the construction of a structure, say a building; it occurs in an orderly manner 
where required materials are assembled, and construction begins from the base and 
steadily progresses till the uppermost storey. Likewise, building a cilium follows a 
structured process starting from the base to the tip. Interestingly, cilia are devoid of 
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ribosomes; as a result, protein synthesis does not occur in the cilium. Hence, cargo for 
ciliary construction is synthesized and ferried from the cytoplasm, deposited at the base 
of the cilium - at the basal body [13], and then transported to the growing end of the 
cilium [14, 15]. This exquisite process is termed intraflagellar transport (IFT) [15-17].  
Kozminski et al. observed bidirectional particulate movement in paralyzed 
flagella of Chlamydomonas reinhardtii that kick-started the series of experiments 
eventually leading to the discovery of IFT [16]. Subsequently, work from Piperno and 
group as well as Cole and colleagues identified the biochemical nature of IFT by 
purifying IFT components from flagella of Chlamydomonas and identified two distinct 
complexes [18, 19]. These complexes were termed complex A and complex B. Complex 
A is smaller (550-kDa) and composed of 6 protein subunits while complex B is larger 
(750-kDa) and is comprised of 14 subunits [19, 20].  
Functional and genetic analyses revealed distinct roles of these complexes in IFT. 
While complex B moves in an anterograde fashion, that is, from the base towards the tip 
of the cilium (plus end movement), complex A moves in the reverse or retrograde 
direction (minus end movement) [20]. Motor proteins are the backbone of this transport 
system, with kinesin 2 driving anterograde movement, whereas cytoplasmic dynein 2 
powers the retrograde movement [20, 21].  
Interestingly, mutant analysis of components of IFT revealed exciting aspects. 
Mutations in components of complex B typically resulted in failed growth of flagella, 
unlike disruption of complex A which permits flagellar assembly [20, 22]. From these 
observations, a generic model of IFT has been proposed.  According to this model, 
precursors for building the cilium are assembled at the base of the cilium. Kinesin-2 
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transports IFT-A, IFT-B and other cargos from the base of the cilium to the tip. The cargo 
is released after dissociation of kinesin-2, at the tip of the cilium. After a remodeling 
event, cytoplasmic dynein transports IFT-A, IFT-B and kinesin-2 to the base of the 
cilium, where they can be recycled or destroyed accordingly [14, 15, 23-25]. Several 
aspects of IFT still beg for clarity. The precise genetic regulations, the nature of cargo, 
recognition of cargo amongst others are a few of the questions that still lack satisfactory 
answer. Given that IFT is at the heart of constructing a cilium, it comes as no surprise 
that the components of complex A and B are conserved from Chlamydomonas to humans 
[20].  
Cilia are complex in their structural organization as well as in their construction. 
Naturally, the question to follow would be about the functions of the motile cilium. Does 
the function justify such a complexity? It indeed does as will be clear in the following 
section. 
 
1.5 The motile cilium: structure and assembly and motility 
From form, arises function. So before delving into the functions of motile cilia, let me 
review additional details of their structure. As mentioned in section 1.3, the microtubule 
doublets in a motile cilium are arranged in the 9+2 order. The outermost microtubule is 
designated as the ‘A’ tubule, and fused to this is the inner ‘B’ tubule (figure 1.2) [3]. 
Each microtubule doublet is connected to the neighboring doublet through the nexin link. 
In addition, the nexin link functions as a regulatory complex – the dynein regulatory 
complex (DRC) to regulate the function of the dynein motors discussed below [4, 26].  
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The doublets are connected to the central pair through the radial spokes, thereby 
ensuring transmission of signals from the central pair to the doublets [27, 28]. Genetic 
evidence suggests that these components are vital to the form and function of motile cilia, 
as the loss of these components leads to aberrant motility and consequently, results in a 
disease condition termed primary ciliary dyskinesia (discussed in section 1.7) [29]. 
  Dynein motors that power motility are precisely organized into two rows or arms 
(outer and inner) along the doublets as visualized by electron microscopy [30]. The outer 
dynein arm (ODA) is located peripherally on the A tubule, whereas the inner dynein arm 
(IDA) is on the inner side of the A tubule as seen in figure 1.2. These arms are arranged 
in a periodic fashion spaced at 96 nm along the A tubule [30, 31]. The dynein arms 
consist of protein complexes forming the heavy, light and the intermediate chains. In 
Chlamydomonas, the ODA consists of three heavy chains, two intermediate chains and 
nine light chains, while the human ODA contains only two heavy chains along with 
intermediate and light chains [30]. On the other hand, the composition of IDA is poorly 
understood and thought to contain seven heterodimeric and monomeric heavy chain 
isoforms [26].  
How does a cell achieve this precise biochemical and geometric integration of 
these dynein arm (DA) complexes? It has been mentioned in section 1.4 that cilia are 
devoid of machinery for protein synthesis. Then, how are these complexes assembled? 
Also, what factors regulate the assembly of these complexes?   
A significant breakthrough to this problem came from the work of Huang et al. 
through the analysis of Chlamydomonas mutants with paralyzed flagella [32]. Electron 
microscopy of flagellar axonemes of mutant pf-13 revealed a dramatic loss of the DA. 
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This observation was further supported by biochemical evidence of the loss of dynein 
heavy chain from protein extracts obtained from the mutant cells. These experiments 
suggested that the product encoded by the pf-13 gene was necessary for the cytoplasmic 
preassembly of the dynein complexes [32]. While the exact mechanism is not clear, these 
findings raise an important question - is this mechanism restricted to Chlamydomonas or 
is it conserved in higher animals?  
The enormous implication of this work was realized years later through the 
discovery of a medaka fish mutant for the gene kintoun (ktu) [33]. The ktu mutant, 
isolated from a mutagenesis screen in medaka, had altered laterality of organs due to 
defective ciliary function (ciliary function in determining laterality is discussed in section 
1.7). Even though cilia were specified normally, they were completely immotile. Further, 
electron micrographs of ciliary axonemes revealed loss of ODA as well as IDA from the 
axonemes in ktu mutants thereby explaining the lack of ciliary motility [33].  
Applying the knowledge from medaka, the authors adopted a candidate gene 
approach and screened for KTU mutations in families with cases of ciliary dysfunction 
(primary ciliary dyskinesia- section 1.7). Interestingly, they identified three affected 
individuals who carried a loss of function mutation in KTU. Clinically, the affected 
individuals presented with respiratory problems along with altered placement of internal 
organs, similar to that observed in the medaka mutant. The ultrastructural abnormalities 
in patients were remarkably similar to that of medaka ktu mutant with loss of ODA and 
IDA from respiratory cilia and sperm tails [33].  
Interestingly, KTU localized to the apical cytoplasm and was not detected in the 
ciliary fraction [33]. These results seemed perplexing and led to the question as to why 
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the loss of a cytoplasmic protein would have such a profound consequence on ciliary 
motility. The twist in the tale came when the authors made the connection that ktu was, in 
fact, a homolog of the Chlamydomonas pf13 gene [33]. Armed with this knowledge, 
along with biochemical evidence, the authors showed a drastic reduction in the 
cytoplasmic levels of heavy chains of outer and inner dynein arms in the pf13 mutants. 
This revealed that in the absence of Pf13, functional dynein complexes are not 
assembled. These findings lead to questioning the molecular mechanisms by which this 
assembly process occurs. Even though the authors provide evidence of interaction of Ktu 
with a chaperone protein Hsp70 and dynein intermediate chain DNAI2, the exact 
molecular mechanism is still elusive [33, 34]. 
The discovery of KTU as an assembly factor laid the foundation for 
understanding the process of preassembly of DA. Subsequently, few other genes with 
homologs in Chlamydomonas, encoding proteins with functions in the preassembly of 
DA have been identified. In view of their functions, these genes have been named as 
dynein axonemal assembly factors or DNAAF’s. Currently, three such factors listed in 
table 1.1, have been identified.  
 
Table 1.1 Axonemal dynein assembly factors  
Factor Dynein arm defects Reference 
DNAAF1 (LRRC50) Loss of ODA and IDA [35, 36] 
DNAAF2 (KTU) Loss of ODA and IDA [33] 
DNAAF3 (C19orf51) Loss of ODA and IDA [37] 
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However, this is not an exhaustive list as recent reports of mutations in novel 
genes with similar ultrastructural as well as clinical phenotypes are being discovered. 
Some examples of this include the recently identified mutations in dyslexia suseptibility1 
candidate 1 gene DYX1C1 which led to the loss of ODA and IDA in a manner similar to 
loss of other assembly factors [38, 39]. Another example (discussed in detail in the next 
chapter) is leucine-rich repeat encoding gene LRRC6. Loss of LRRC6 recapitulates the 
phenotypes discussed above [40, 41]. From these examples, it is clear that we have just 
begun to scratch the surface, as far as understanding the process of DA assembly is 
concerned. As more mediators emerge, and processes identified, hopefully a solution to 
the problem of dynein assembly will emerge.  
Now that the structure and assembly of motile cilia have been discussed, the 
most-important aspect– motility remains to be examined. Ciliary beating is an extremely 
fascinating feature, which has not only attracted the attention of biologists, but also of 
physicists who have corroborated experimental findings with modeling to unravel the 
physical constraints of motility [42-45]. Significant advances in the understanding of 
ciliary motility have been derived from a detailed analysis of Chlamydomonas mutants 
with defective flagellar beating [4].  
Ciliary motility occurs by the orchestrated activity of dynein arms that are present 
on the axoneme. These motor proteins utilize chemical energy from ATP hydrolysis to 
generate force to produce sliding of the outer microtubule A with respect to inner 
microtubule B [30, 46]. ODA present on the A tubule of one of the doublets, walks along 
the B tubule of the neighboring doublet, to create a sliding movement. While one set of 
doublets creates a sliding motion, the opposing doublets mediate bending aided by IDA, 
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leading to ciliary beat [30, 46]. The process of ciliary beating can be broken down to two 
distinct strokes- a forward effective stroke to create the forward thrust and, a recovery 
stroke to restore the initial position as illustrated in figure 1.3 below [1, 47]. In this 
manner, a wavelike pattern of ciliary beat is instituted. 
 
 
Figure 1.3: Mechanics of a ciliary beat.  
Ciliary beating consists of two distinct strokes- effective (A) and recovery (B). The final 
position of the cilium during each stroke is shown in dark brown. The purple arrow 
indicates the direction of the beat. 
 
 
There are two aspects to ciliary beat- the beat frequency and the amplitude.  ODA 
regulates the beat frequency by controlling the rate of sliding, whereas IDA regulates the 
waveform by regulating the bending [48]. In a biological context, several signaling 
molecules like cyclic adenosine monophosphate (cAMP), cyclic guanosine 
monophosphate (cGMP), intracellular calcium and pH regulate ciliary beating [49]. The 
ciliary beat frequency, as well as amplitude, are important readouts of ciliary function 
and are diagnostic in cases of pathologies arising due to defective cilia [29] (discussed 
further in section 1.7).  
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The picture is more complicated than what is known at the moment. The model 
presented, explains the mechanics of ciliary motility in situations of planar and linear 
motility like that of transport of mucus in the respiratory tract. However, the situation 
gets tricky in the case of ciliary motion within cavities during embryonic development. A 
distinct class of motile cilia found in a transient organ of laterality in vertebrates, exhibit 
rotary movement as opposed to a whip like beating [50, 51]. A simple linear model fails 
to explain directional transport in case of rotary motion in such situations. This aspect has 
been elaborated in the following section.  
Having discussed the structural intricacies of motile cilia, let us examine the 
functions of this remarkable organelle.  
 
1.6 Functions of motile cilia 
From the name, it is apparent that the function of motile cilium is intrinsically linked to 
motility. Let us examine some of these aspects in this section. In the case of single-celled 
organisms like Chlamydomonas, flagellar beating is essential for motility [4, 52] as well 
as mating behavior [53, 54]. In contrast, higher animals differentiate motile cilia in 
limited tissues only. Let us examine the biological contexts where ciliary functions are 
critical in humans. 
 It can be rightly said “We breathe, therefore, we exist.” Respiration and by 
extension, respiratory health are critical determinants of a healthy life. However, the 
inhaled air is laden with foreign objects, bacteria, pollutants and other particulates that 
need to be prevented from reaching the lungs. During airflow into the respiratory tract, 
these particulates are trapped by mucus and subsequently expelled [55, 56]. This 
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clearance of mucus is dependent on motile cilia that line the respiratory epithelium. Cells 
of the respiratory tract bear multiple motile cilia on the apical surface that beat in a 
coordinated manner to clear mucus away from the lungs. This biological process termed 
as mucociliary clearance is vital for proper respiratory function [57-59].  A morbid 
consequence of defective cilia in the respiratory tract is the development of chronic 
respiratory distress. In individuals with defective cilia, mucociliary clearance is affected 
and consequently, the lungs fill up with mucus making it hard to respire. Thus, the motile 
cilium has an indispensable role in ensuring smooth functioning of the respiratory tract 
[59].  
Multiciliated ependymal cells line the ventricles of the brain. Periodic beating of 
these motile cilia ensures proper circulation of cerebrospinal fluid (CSF) [60, 61]. The 
flow of CSF has several crucial functions like providing protection to the brain, clearing 
debris, collection and distribution of metabolites and guidance of neuroblasts, to name a 
few. Therefore, proper CSF flow is imperative for maintaining homeostasis in the 
nervous system. Impaired ciliary motility, consequently leads to impaired flow and 
accumulation of CSF in the brain ventricles causing swelling of the ventricles [62, 63]. 
This swelling is clinically termed as hydrocephalus.  Furthermore, data from animal 
models also substantiate that ciliary dysfunction leads to the development of 
hydrocephalus [63-72].    
  As discussed at the beginning of this thesis, motile cilia in the male and female 
reproductive system are central to the continuity of life. In the male reproductive system, 
robust flagellar beating ensures motility of the sperm [73]. Likewise, in the female 
reproductive system, action of motile cilia of the fallopian tubes ensures proper passage 
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of the ovum towards the sperm [74]. In addition, ciliary beating is an important 
determinant for fertilization and subsequent transport of the embryo from the fallopian 
tube toward the uterus [75]. Hence, alterations in ciliary function lead to infertility, the 
extent of which depends on the severity of the dysfunction [73]. Thus, ciliary function 
lies at the core of the development of a new life form. 
One of the earliest decisions in a vertebrate embryo is about generating sidedness. 
To an external observer, it may look like we are symmetrical on the surface, but 
internally our visceral organs have a distinct sidedness. For example, the apex of the 
heart, the spleen and the stomach lie on the left side, while the liver is always positioned 
on the right side in the abdominal cavity [51]. What is the basis for this morphological 
asymmetry? While the details are being worked out, it is interesting to note that during 
development, molecular asymmetries of gene expressions precede the establishment of 
morphological asymmetry [76-79].  The basis of this phenomenon remained a mystery 
till the discovery and understanding of the functions of a transient structure called the 
node. The node is a pit like structure (figure 1.4) at the end of the notochord containing 
motile cilia, which beat to drive a leftward flow of extraembryonic fluid. This process, 
called the nodal flow is largely conserved in the vertebrates. 




Figure 1.4: Function of motile cilia in the mouse node.  
Posteriorly tilted motile cilia beat in the node to drive a leftward fluid flow. Primary cilia 
present on the perinodal cells sense the fluid flow (indicated by the deflections). The 
arrowhead indicates the direction of the flow. Basal bodies indicated as red circles; are 
placed in a more posterior location. R and L refer to the right side and left side 
respectively, A and P refer to anterior and posterior side of the node. Figure modified 
from reference [51]. 
 
 
The discovery that nodal cilia are required to institute left-right asymmetry (LRA) 
comes from genetic analysis of mouse mutant for genes encoding the motor protein 
kinesin [50, 80]. Mice mutant for kinesin encoding genes Kif3b or Kif3a fail to assemble 
cilia, and further, 50% of mutant embryos have altered LRA [50, 80]. Live microscopic 
observations of the node showed a complete absence of flow in Kif3 mutant embryos, 
while a strong leftward flow was detected in the wild-type embryos. These studies 
highlight the importance of cilia mediated flow in establishing LRA. To lend further 
support, Supp et al. demonstrated randomization of left-right axis in mice mutant for the 
gene encoding left-right dynein [81]. In Lrd mutant mice, cilia are specified normally but 
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are immotile due to the absence of a specific dynein. The consequent impaired nodal flow 
leads to alterations in LR symmetry in the embryos [82, 83]. Taken together, these 
findings revealed that the establishment of the LRA is critically dependent on proper 
ciliary function in the node. Further, intriguingly; flow generated by as few as two motile 
cilia appear to be sufficient for this process in the mouse node [84].  
As discussed earlier, during development, molecular asymmetries precede the 
establishment of morphological asymmetry. Cilia driven directional flow in the node is 
the trigger to institute the LR symmetry breaking through the activation of the Nodal-
signaling pathway. As illustrated in figure 1.5, upon activation of the Nodal pathway, the 
expression of Nodal, a transforming growth factor beta -TGFβ member, expands on the 
left side into the neighboring lateral plate mesoderm. Subsequently, Nodal induces the 
expression of another TGFβ member- Lefty2 and the paired-like homeodomain 
transcription factor Pitx2, in addition to inducing its own expression. Lefty2 can 
competitively bind to Nodal receptors to downregulate the levels of Nodal. In addition, 
being a monomer, Lefty2 diffuses faster and farther than dimeric Nodal, and thus restricts 
its activity to the left side. Subsequently, Pitx2 directs morphological asymmetry by 
governing gene expression cascade important for left-sided morphogenesis. In this 
intricate manner, ciliary activity in the node helps to ensure a successful breaking of LR 
symmetry. 
 




   
Figure 1.5: Nodal pathway and the determination of left-right asymmetry (LRA).  
In this simplified schematic, molecular cascade following activation of the nodal pathway 
is indicated. R and L refer to the right side and left side respectively. Black lines indicate 
cilia in the node. Illustration obtained from reference [51]. 
 
Ciliary beat pattern in the node is very distinct - rotary motion unlike the planar 
whip-like fashion in the examples discussed earlier. This raises two questions: how is a 
rotary beating pattern achieved? In addition, how does rotary beating produce a 
directional flow? The first problem remains unresolved, as we do not have any 
satisfactory explanations for this type of motility. The second problem is interesting, 
 Motile cilia in health and disease 
 
20 
since a rotary beating is expected to produce a vortex instead of directional flow. Here, 
theoretical physicists could predict that a posterior tilt in the rotational axes of the nodal 
cilia could accomplish a directional flow [42]. In such a scenario, the effective stroke 
would be more efficient than the recovery stroke. This arises due to the recovery stroke 
having to move fluid closer to the cell surface, where viscosity is higher [51]. 
Experimental proof for this prediction came from studies which utilized high-speed 
videomicroscopy to demonstrate a posterior tilt in rotational axes of the node cilia [7, 85]. 
Further, it was seen that the basal bodies of nodal cells shifted from the central to a 
posterior position as directed by the planar cell polarity (PCP) pathway operating in the 
node [86-89]. Thus, cilia are uniquely configured to beat in a rotary manner to ensure 
directional fluid flow in the node. 
Despite the lingering inadequacies in understanding ciliary functions in the node, 
it is clear that motile cilia are indispensable for the process of instituting LRA. Thus, 
precise ciliary functions are obligatory to guarantee a successful developmental outcome.  
It was traditionally assumed that motile ciliary functions were restricted to 
biological contexts dependent on motility as discussed earlier. However, there is growing 
evidence that motile cilia can also perform sensory functions. While, it is easier to 
reconcile these two aspects in case of unicellular organisms like Chlamydomonas, recent 
studies show that this attribute is true also in the case of the vertebrates. For example, 
results from the work of Shah et al. demonstrate that bitter taste receptors are localized on 
the motile cilia of the human airway epithelium [90]. Further, these receptors respond to 
bitter compounds and cause an increase in ciliary beat frequency in order to clear the 
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offending compound [90]. Thus, the motile cilia can effectively juggle chemosensory as 
well as motility roles.  
Nodal flow is sensed by primary cilia present on the edge of the node (figure 1.4) 
[91]. In a surprising discovery, Kamura and colleagues report that the medaka node is 
devoid of primary cilia and contains only motile cilia [92]. This implies that motile cilia 
in the node should be able to generate as well as sense the flow. The literature is replete 
with examples of motile cilia being able to sense and respond to microenvironmental 
stimuli in addition to motility [12]. Hence, the traditional distinctions are fading away as 
we begin documenting evidence that shed new light on this ancient organelle.     
From these examples, it is clear that motile cilia are indispensable for the survival 
of an organism. Also, from the preceding sections, we understand that normal ciliary 
functions involve many players and several avenues for errors to occur. I have presented 
the repercussions of altered form and function of motile cilia in the next section.  
 
1.7 Primary Ciliary Dyskinesia (PCD)  
Given the wide variety of functions performed by motile cilia, it is to be expected that 
any deficit in the functioning of cilia should have profound consequences. Indeed, this is 
the case, as defects in ciliary functions leads to a host of conditions known as 
ciliopathies. Of these, a disorder arising from the dysfunction of the motile cilium is 
termed as primary ciliary dyskinesia (PCD) [73].   
 PCD is an inherited genetic disorder with an incidence of PCD around 1 in 
10,000-20,000 births [93, 94]. Clinical features of PCD are varied and reflective of the 
tissues in which the defects occur. As described in the preceding section, clinical features 
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of PCD include chronic respiratory infections, persistent cough, hydrocephalus and 
altered fertility consistent with aberrant ciliary functions in these tissues [47]. Of these 
patients, approximately 50% present with situs abnormalities. This subtype of PCD cases 
with respiratory insufficiency, infertility and ‘situs inversus’ (figure 1.6) are clinically 
categorized to have Kartagener syndrome (KS) [51]. Interestingly, studies of patients 
with KS were instrumental in linking ciliary dysfunction to the disease pathology [95, 
96]. 
 
Figure 1.6: Situs inversus in a case of Kartagener Syndrome (KS).  
Placement of internal organs of a normal human (A) as compared to a patient with KS is 
illustrated in this figure. The positions of internal organs are reversed in mirror symmetry 
in case of KS patients. Figure obtained from reference [51]. 
 
   
 Motile cilia in health and disease 
 
23 
The nomenclature of PCD has evolved over time as the understanding of the 
scope of the disease broadened. Work by Afzelius in the 1970’s demonstrated that cilia 
were immotile in patients with KS, and, further showed that dynein arms were missing 
from ciliary axonemes [95]. This observation led to the term ‘immotile cilia syndrome’ to 
describe such a clinical presentation. However, it became apparent that in certain 
instances, ciliary motility was not lost per se, but ciliary beating was uncoordinated and 
aberrant. This observation revised the nomenclature to ciliary dyskinesia syndrome. 
Several factors; genetic and environmental (for example, smoking), can affect ciliary 
function. Hence, to distinguish those with a genetic etiology, the term ‘Primary ciliary 
dyskinesia’ was coined [74, 97]. 
Diagnosis of PCD is complicated, and based on the patient history along with 
laboratory investigations. The most common clinical feature is respiratory problem often 
manifesting as a persistent cough and respiratory distress. Historically, diagnosis of PCD 
hinged on being able to pick up ultrastructural abnormalities of the respiratory cilia. 
Defects in the ODA are the most frequently encountered defect in PCD cases [98]. 
However, considering that certain cohorts of PCD patients do not carry ultrastructural 
deficits, a negative EM finding does not necessarily exclude the diagnosis of PCD [93, 
99, 100]. Currently, a battery of tests is used to aid in the diagnosis. These include: 
• Measurement of nasal nitric oxide: Nitric oxide (NO) is a biological modulator of 
ciliary beating. In patients with PCD, NO production is markedly reduced, and 
consequently, measurements indicate very low levels of NO [101-105]. 
• Assessment of ciliary functions like ciliary beat frequency and beat pattern from 
nasal biopsy samples [106-108]. 
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• Demonstration of ultrastructural abnormalities of the axonemes obtained from the 
patient tissues [109]. 
• Screening for genes implicated in PCD [29, 93, 110]. 
 
What is the genetic basis of PCD? Since cilia are composed of hundreds of proteins 
(section 1.9 describing the screens), one would expect that loss of function mutations in 
the genes that encode these proteins would result in PCD. Therefore, it is not surprising 
that a genome-wide linkage analysis of thirty-one PCD families carried out by J-L Blouin 
and colleagues, failed to provide a major locus that harbored a causative mutation in 
these families [111]. From consolidating all the studies so far, mutations in a modest 
figure of 26 genes have been identified to underlie the genetic basis of PCD [29, 112]. 
Furthermore, these genes can be broadly grouped into several classes depending on 
functional similarities. These include genes encoding components of dynein subunits, 
genes encoding components of dynein preassembly, and genes encoding structural 
components like radial spokes and dynein regulatory complexes [29].  
As discussed in section 1.5, the concerted action of DA power motility. Therefore, 
mutations affecting the components of the DA are expected to render cilia immotile. This 
is indeed the case as mutations in genes encoding components of the outer dynein arm: 
DNAH5 (dynein axonemal heavy chain 5) [113-116] as well DNAI1 (dynein axonemal 
intermediate chain 1) account for approximately one-third of known cases of PCD. 
Likewise, mutations in other components of DA have been identified to cause PCD [93]. 
In most cases, ultrastructural observations of cilia from patients have been useful to 
identify the nature of underlying ciliary defects. However, ultrastructural analysis as a 
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diagnostic tool cannot be relied on extensively, since not all PCD cases present with 
abnormal ultrastructural defects [100, 117]. For example, PCD patients carrying 
mutations in dynein axonemal heavy chain DNAH11 (dynein axonemal heavy chain 11) 
present with normal ciliary ultrastructure [118-121]. Besides, electron microscopy is 
tedious, time-consuming and is not ideally suited for large-scale analysis. Hence, it is 
crucial to identify the genes responsible for PCD in order to develop accurate genetic 
testing. 
 The number of genes identified so far explains less than two-thirds of PCD cases 
[98, 122]. Hence, to understand the biology of PCD, it is imperative to identify genes 
whose loss of function can lead to PCD. However, this is often complicated by 
limitations arising from inadequate clinical material. Also, understanding the molecular 
basis of a disease requires a system that is amenable to experimental manipulation. How 
does one overcome these restrictions? One possibility is to use model systems to study 
PCD and tease apart the genetics of the disease. This throws up a lot of questions 
regarding the type of model system that could potentially be a useful one to study PCD. 
Is it possible to extend data from a suitable model organism to deepen the understanding 
of PCD? It is indeed possible, as discussed in the following section. 
 
1.8 The zebrafish model system to study motile cilia  
The evolutionary conservation of cilia opens an endless array of model systems to choose 
from in order to study various aspects of ciliary biology. Amongst them, the most 
common ones are the unicellular organisms like Chlamydomonas, invertebrates like C. 
elegans and Drosophila and vertebrates like zebrafish, Xenopus and mouse [123]. The 
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single most important model that has paved way for understanding of ciliary structure 
and function is the biflagellated green alga Chlamydomonas [4]. Several seminal 
discoveries in ciliary biology have been made using this organism. From the discovery of 
IFT, decoding the structural details of the cilium, motility, assembly of dynein arms and 
discovery of novel genes and proteins through screens are few examples of the immense 
advancements made from studies utilizing Chlamydomonas as a model system [124].  
However, unicellular as well as invertebrate models suffer from several 
drawbacks. Importantly, not all genes encoding for ciliary components are conserved 
between lower models and human. In addition, vertebrate-specific physiological 
situations in which ciliary function is critical cannot be recapitulated in a 
unicellular/invertebrate model. A case in point is the determination of LRA through 
ciliary motion in the organ of laterality in vertebrates. Modeling PCD in invertebrate 
models is challenging and does not fully recapitulate the pathology. Besides, very few 
tissues differentiate motile cilia in invertebrates. Also, deviations from conventional 
ciliary mechanisms are encountered in invertebrates. For example, the construction of a 
sperm flagellum in Drosophila occurs via an IFT independent pathway [125]. As a result, 
these factors place considerable limitations on the mechanisms to be gleaned from the use 
of such model systems.   
Hence, there is a strong need for vertebrate models to understand as well as 
validate finding from single-celled and invertebrate models. To this end, the use of 
vertebrate models like zebrafish, medaka, Xenopus, and mouse have been tremendously 
beneficial. These model systems enable the precise modeling of pathology of interest and 
 Motile cilia in health and disease 
 
27 
study the progression of a disease condition, along with opening up vistas for 
therapeutics.  
Given its developmental and genetic homology with humans, the mouse model is 
very promising. It indeed is, as seen from few of the examples discussed earlier in section 
1.6. However, a major challenge has been to obtain mutants in mice. Also, the mouse 
model is not conducive for rapid knockdown of genes, thereby limiting its applicability in 
carrying out large-scale screens to identify novel ciliary genes. Under these 
circumstances, is it possible to obtain rapid knockdown of genes in a vertebrate model? 
In this scenario, there is a model organism that can rise to this challenge - the zebrafish. 
The prominent features of the fish model, as well as its importance in ciliary research, 
have been summarized in the following discussion. 
The zebrafish as a developmental model attained spotlight in the 1980’s due to 
pioneering work by George Streisinger [126]. This caught the attention of several groups 
who further exploited the ability to use zebrafish to address a wide range of 
developmental questions, leading to the dawn of the zebrafish era.  
So what makes the zebrafish such a powerful model? Zebrafish model has several 
inherent features that make it particularly amenable to embryological and genetic 
analysis. Mating cycles typically produce large clutches of embryos that are fertilized 
externally, thereby ensuring abundance as well as ease to obtain embryos for analysis. 
The embryos are transparent and developmental time for most organ systems is short, and 
typically most of the organ systems are well developed within 2-3 days. These features 
enable development to be visualized in real time, using a combination of microscopic 
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approaches. This can be further extended to developmental analysis like lineage tracing 
of specific cell types as well as organogenesis.  
Another feature that has made zebrafish useful to developmental biologists is the 
ability to induce mutations and carry out screens to identify different aspects of 
development. In particular, the mutagen ENU (N-ethyl-N-nitrosourea) can be readily 
used to create mutants. Further, the ability to map and characterize the mutants thus 
obtained, has positioned zebrafish as one of the most powerful developmental models. 
Thus, it comes as no surprise that much research is ongoing to create zebrafish models for 
human disease. The optical transparency of the embryos, coupled with the ability to 
induce mutations, enables rapid scoring of phenotypes; thereby, making it particularly 
attractive to carry out large-scale mutagenesis screens. This was successfully 
demonstrated by large-scale ENU based screens carried out Wolfgang Driever, Nusslein 
Wolhard and others, who uncovered several mutants defective in various developmental 
processes [126, 127]. Interestingly, some of the mutants identified from their screen still 
continue to provide novel insight into human disease (a few examples have been 
discussed in chapter 2). In addition, the zebrafish genome has been sequenced and has 
revealed a high degree of homology with humans, indicating that results obtained from 
the analysis of zebrafish models have a direct bearing on understanding the basis of 
human diseases. The field has developed further, thanks to international collaborative 
efforts, to consolidate resources in the form of ZIRC (zebrafish international resource 
centre) which houses and supplies mutant and transgenic lines to researchers in need. 
Further efforts to integrate resources can be seen through the development of a useful 
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database- the ZFIN (zebrafish information network) where data from relevant studies are 
curated and stored online for ready access by interested investigators [128, 129].   
At present, the field is rapidly moving forward to a point of creating targeted mutants 
using an arsenal of reverse genetics tools like- the zinc-finger nucleases (ZFN) [130-132], 
Transcription activator-like effector nucleases (TALENs) [133, 134] and Clustered, 
regularly interspaced, short palindromic repeat CRISPR-Cas system [135-137]. Perhaps, 
the single most-important tool that can be well exploited in zebrafish is the ability to 
achieve a rapid knockdown of genes using antisense oligonucleotides called morpholinos. 
In this thesis, morpholinos have been used extensively to achieve efficient knockdown of 
genes.  
What are morpholinos? What are the advantages of the morpholino based approach in 
zebrafish?  
1.8.1 Antisense mediated gene knockdown in zebrafish: Morpholino-based strategy 
One of the daunting tasks for a geneticist is to create an effective knockdown of a gene 
under study. Making a mutant is often laborious as well as time consuming. Likewise, 
mapping of mutants already isolated from screens is often arduous. It is in the face of this 
challenge that the use of morpholinos has ushered in a revolution. 
 Morpholinos (MOs) are chemically synthesized short oligonucleotides of about 
25 base pairs (bp) in length. Chemically, they possess a six-membered morpholine ring, 
unlike DNA and RNA, which contain a five-membered ribose ring as seen in figure 1.7 
[138]. Despite this chemical difference, MOs can bind to its target RNA through the 
Watson-Crick base pairing. Further, this chemistry prevents degradation of MOs by 
nucleases and consequently imparting it with remarkable stability.  







Figure 1.7: Structure of a morpholino. 
Chemical structure of a MO (A), compared to the structure of DNA oligonucleotide (B). 
Redrawn from reference [138].   
 
 
Based on the mechanism of action, a morpholino (MO) can be classified as splice-site 
blocking or translational blocking. Splice-site MOs bind to the splice junctions of pre-
mRNA and inhibits the spliceosome machinery from processing the pre-mRNA. On the 
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other hand, translational blocking MOs bind to complementary sequences near the 
5’untranslated region within the proximity of the start codon, and prevent translation of 
maternal as well as zygotic transcripts, by blocking the assembly of ribosomes [138]. The 
efficiency of knockdown in case of a splice-site blocking MO can be readily assessed by 
performing an RT-PCR from RNA obtained from morphant embryos. Likewise, the 
efficacy of knockdown using a translational blocking MO can be evaluated by using 
suitable antibodies against the protein of interest. With this background, let me highlight 
some of the salient features and the advantages of using MOs in zebrafish.  
In zebrafish, MOs can be injected into a single-cell stage embryo and subsequently 
monitored for phenotypes arising due to knockdown of a particular gene [139]. As 
mentioned earlier, the ability to collect large numbers of embryos in a single session 
provides an abundance of material for large scale knockdown studies. Application of this 
reverse genetics approach in zebrafish has been hugely successful for various reasons and 
some of them are: 
• The ability to rapidly knockdown a particular gene as well as to target specific 
splice variants of a gene and assay the outcome of the knockdown. In addition, 
combinations of MOs can be administered to knockdown multiple genes. 
• Uniform distribution: MOs distribute very well in the embryo. Therefore, the 
issue of mosaicism due to improper distribution of an MO does not occur. 
• Easy to design and target alternate splice forms. 
• Spatial and temporal control of knockdown using a special kind of 
photoactivatable MOs [140]. These MOs can be activated upon exposure to a 
suitable light source at the desired time point.   
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• It is straightforward to test the efficiency of knockdown.  
From these features, it is clear that MOs are an excellent tool to achieve a 
knockdown of gene of interest. However, as with the use of any external chemical, one 
must be vigilant of non-specific off-target effects [141, 142]. A thorough analysis with 
appropriate control MOs is a must to rule out phenotypes arising from nonspecific effects 
of the MO. Several types of control MOs can be designed, ranging from the standard 
control MO to a gene-specific control.    
With that, I have illustrated the potential of zebrafish as an excellent 
developmental model, as well as covered some of the tools available at our disposal to 
exploit this versatile model. This raises the obvious question as to how to employ the fish 
model to study motile cilia.  
 
1.8.2 Zebrafish model to study cilia and PCD 
Several tissues in the zebrafish embryo differentiate motile cilia during development. 
This sub-section examines the distribution and function of motile cilia in zebrafish 
embryos. Further, the consequences of altered function have been explained in this sub-
section. For the sake of brevity, the discussion has been restricted to only those tissues 
that will be of relevance to the results discussed in this thesis: namely Kupffer’s vesicle, 
the otic vesicle, the pronephric duct and the spinal canal. What are the functions of cilia 
in above-mentioned tissues?  
The first tissue to differentiate motile cilia in the zebrafish embryo is Kupffer’s 
vesicle (KV), which is the organ of laterality in the fish embryo. KV is a transient 
spherical embryonic organ located at the posterior end of the tailbud. It is an enclosed 
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cavity which is lined by cells bearing mono motile cilia as shown in figure 1.8 A. 
Ultrastructurally, cilia in zebrafish KV have been observed to contain the 9+0 as well as 
9+2 arrangement of microtubules. As in the mammalian node, rotary counterclockwise 
beating of motile cilia in KV leads to a leftward fluid flow and consequent breaking of 
the left-right asymmetry [143]. Therefore, any disruption to ciliary length, and/or beating 
in KV would consequently lead to an altered LRA. In this respect, KV is functionally 
analogous to the mammalian node. The fish embryo provides an elegant system to image 
ciliary beating in KV as well as to assay the consequence of disruption of ciliary beating 
and flow. The results obtained by employing such an assay to record the motility profiles 
of embryos with knockdown of a subset of candidate genes with potential ciliary function 
has been reported in chapter 5. Further, consequences of an altered LRA in zebrafish can 
be easily scored by live and direct visual observation of organs like the heart. Alternately, 
readouts of sidedness like the left-sided expression of lefty2 can be scored in fixed 
embryos through in situ hybridization (results in chapter 5). Immunofluorescence based 
method to score for the sidedness has been presented in chapter 6.  
 




Figure 1.8: Motile cilia in zebrafish embryo.  
The panels show motile cilia in various tissues of the zebrafish embryo as visualized by 
labeling cilia with anti-acetylated tubulin antibody at two different developmental stages. 
Cilia present in KV at 8 somites are shown in panel A. Cilia are present in the pronephric 
duct (B) and the floor plate (C) at 24 hours post fertilization (hpf). White arrowheads in 




Therefore, KV is a versatile tissue to assay ciliary form and function. Earlier, I 
illustrated the possibility of using MOs to generate knockdown of a particular gene in the 
fish embryo (section 1.8.1). Essner et al. extended this further and demonstrated that 
knockdown of genes specifically in KV can be achieved by injecting MOs into the yolk 
at 512 to 1000 cell stage of development [143]. This provided a handle for researchers to 
fine-tune studies concerning ciliary motility in KV and LRA determination.  
Motile cilia are present in the inner ear (otic vesicle) of zebrafish embryos during 
early development. In the otic vesicle, ciliary motion is important for the proper 
development of mineralized particulate structures named otoliths. These otoliths are 
formed by coalescing of proteins and mineral particles like calcium carbonate, and are 
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important for sensing gravity. Ciliary motility is important to ensure proper dispersion of 
otolith precursors in the otic vesicle [144]. Thus, by 24 hours post fertilization (hpf), two 
distinct otoliths can be discerned in a wild-type embryo. However, perturbed ciliary 
motility often results in altered otolith counts. Hence, alterations in otolith counts can be 
suggestive of ciliary dysfunction in the ear.    
Motile cilia (9+2 configuration) line the kidney, or the pronephric duct (PND) of 
the zebrafish embryo, where they beat to clear fluid wastes from the duct. Interestingly, 
two distinct kinds of cilia- monocilia as well as multicilia can be seen in the PND. 
Initially, the duct is lined only by monocilia. However, post 30 hfp, bundles of multicilia 
can be seen in the PND in a “salt and pepper pattern.” A pathological consequence of 
altered ciliary beating in the PND is the development of kidney cysts, a feature 
reminiscent of the human kidney disease [145]. Screens have uncovered several genes 
with important functions in ciliary, as well as, kidney development with direct relevance 
to human disease. Furthermore, cilia in the PND can be visualized live, and in fixed 
preparations using immunofluorescence methods (figure 1.8 B). In addition, 
videomicroscopy tools can be employed to record and analyze ciliary motility in the 
PND. Therefore, the zebrafish PND provides a valuable opportunity to investigate ciliary 
structure and dynamics in a relatively easy manner and has applicability to human 
pathological conditions. 
 Cilia present in the spinal canal of the fish embryo (figure 1.8 C) beat to move 
the CSF in the spinal canal [145]. An alteration in ciliary beating leads to the 
accumulation of fluid in the brain causing hydrocephalus (discussed in section 1.6). 
Hydrocephalus is apparent in the affected embryos by 48hpf and is simple to score and 
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analyze. Similar to the PND, video microscopy tools can be used to image ciliary motility 
in the spinal canal. 
In addition to these features, the body of embryos deficient in ciliary function 
often takes a curved appearance unlike the wild-type embryo with a straight body. This 
makes it easy to visually screen for mutants or morphants with suspected ciliary 
dysfunction. Thus, the contribution of the zebrafish model towards understanding ciliary 
biology is immense. With the ability to rapidly knockdown genes and edit genomes, 
zebrafish is at the forefront of the developmental genomics revolution. Every aspect of 
fish development renders it to be suitable for experimental manipulation.  
The motile cilium is a complex organelle necessary for the development and 
survival of an organism. Hence to understand the biology of the organelle, it is important 
to identify its constituents. How are these components identified? The lessons learnt from 
several screens conducted in the past with an aim to identify ciliary constituents have 
been presented in the next section. 
 
1.9 Ciliome screens: successes and pitfalls 
Identifying the constituents of the cilium and characterizing their function is one of the 
biggest challenges in ciliary research. In fact, the first step in understanding the function 
would be to understand the form. So, to do that one needs to identify the molecular 
constituents of the cilium. This marked the beginning of a series of large-scale analysis 
by several groups that eventually culminated in identifying hundreds of proteins that 
make up the cilium [146].  
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Several screens have been conducted in the past few years aimed at characterizing 
the ciliary constitution. Depending on the experimental approach, these screens can be 
classified as proteomics or genomics-based. The proteomic approach relies on the 
isolation of cilia, centrosomes or centrioles, followed by separation of constituent 
proteins using tools such as gel electrophoresis, and finally identify peptides using liquid 
chromatography- mass spectrometry (LC-MS).  
In the first proteomic attempt, cilia from cultured human bronchial epithelial 
tissue were subjected to detergent extraction and gel electrophoresis followed by LC-MS 
[147]. The study yielded 214 proteins, including known components like tubulins, 
components of dynein arms and radial spoke proteins, and laid the foundation for 
identification of structural components of the cilia. This was followed by approaches 
where ciliary axonemes were isolated and proteins characterized from organisms like 
Tetrahymena thermophilus [148] and Chlamydomonas [149]. These proteomic screens 
were successful in the identification of structural components of cilia. Given the 
evolutionary conservation of ciliary morphology and structure, it is hardly surprising that 
these different approaches identified a core complex of components like kinesins, 
dyneins, tubulins and radial spoke proteins along with several uncharacterized proteins. 
Proteomic analysis has also been carried out on organelles like human centrosomes [150] 
and centrioles from Chlamydomonas [151]. Since cilia extend from basal bodies, the 
rationale here was to identify novel components of the ciliome that may have been 
missed by analysis of isolated ciliary axonemes alone. However, centrosomal proteome 
analysis is complicated due to the presence of large protein complexes constituting 
pericentriolar material, and it is not clear how many of these proteins also have a role in 
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ciliogenesis. Therefore, analysis of centrosomes and centrioles does not adequately 
represent the complex constitution of the cilium and can at best complement data already 
obtained by other studies. 
Although proteomic approaches have provided a structural definition of the 
cilium, they have inherent shortcomings. The detection of low-abundance proteins is a 
potential problem. Technical issues (such as losing proteins during the extraction process) 
are also important points to bear in mind while carrying out a proteomic screen. Another 
limitation of the proteomic approach is that it will fail to detect proteins with potential 
ciliary roles that do not localize to cilia [146]. 
On the other hand, genomics-based approaches aimed at characterizing the 
ciliome (genetic makeup of the cilium) have yielded a vast repertoire of genes with 
potential roles in the cilium. The availability of genome sequences of several organisms 
and the fact that several components of cilia are conserved makes it possible to perform a 
comparative genomic analysis to identify novel components of the ciliome. This has been 
notably exploited in two studies [151, 152]. Comparative genomic strategy relies on a 
subtraction analysis. Intersections between genomes of distantly related ciliated 
organisms like humans and Chlamydomonas yielded several conserved ciliary genes in 
addition to genes with housekeeping functions. Subtraction with the genome of 
Arabidopsis, a non-ciliated organism, allowed the elimination of the housekeeping and 
other non-specific genes. Thus, the resulting set was enriched for genes with potentially 
important roles in cilia.  
A common feature of lists generated by genomics approach is that they contain 
large numbers of genes, typically over 600. Hence, a validation step is required to 
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ascertain as to how many of these genes are involved in ciliogenesis or ciliary functions. 
Validation identified few genes with direct relevance to human ciliopathy [151-153]. 
However, the problem is that nothing can be said about the rest of the genes revealed by 
these studies. Also, data from studies using model systems like C. elegans that does not 
have motile cilia may not add substantial knowledge to the analysis of the motile ciliome 
[154, 155]. In fact, this is also true for the study exploiting Chlamydomonas flagellar 
regeneration [153]. Despite the conservation of ciliary structures between 
Chlamydomonas and vertebrates, several motile cilia genes of vertebrates are absent from 
Chlamydomonas. 
With many screens being conducted and a large list of components identified, 
there is a pressing need to integrate these studies as a resource for the community. 
Therefore, these studies have been integrated to form databases, which serve as an online 
resource for researchers interested in ciliary biology (figure 1.9) [146, 156]. These 
databases can be accessed at: 
1. Ciliome database: http://www.sfu.ca/~leroux/ciliome_database.htm 
2. Cilia proteome database: http://v3.ciliaproteome.org/cgi-bin/index.php 




Figure 1.9: Ciliary databases  
Studies from different screens are organized into databases for ease of access. Two such 
databases are highlighted here- the ciliome database on the left and the cilia proteome 
database on the right.  
 
 
From all these studies, it is clear that a vast repertoire of genes is required for the 
formation and function of the cilium. A major shortcoming, as revealed by these studies 
is the absence of a systematic functional analysis of the identified constituents. Most 
importantly, a vertebrate-specific, whole organism based screen with a thorough 
functional analysis is absent. This deficiency provided us with a distinct niche to explore 
and identify novel regulators of motile ciliary structure and function. This forms the basis 
of my thesis.  
1.10 Foxj1 as the master regulator of motile ciliogenesis 
An important starting point to address the above question is to discover if there is a 
principal regulator that could orchestrate motile ciliogenesis. From the previous section, 
it is clear that several groups have attempted to identify components that makeup motile 
cilia. While screens continue to extend the list of ciliary constituents, an unsolved puzzle 
 Motile cilia in health and disease 
 
41 
has been regarding a factor that unifies them all. In other words, is there a central 
regulator for motile ciliogenesis? The question is undoubtedly ambitious, for if such a 
regulator existed, it would lead us on a better path to understand the biology of motile 
ciliogenesis. 
Indeed, such a regulator exists as was demonstrated by work from our group as 
well as that of Chris Kintner’s group [157, 158]. The transcription factor Foxj1 is a 
member of the forkhead family of transcription factors and is both necessary and 
sufficient for motile ciliogenesis. The name forkhead is derived from the appearance of 
an ectopic head structure resembling a fork, in Drosophila mutant for the founding 
member of this gene family, fork head. Structurally, the forkhead domain possesses three 
α helices and three β-sheets which are connected to a pair of loops leading to a helix-turn-
helix DNA binding domain. Biologically, the forkhead transcription factors play key 
roles in development by regulating the expression of genes in diverse processes like 
apoptosis, cell-cycle, energy metabolism, longevity and organ development to name a 
few. 
Over the years, multiple lines of evidence suggested a possible link between 
motile ciliogenesis and Foxj1 based on expression analysis, mutant studies and cell 
biological investigations [69, 159, 160]. However, the turning point in the story came 
from two independent studies, which showed that Foxj1 was not only necessary but also 
sufficient for the biogenesis of motile cilia. Using two vertebrate models, zebrafish and 
Xenopus, our group and the Kintner group independently showed that the loss of Foxj1 
led to widespread loss of motile cilia from tissues differentiating motile cilia [157, 158]. 
In a dramatic twist, ectopic provision of Foxj1 was sufficient to induce functional motile 
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cilia, thus, providing clear-cut evidence that Foxj1 is not only necessary but is also 
sufficient for motile ciliogenesis in vertebrates [157, 158].  
Having established that Foxj1 is central to motile ciliogenesis, the next question 
to ask would be how does Foxj1 program motile ciliogenesis? Given that Foxj1 is a 
transcription factor and that it is a transcriptional activator, it is reasonable to hypothesize 
that Foxj1 may transcriptionally control the suite of genes required for motile 
ciliogenesis. This is indeed the case, as Yu et al. showed that several genes that encode 
components of the motile cilium are induced by Foxj1 [157]. For example, the expression 
of a suite of genes within cells that differentiate motile cilia, like dnah9 (encodes left-
right dynein, and is important for ciliary motility), cent2 (encodes centrin2, a key 
component of centrosomes), tektin1 (encoding tektin1 important for structural integrity of 
cilium), wdr78 (encoding a Wdr protein), efhc1 (encoding an EF hand containing protein) 
and a gene encoding dynein intermediate chain was dependent on Foxj1 [157]. This 
indicated that Foxj1 could activate the motile ciliogenic pathway through activation of 
genes encoding components of the motile cilium. Furthermore, this requirement is 
conserved in vertebrates [159]. 
While the role of Foxj1 as the master regulator of motile ciliogenesis is conserved 
in vertebrates, very little is known about its evolutionary history in other groups of 
animals. We carried out detailed bioinformatic analysis of diverse eukaryotic genomes, 
and found that foxj1 orthologs were present only within the unikont lineage [161]. Hence, 
to test the possibility of an evolutionary connection, we misexpressed tagged foxj1 
orthologs from different phyla like placozoa, platyhelminthes, and echinodermata in 
zebrafish embryos. Surprisingly, this ectopic expression led to strong induction of motile 
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ciliary genes in zebrafish indicating a conserved role for foxj1 in the regulation of motile 
ciliary genes. In addition, inactivation of foxJ1 in the flatworm Schmidtea mediterranea 
led to impaired motile ciliary differentiation [161]. Taken together, these findings 
confirm an ancient evolutionary association between Foxj1 and the motile ciliogenic 
program.  
Transcriptional control of ciliogenesis is complicated by the fact that there are 
other winged-helix transcription factors that are members of the regulatory factor X- rfx 
family, which have been shown to be important for ciliogenesis in invertebrate as well as 
vertebrate organisms. Members of this family, for example, Rfx2 and Rfx3 are expressed 
in ciliated tissues like brain, testes and the node. Loss of these genes leads to defective 
ciliary structure and functions, indicating the importance of these genes in regulating the 
expression of key ciliary genes [159]. Future work is needed in understanding the 
hierarchy and regulation of these genes. 
 
1.11 Foxj1: new paths to explore 
The discovery of Foxj1 as the master regulator of motile ciliogenesis raises several 
exciting possibilities. One is to identify as many genes as possible that are induced by 
Foxj1. Since Foxj1 regulates several aspects of ciliogenesis, it is possible that this 
exploration would lead to the discovery of novel regulators of motile ciliogenesis. Is there 
a systematic manner to identify and characterize a large cohort of Foxj1-induced genes? 
What is the relevance of these genes to human health and disease? How can the zebrafish 
model be exploited to characterize novel genes with potential ciliary function? The 
answers to these questions form the basis of the results discussed in this thesis. 
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In this chapter, I introduce the leucine-rich repeat containing (LRR) family and outline its 
importance in ciliary function as well as human health. I begin the chapter with an 
introduction to the Lr repeat, and then go on to discuss the findings that identified a role 
for the two known LRR proteins in the functioning of cilia and the pathogenesis of PCD. 
Finally, I conclude this chapter by highlighting the functional diversity of these proteins 
and the lacuna in our understanding of the functions of LRR proteins. This chapter forms 
the background for results reported in chapter 6.  
 
2.2 Leucine-rich repeat containing proteins: an introduction   
 
Proteins containing the Lrr are an evolutionarily conserved family of proteins found 
across all living organisms starting from viruses to humans. Leucine-rich repeat 
containing (Lrrc), as the name implies refers to a group of proteins containing a repeating 
unique motif that is rich in leucine (L). Biochemically, these repeats can be represented 
by a conserved 11 amino acid residue represented as LxxLxLxxNxL, where: 
L = leucine (can be substituted by isoleucine, valine, or phenylalanine)  
x = any amino acid  
N = cysteine, asparagine, serine or threonine [162].  
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The presence of two or more such residues in tandem constitutes the LRR domain, and 
these domains in turn can be present from 2 to 45 repeats in a protein as illustrated in 
figure 2.1.   
  
Figure 2.1: Generalized structure of an LRR  
L is leucine; x is any amino acid and N is cysteine, asparagine, serine or threonine 
 
The uniqueness and abundance of LRR containing proteins have attracted the 
attention of structural biologists who determined that the presence of LRR lends 
characteristic architectural attributes to a protein. Based on the crystal structure of an 
LRR containing protein, ribonuclease inhibitor, Kobe and Deisenhofer deduced that the 
presence of multiple LRR domains led to the formation of a curved or horseshoe-shaped 
structure in the protein [163]. This finding raised the question of the role of this particular 
design in the function of an LRR containing protein. The answer to this question came 
from further advances made by Kobe et al. who uncovered that the concave side of the 
horseshoe is the site for binding of a variety of ligands [164, 165]. Interestingly, the 
concave region can interact with several other proteins and provide an excellent platform 
for protein-protein interaction [166]. Since LRR containing proteins, by virtue of their 
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architecture can engage in protein-protein interaction, what functions do these proteins 
play in development and disease?  
The answer to the above question is far from being clear at the moment. However, 
studies from several groups have provided evidence that LRR proteins perform several 
important functions in the cell. Some of these functions include modulation of gene 
expression, DNA repair, recombination and immune modulation, to name a few [167-
169]. Interestingly, neurobiologists have uncovered several roles of LRR proteins in the 
developing nervous system [170].  
This brings up the challenges of studying the functions of LRR proteins. From the 
functional diversity of LRR containing proteins, clearly the mere presence of LRR does 
not ascribe a particular function to the protein. Unlike proteins with particular domains, 
from which its potential function can be gleaned, LRR proteins present a tough situation 
in that it is almost impossible to guess the function of a protein purely on the basis of the 
occurrence of LRR domains in it. In other words, given the diversity of roles performed 
by LRR proteins, it becomes extremely difficult to predict the function of any LRR 
protein. Another aspect that complicates the analysis further is the pleiotropic functions 
of LRR proteins. The importance of studying motile cilia has already been introduced in 
chapter 1. The introduction can be further extended to ask: What are the roles of LRR 
proteins in motile cilia? The following sections examine the role of LRR proteins in 
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2.3 LRRs and cilia: the human connection   
 
A sketchy connection between genes encoding LRR proteins and cilia emerged in early 
1990’s and early 2000 primarily from three different lines of investigation. The first was 
through the analysis of mutants for LRR encoding genes, secondly expression studies 
which showed the presence of LRR transcripts in regions containing motile cilia and 
finally to bolster it all, LRR containing proteins were discovered in the ciliary proteome. 
Again, the importance of these clues became apparent when mutations in LRR encoding 
genes were identified to cause PCD. All the pieces of the puzzle fell into place and 
culminated in the discovery that LRR proteins were crucial for the functioning of cilia 
and that mutations in LRR encoding genes can lead to PCD. Currently, mutations in two 
LRR encoding genes - LRRC50 and LRRC6 have been identified to cause PCD. What are 
their roles in motile cilia?  
2.4 Role of Lrrc50 and Lrrc6: Insights from model systems 
 
Insights from two model organisms - Chlamydomonas and zebrafish, have been 
instructive in decoding the functions of LRR proteins in cilia. The background of their 
discovery, details of their molecular functions in model systems, and finally, their roles in 
PCD is discussed in this section. 
2.4.1 Role of Lrrc50: Chlamydomonas leads the way 
Ciliary biology has richly benefited from the contributions of several model organisms 
due to its evolutionary conservation as seen in section 1.8. Further, the discoveries made 
in model systems have often had a direct impact on understanding the pathological basis 
of PCD. The KTU story (discussed in section1.5) is one such example. The discovery and 
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functional analysis of Lrrc50 and Lrrc6 is another such instance. The role of ODA7 
(Chlamydomonas ortholog of LRRC50) was initially discovered in Chlamydomonas, 
where it was identified as the protein responsible for the preassembly of ODA and IDA.  
Kamiya initially described the ODA7 mutant in 1988 [171]. However, the precise nature 
of its function was not known until later, when David R. Mitchell and colleagues showed 
that ODA7 encoded an evolutionarily conserved LRR domain containing protein [172]. 
Further, the absence of Oda7 led to a reduction in the swimming velocity of the mutants. 
Additionally, electron microscopy of mutant axonemes revealed a loss of the outer 
dynein arms [172]. It is not clear from this study if the assembly of inner dynein arm is 
affected. Taken together, these findings demonstrated the requirement of Oda7 in the 
assembly of the outer dynein arm.  
2.4.2 Lrrc50 and Lrrc6 are required for ciliary functions in zebrafish 
The requirement of Lrr proteins in motile cilia during vertebrate development was first 
identified in the zebrafish. As mentioned earlier in section 1.8, the late nineties saw the 
emergence of zebrafish as a promising vertebrate developmental model. This revolution 
was steered by a series of large-scale ENU mutagenesis screens designed to uncover 
different aspects of development of zebrafish. From a screen for mutations affecting 
development of midline and body shape, two mutants - switch hitter (tm317, figure 2.2)  
and tg238a were obtained among others (table 2.1) [173, 174].  
The tm317 mutants presented with features of ciliary dysfunction like the 
presence of curved body, as well as kidney cysts as seen in figure 2.2. J. Sullivan- Brown 
et al. followed the lead, mapped the tm317 mutation, and found it to disrupt lrrc50 (table 
2.1) [175]. Zebrafish Lrrc50 is a 562 amino acid protein containing six Lrr followed by a 
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leucine cap domain and a coiled-coil domain [175]. The findings from this study have 




Figure 2.2: Phenotype of lrrc50 mutant. 
Panel A is a wild-type zebrafish embryo at 5 days post fertilization. B is a tm317 mutant 
at the same developmental stage. Note the presence of CBA (blue arrowhead) and kidney 
cyst (red arrow). Figure obtained and modified with permission from reference [175]. 
 
 
Independently, Ellen van Rooijen et al. demonstrated that mutations in lrrc50 led 
to perturbed ciliary functions in zebrafish through the analysis of hu225H mutant [176]. 
The hu225H mutant was isolated from a forward genetic screen for mutations affecting 
ciliary motility and had large cysts in the kidneys. In addition, the mutants were also 
observed to have defects in LRA, consistent with defective ciliary function [176]. In the 
mutants, a mutation in exon 4 of lrrc50 converted leucine at position 88 to a stop codon 
as shown in table 2.1 [176]. To verify the genetic basis of this mutation, rescue 
experiments were carried out. Ectopic provision of full length Lrrc50 was able to rescue 
the phenotypes of mutant embryos significantly. However, injection of a truncated 
version of the construct in which the first Lrr domain was deleted led to no rescue of the 
phenotype. This indicated that the Lrr domain in Lrrc50 is necessary for its function. 
Furthermore, the authors confirmed the observations by David R. Mitchell and colleagues 
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[172] regarding the ultrastructural deficits in lrrc50 mutants. Similar to ODA7 mutants in 
Chlamydomonas, axonemes of lrrc50 mutant were devoid of both the DA. These findings 
provided further proof that Lrrc50 was important for the assembly of ODA and IDA. 
Also, the mutation maps to the Lrr precisely, thus indicating that the Lrr domain is crucial 
for the functioning of the protein [176].  
These studies have highlighted the importance of Lrrc50 in the structure and 
function of cilia even though the precise molecular mechanism has not been identified. It 
was mentioned in section 2.4 that zebrafish mutants have been instrumental in identifying 
the function of two LRRs in PCD. The functions of one of them - Lrrc50 has been 
discussed above. What about the other one - Lrrc6? What insights about the functions of 
Lrrc6 have been gleaned through analysis of zebrafish mutants?  
Like lrrc50, zebrafish mutants provided the first insight into the functions of 
Lrrc6 in ciliary structure and function. Several screens have isolated mutant for Lrrc6 and 
the mutants presented with kidney cysts. The tg238a mutant originally obtained from the 
Tubingen screen [173] was mapped by Serluca F.C et al. and found to disrupt Lrrc6 
[177]. In addition, the fa20r mutant isolated in another screen for kidney cysts (figure 
2.3), was similarly found to disrupt Lrrc6 [177].  
 
 




Figure 2.3: Presence of kidney cysts in lrrc6 mutants.  
Two different strains carrying mutations in lrrc6 (panel B and C) are compared to a wild-
type sibling (A) at 5dpf. Note the presence of large kidney cysts (black arrow) and CBA. 
Figure obtained with permission from [177].  
 
Likewise, Nancy Hopkins and colleagues discovered that mutations in seahorse (sea) led 
to the development of CBA and kidney cysts in zebrafish embryos [178, 179]. Given this 
background, what is the function of the product encoded by sea? What is the connection 
between sea and cilia? The solution emerged four years later from the combined work of 
Kishimoto N et al. [180] and Serluca F.C et al. [177]. 
Kishimoto et al. further characterized the seahorse mutant - hi3308 obtained from 
an insertional mutagenesis screen [178] to identify genes causing kidney cysts [180]. In 
addition to curved body and kidney cysts, they observed that LR symmetry was grossly 
affected in the sea mutants. They further discovered that sea encoded a conserved Lrr 
containing protein, which was the ortholog of the human LRR encoding gene- LRRC6 
(lrrc6 or lrrc6l in zebrafish). Subcellular localization analysis revealed that Lrrc6 
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localized to the cytoplasmic puncta in tissues bearing motile cilia. Also, the expression 
pattern of lrrc6 in the zebrafish embryo was restricted to tissues expressing motile cilia 
like KV, the otic vesicle, the PND and the floor plate of the neural tube suggesting a 
possible ciliary role for lrrc6 [180]. This finding is similar to an earlier observation by Ji-
Chun Xue and Erwin Goldberg; who identified a novel testis-specific LRR protein during 
mouse spermatogenesis, and named it as LRTP [181] (subsequently identified as 
LRRC6). Similarly, work from McClintock and colleagues also predicted Lrrc6 as a 
potential ciliary gene based on its expression in mouse ciliated tissues [182]. However, 
the presence of a particular transcript in a tissue does not indicate the type of function it 
may be involved in. A case in point is LRRC52, which is present in the testis, but has no 
ciliogenic role [183]. Then, what is the actual role of Lrrc6 in cilia?  
Kishimoto et al. examined cilia in sea mutants and morphants and found no 
differences in the length and density of cilia when compared to the wild-type [180]. 
Perplexingly, even ciliary beating was normal. This is counterintuitive to what would be 
expected in embryos presenting with kidney cysts. To confound the problem, no 
ultrastructural abnormality in ciliary architecture was observed in sea mutants. These 
conflicting observations raised the question if Lrrc6 had a dedicated function in cilia?  
It is in this context that the work from Serluca F.C et al. attained importance as 
they showed for the first time that Lrrc6 was necessary for proper ciliary architecture and 
function through the analysis of sea tg238a and sea fa20r mutants (table 2.1) [177]. Lrrc6 
is a 440 amino acid protein containing four Lrr domains with an Lrr cap and a coiled-coil 
domain. What were their findings? What new insight did it provide about the function of 
 Leucine-rich repeats in cilia and ciliopathies 
 
54 
Lrrc6? In the subsequent section, a comparative analysis of findings from Lrrc50 and 
Lrrc6 mutants has been presented. 
  
Table 2.1 Mutants used for analysis of Lrr functions in zebrafish  
Mutant  
 












T/A mutation, converting 
leucine to a stop codon 






Missense mutation L93P 













Transition 702C to T, 
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2.4.3 Ciliary length is unaffected in mutants for lrrc50 and lrrc6 
Since, the lrrc50 and lrrc6 mutants presented with kidney cysts suggestive of impaired 
ciliary function; it is not surprising that the authors turned their attention towards cilia 
[175, 177]. Reduction in ciliary length in the PND causes impaired fluid clearance and 
consequently leads to the development of cysts. In this setting, it is natural to probe if the 
cysts observed in the mutants arose from any alterations in ciliary length. Surprisingly, 
examination of cilia in the pronephric duct revealed no alteration in the length of the 
cilium. Ciliary lengths in the lrrc50, as well as the lrrc6 mutants, were comparable to that 
of the wild-type as shown in figure 2.4 [175, 177].  
  
 
Figure 2.4: Ciliary length is unaffected in lrrc50 and lrrc6 mutants.  
Panels A to D show pronephric duct cilia (green) of wild-type (A, C) and lrrc50 mutant 
(B) and lrrc6 mutant (D) stained with anti-acetylated tubulin antibody at 27hpf. Nuclei 
appear in blue color in all the panels. There is no apparent difference in length of cilia 
between wild-type and mutants. Figure modified with permission from references [175, 
177]. 
 
Considering that ciliary length in the mutants is unaltered, what is the cause of 
kidney cysts in these mutants? Could a perturbed motility be the cause?  
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2.4.4 Ciliary motility is affected in lrrc50 and lrrc6 mutants 
Ciliary motility in the PND was assessed using direct live videomicroscopic assay. 
Interestingly, lrrc50 mutants displayed a complete absence of motility while lrrc6 
mutants had very low to almost absent motility [175, 177]. Thus, the identification of 
altered motility helped to explain the development of cysts in the mutants as altered 
motility would impair fluid clearance in the duct and lead to cysts. Further, J. Sullivan- 
Brown et al. followed the motility profile of cilia in the PND starting from 26-30 hpf to 3 
days post fertilization (dpf). They found that in the wild-type, ciliary beating was 
observed as early as 26hpf, although coordinated beating was visualized only by 2 dpf. In 
contrast, lrrc50 mutants completely lacked motility all the way from 26 hpf. These 
observations revealed an important finding that the immotility of cilia preceded the 
development of cysts [175]. Serluca F.C et al. used a similar assay and discovered a 
similar dysmotilty pattern in lrrc6 mutants [177]. This was in direct contrast to findings 
from Kishimoto et al. who reported ciliary motility to be unaffected in hi3308 mutants 
[180]. Surprisingly, the effect of the loss of Lrrc6 is not very pronounced in KV as beads 
injected into KV were found to flow in a strong counter clock movement in 20% of the 
embryos. The authors argue that this could arise due to the maternal contribution of lrrc6 
[177].    
 In another contrasting finding from the hi3308 study, Serluca F.C et al. reported 
that ciliary axonemes from lrrc6 mutant fish embryos are devoid of ODA and IDA [177]. 
The absence of dynein arms explained the lack of ciliary motility as observed in lrrc6 
mutants, and is similar to what was observed for lrrc50 mutants. Based on the 
experimental evidence, it can be concluded that loss of Lrrc50 and Lrrc6 leads to a loss of 
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DA and consequent ciliary dysmotility that is the primary cause of cysts in the mutants. 
These findings are in agreement with the work from Sun et al. that mutation in ciliary 
genes is the primary cause of kidney cysts [178]. I have elaborated on how these studies 
have advanced our understanding of ciliary functions in human health in the next section.  
 
2.5 Mutations in LRRC50 and LRRC6 cause PCD   
Given the overwhelming data supporting ciliary roles for lrrc50 and lrrc6 from model 
organisms, one would expect that it is a matter of time before these genes were 
implicated in PCD. This is indeed the case, as recent evidence identified mutations in 
LRRC50 and LRRC6 to be the genetic basis of PCD in a subset of cases. Key findings 
from these studies are summarized in this section.  
2.5.1 Loss of LRRC50 leads to ciliary dysfunction    
Loges et al. carried out whole-genome scans to identify mutations in a cohort of seven 
consanguineous PCD families with confirmed loss of ODA and IDA [35]. From the hits 
obtained from the single nucleotide polymorphism (SNP) arrays, they narrowed down on 
LRRC50 as a potential candidate based on existing evidence from Chlamydomonas and 
zebrafish. Likewise, Philippe D et al. used a similar reasoning and directly screened for 
mutations in LRRC50 in 24 cases of PCD with a confirmed loss of ODA and IDA [36]. 
Both the studies identified mutations in LRRC50 to underlie the genetic basis of PCD in a 
subset of these patients. In the patients, large deletions as well as missense mutations in 
LRRC50 were observed. Further, the mutations were recessive with carrier parents being 
unaffected.    
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The affected individuals presented with several clinical features arising due to 
ciliary dysfunction like bronchitis, sinusitis, chronic infections of the upper and lower 
airway, infertility and ‘situs inversus’ to name a few. A videomicroscopic examination of 
respiratory cilia showed a complete lack of motility with ciliary beat frequency of zero. 
Further, the axonemes from the patients showed a drastic loss of both ODA and IDA 
complexes [35, 36]. As discussed in section 1.5, these complexes are critical for motility, 
and the loss of the dynein arms will result in dysmotile cilia. Additionally, 
immunofluorescence microscopy using antibodies listed in table 2.2 revealed that the 
components of DA are missing from the ciliary axonemes of the patients (figure 2.5) 
[35]. Unlike the control, no or very little fluorescence was observed in the ciliary 
axonemes of the respiratory epithelium from a PCD patient with a loss of LRRC50 
(figure 2.5B-E).  
 
       Table 2.2 Markers used for to determine the localization of the dynein arms 
Marker for Antibody  Expected wild-type Localization 
Outer dynein arm 
DNAH5 Entire axoneme 
DNAI2 Entire axoneme 
DNAH9 Proximal part of the axoneme 
Inner dynein arm DNALI1 Entire axoneme 
 
These studies provide a good example of how knowledge obtained from model 
systems can be used to advance the understanding of PCD. 
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Figure 2.5: Effect of loss of LRRC50 on other ciliary components. 
Loss of LRRC50 leads to loss of the components of the ODA and IDA from respiratory 
epithelial cells of PCD cases arising due to mutations in LRRC50. Panels B- E compares 
the localization of components of the ODA and IDA in an unaffected control versus 
patient (OP250-II1) respiratory epithelial cells. The cells are also visualized using DIC 
microscope. From the panels, it is clear that the axonemes are either devoid or have 
reduced immunoreactivity against antibodies for the dynein arm components. Figure 
obtained with permission from reference [35]. 
 
 
Loges et al. identified Lrrc50 to be expressed in the mouse node during early 
gastrulation embryos and in ciliated cells of the upper airways [35]. This is in agreement 
with the observations of Philippe D et al., that the expression of human LRRC50 was 
restricted to adult trachea and testis [36]. Interestingly, Loges et al. do not detect any 
expression of Lrrc50 in the mouse kidneys [35]. This is consistent with the findings from 
both the groups regarding the absence of cysts in their PCD patients [35, 36]. The authors 
argue that this discrepancy in the expression pattern, as well as phenotypes, could arise 
from differences in the embryological origins of zebrafish and human kidneys.  
Philippe et al. used the information from PCD patients and provided further 
insights into the functions of LRRC50 using a combination of biophysical and genetic 
tools in Chlamydomonas and Trypanosoma brucei [36]. From the LRRC50 mutations 
identified, the effect of one of the variants (p.Leu175Arg) was modeled in 
Chlamydomonas. The authors reported that the residue Leu92 (the functional equivalent 
of human Leu175 in Chlamydomonas) in Oda7 is evolutionarily conserved and is 
necessary for the hydrophobic nature of the LRR arcs. The disruption of this residue 
would likely lead to loss of function of LRRC50 protein. The authors tested this 
hypothesis by performing rescue experiments in Chlamydomonas ODA7 mutant. 
Expression of wild-type ODA7 rescued the motility phenotype of ODA7 mutants. 
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However, expression of mutant versions L92R or L92D did not rescue the phenotype 
demonstrating the importance of the LRR domains for proper function of LRRC50. They 
further strengthened the analysis by demonstrating that loss of LRRC50 ortholog in 
Trypanosoma brucei led to a loss of ODA from flagellar axonemes and consequent loss 
of motility [36]. Taken together, these studies highlighted that LRRC50 is a critical 
regulator of the assembly of the dynein arms. In view of this function, LRRC50 is also 
known as DNAAF1 (discussed in section 1.5). Further, like the zebrafish Lrrc50, LRR 
domains are specifically required for this process [36]. This brings us to the question 
regarding the function of LRRC6. Is there an evidence linking mutation in LRRC6 to 
PCD?  
 
2.5.2 Loss of Lrrc6 leads to ciliary dysfunction    
Even though studies in zebrafish ascribed a bona fide role for Lrrc6 in ciliary motility, it 
was not until recently that studies showed mutations in LRRC6 to be the cause of PCD 
[40, 41]. Kott et al. used a candidate-based approach and suspected the role of LRRC6 in 
a cohort of PCD cases, based on strong evolutionary backing from diverse model systems 
[40]. For example, the zebrafish sea mutants (discussed in section 2.4.4) provided 
irrefutable evidence that loss of Lrrc6 led to an absence of DA from ciliary axonemes, 
accompanied by a concomitant loss of ciliary motility [177]. In addition, the loss of tilB 
(LRRC6 ortholog) in Drosophila led to infertility of male flies [184], highlighting the 
possibility of LRRC6 as a potential candidate for PCD. Kott et al. performed a 
homozygosity mapping of seven cases of PCD with a confirmed loss of both the outer 
and the inner dynein arms and identified a list of twenty potential candidates. As 
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expected, the loss of DA rendered cilia immotile. From this list, they narrowed down on 
LRRC6 based on the overwhelming supporting evidence listed above. Sequence analysis 
of LRRC6 revealed the presence of mutations that resulted in a premature truncated 
version of LRRC6. This study provided the first evidence that the loss of function of 
LRRC6 resulted in PCD [40].  
 Horani et al. advanced the story further by using an elegant system of shRNA 
mediated knockdown of LRRC6 in human airway cells in culture [41]. Using this setup, 
Horani and colleagues were able to recapitulate dynein arm defects observed previously 
by electron microscopy in PCD cases arising due to mutations in LRRC6. Further, ciliary 
differentiation was not affected upon knockdown of LRRC6. However, the motile cilia 
had a very significant reduction in beat frequency [41].  
The decisive finding that Horani et al. advanced over the previous studies was that 
of the transcriptional connection between FOXJ1 and LRRC6. Their study used 
differentiating human tracheal epithelium in culture, and identified that the expression of 
LRRC6 was dependent on FOXJ1. Furthermore, loss of FOXJ1 led to a marked reduction 
of LRRC6; indicating that FOXJ1 can regulate the transcription of LRRC6 [41]. These 
observations are in agreement with previous findings that Foxj1 is the master regulator of 
motile ciliogenesis [157, 158]. 
Given the similarity in structural deficits due to mutations of LRRC50 as well as 
LRRC6, it begs the question if these proteins are redundant? It appears from these studies 
that they are not and further; LRRC6 is a new player, required for the cytoplasmic 
preassembly of the dynein arms. Additionally, the literature discussed so far has provided 
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compelling evidence for a direct requirement for LRRC50 and LRRC6 in the function of 
motile cilia and its impact on human health.  
 
2.5.3 Interaction partners for LRRC50 and LRRC6: A fleeting glimpse 
 
 Taking together all the experimental evidence, it is clear that LRRC50 and LRRC6 play 
non-redundant roles in the cytoplasmic preassembly of DA, and by extension; are 
indispensable for ciliary motility. Thus posing a question of how do these proteins 
function in the cell? Who do these proteins partner with in order to achieve this molecular 
assembly of dynein arms? Unfortunately, there are fewer answers at the moment. While 
the interaction partners for LRRC50 remain to be identified, two recent reports from last 
year have identified few partners for LRRC6. Two studies from last year identified 
mutations in a gene encoding a zinc finger, MYND-domain-containing protein 
ZMYND10, as being causative of PCD [185, 186]. Ciliary defects include immotile cilia 
with a loss of ODA and IDA in Drosophila, zebrafish and humans. Further biochemical 
analysis confirmed that ZYMND10 interacts with LRRC6; raising the possibility that 
ZYMND10 functions with LRRC6 in the preassembly of DA.   
In another study, Lrrc6 was found to interact with a helicase Reptin [187]. Loss of 
Reptin compromised ciliary motility and presented with ultrastructural defects 
reminiscent of the loss of Lrrc6. Further, a yeast two-hybrid screen identified Reptin as 
the binding partner of Lrrc6. This interaction was confirmed by a co-immunoprecipitation 
assay. Thus, this study identified a new Lrrc6 interactor - Reptin which functions in the 
formation of dynein arms and may be a potential candidate gene for PCD [187].  
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These studies are very significant in that it provides direct evidence that proteins 
with functions in other biological processes can also have a parallel ciliary role. 
Conversely, proteins with ciliary roles can participate in other biological processes. An 
example is the role for LRRC50 in cancer as is shown by Basten S.G et al.[188]. In the 
absence of identified interactors, the precise pathways in which these LRR proteins 
operate remain a mystery.  
 
2.6 LRR and cilia: Unanswered questions 
 
The analysis of LRR proteins has raised more questions than answers. How is functional 
diversity imparted to an LRR containing protein? What is the function of individual LRR 
domains in an LRR containing protein? Where does the specificity of function arise? 
How is the activity of LRR proteins moderated in a cell? How do the known LRR 
proteins balance ciliary as well as non-ciliary roles? The list of questions is endless, and 
the take home message is that LRR proteins are necessary for the proper functions of 
motile cilia. Also, we have just begun to understand the roles of these proteins in cilia and 
have a long way ahead.   
 
2.7 Concluding remarks 
 
To conclude, LRR members are an interesting as well as important group of proteins in 
ciliary function and human health. However, the understanding about the molecular 
functions of these proteins is inadequate. As discussed earlier, zebrafish provides an 
excellent system to discover novel genes with direct relevance to PCD. Hence, combining 
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these aspects, there is an excellent window of opportunity to identify and characterize 
these genes in greater detail. Therefore, I pursued a detailed analysis of genes encoding 
Lrr proteins and selected one such candidate for detailed characterization. The rationale 
and results of what has been uncovered from such an investigation will be the basis of 
chapter 6.  
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Chapter 3 : Hypothesis, Rationale and Objectives 
 
 
3.1 Hypothesis, rationale and objectives of this thesis 
 
From the introduction, it is clear that motile cilia are indispensable for the physiological 
homeostasis and the development of an organism. Surprisingly, the field stands today at a 
point, where we are yet to understand the genetic makeup of motile cilia in its entirety. 
From studies on PCD, it is clear that we are far from having identified all components of 
motile cilia. There are two important points to be noted here that include the 
identification of novel components important for motile cilia and evaluation of the 
contribution of these components in motile cilia. Several prior screens, in particular the 
genomics-based screens have made very limited advances over the second aspect. 
Therefore, there is a pressing need to identify and validate novel genes for roles in motile 
cilia formation and function.   
Armed with the discovery that Foxj1 is the master regulator of motile 
ciliogenesis, we hypothesized that identifying and characterizing genes induced by Foxj1 
will help identify novel genes with roles in the structure and function of motile cilia. To 
test this hypothesis, we designed a screen to identify genes induced by Foxj1 (Foxj1-
induced genes or FIGs) and furthermore, validate and uncover ciliary functions for some 
of the targets.  
In chapter 2, I have highlighted the emerging importance of a class of proteins 
with leucine-rich repeats in motile cilia. The discussion on the roles of LRRC50 and 
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LRRC6 makes it is clear that LRR proteins play crucial roles in ciliary structure and 
function, and directly affects human health through its association with PCD. The 
discussion further sheds light on the fact that our current understanding of LRRs in cilia 
and ciliopathies is extremely limited. Our analysis of FIGs uncovered several novel genes 
encoding Lrr proteins. Taking this into consideration, we hypothesized that analysis of a 
subset of FIGs that encode Lrr members will uncover novel regulators of motile 
ciliogenesis. To test this hypothesis, I designed a screen to identify and characterize novel 
Lrr encoding genes important in the structural and function of motile cilia. From the hits 
obtained, I pursued the detailed characterization of a novel Lrr encoding gene- lrrc9.  
Hence, in broad terms, the objectives of the present study reported in this thesis 
are to identify and characterize novel genes necessary for the development, structure and 
function of motile cilia in human health and disease.   
The specific aims of this thesis are: 
I. To identify and characterize FIGs. The detailed strategy of the screen, as 
well as the results obtained, has been elaborated in chapter 5.  
II. To characterize the function of a novel leucine-rich repeat encoding gene 
lrrc9 in motile cilia. The discovery, as well as my experimental findings has 
been discussed in chapter 6. 
Our rationale to carry out these screens using a vertebrate model - the zebrafish is based 
on the high degree of conservation of components of motile cilia between zebrafish and 
humans coupled with ease of knockdown of genes in zebrafish.  
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4.1 Zebrafish strains and husbandry 
 
Danio rerio used in the studies described in this thesis, was reared according to standard 
protocols at the Institute of Molecular and Cell Biology-IMCB’s fish facility. Fish strains 
used in this study were maintained according to established zebrafish husbandry 
protocols. The facility has a controlled temperature of 28.5°C and operates a 14-hr light 
and 10-hr dark light cycle. Strains used in this thesis are listed in the table 4.1 below. The 
Singapore National Advisory Committee on Laboratory Animal Research approved 
experiments with zebrafish. 
Table 4.1 zebrafish strains used in this thesis 











AB  Wild-type 
hsp70::foxj1a Used to overexpress Foxj1 
foxj1a::gfp Used to visualize tissues where Foxj1a 
is expressed based on GFP 
fluorescence 




4.2.1 Microinjection of morpholinos and phenotypic observations 
Morpholino oligonucleotides were synthesized and purchased from GeneTools LLC. The 
morpholinos were reconstituted with double-distilled sterile water to obtain a 
concentration of 1mM and stored at room temperature. Initially, an injection volume of 
0.5 and 0.75nl was injected into the animal pole of 1-cell stage zebrafish embryos using a 
N2 gas injector (PLI-100 from Harvard Apparatus). The development of injected embryos 
was followed and noted for appearance of phenotypes like otolith defects, CBA, 
hydrocephaly and kidney cysts under a stereomicroscope. Injections with embryos 
exhibiting 25% and above lethality and/or developmental defects were rejected. 
Injections were repeated with reduced doses and observed for phenotypes. For each 
morpholino, data was collected from two-independent trials. Injections were coded and 
randomized to prevent bias. To test for significance, Fisher’s Exact test (2*2 matrix and 
two-tailed) was used for the phenotypic scores. As shown in table 4.3, the following 
cutoff was chosen for each phenotype. The cutoff was selected to be highly stringent, 
based on observations of wild-type and control-MO injected embryos.  
 
Table 4.2 List of MOs used in this thesis 
Gene 
Symbol/Name 
Gene Description  CG Code Morpholino 
Number 
Morpholino Sequence (5'->3') 
aftphb aftiphilin  CG045 CG045_MO3 TCAACCTGAGAGTGA
TAGAAAACAC 
ak9 adenylate kinase 9  CG010 CG010_MO1 GAAGAGGAATTCAAT
GGTTTACCTC 
arhgef18b rho/rac guanine 
nucleotide exchange 
factor (gef) 18  
CG014 CG014_MO4 AAGTTTCTGCTGGAT
CTCACCTTGC 
bx470211.1 n/a CG063 CG063_MO3 TACCTGAAAGTGAGT
GGAAGGCCAA 
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c18h15orf26 chromosome 15 open 
reading frame 26 
CG021 CG021_MO1 AGTGTTCAAACAACA
AACCTCTTCT 
c20h6orf165 chromosome 6 open 
reading frame 165 
CG005 CG005_MO1 ACGTTACTTCAGACT
CACCATGAAC 
c24h11orf65 chromosome 11 open 
reading frame 65  
CG025 CG025_MO4 GTATCCTATACATGA
CAGGCACGGT 
c6h3orf67 chromosome 3 open 
reading frame 67 
CG006 CG006_MO1 AGGACCAATTTTCCC
CTAACCTCGA 




ces3 carboxylesterase 1 CG057 CG057_MO4 GCACCTGTAATGCAG
CAAGAGAAGA 




clic6 chloride intracellular 
channel 6  
CG043 CG043_MO2 TACAGCAAGAAAGTC
TTACCTTCAC 
cma1 (1 of 
29) 






ct573248.1 syntaxin 19 CG035 CG035_MO1 GCAGCTCCTCCATGC
GGTCCTTCAT 
dlec1 deleted in lung and 
esophageal cancer 1 
CG017 CG017_MO1 TGATGTAAACATAGA
GGGACCTGTT 




ect2l epithelial cell 




fank1 fibronectin type iii and 
ankyrin repeat domains 1  
CG049 CG049_MO1 AACTGAGTGCAGAAT
TCACTTGTGT 
fgfbp2b fibroblast growth factor 
binding protein 2 
CG003 CG003_MO1 GGGTCATTGAGTAAG
GTACACATCC 
hhipl1 hhip-like 1  CG034 CG034_MO2 GAGAACATTCCTGAA
GACAAACAGA 
il1rapl2 interleukin 1 receptor 
accessory protein-like 2  
CG061 CG061_MO1 TGAGGATAATAATTC
TGTACCTTGT 
illr4 c-type lectin domain 
family 4, member m 
CG056 CG056_MO1 TTAACTTAAGAGTGT
TTACCTGTGA 
iqcg iq motif containing g CG004 CG004_MO1 GTATTTCAGTTCATC
TTAAAACCTG 
kcnip1a kv channel interacting 
protein 1  
CG011 CG011_MO2 AGAACAGAGAGAAA
CGTCACCTCAA 
kif6 kinesin family member 6 CG042 CG042_MO1 GGTCAAAATTGAGAC
TGACGGTAAA 
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lace1b lactation elevated 1 CG041 CG041_MO3 TTGGCACACACAAAC
CGTACCTCTT 
lrtomt leucine rich 
transmembrane and o-
methyltransferase 
domain containing  
CG058 CG058_MO1 ACATGGGTATTGTTC
ACATACTGAA 
magi3 (1 of 3) membrane associated 
guanylate kinase, ww 




masp1 mannan-binding lectin 
serine peptidase 1 (c4/c2 
activating component of 
ra-reactive factor)  
CG052 CG052_MO1 ACATAACATCCACTT
ACCTTTAGGT 










specific phospholipase c, 
x domain containing 2 
CG020 CG020_MO1 GGCAGAAAAGGTCTC
TCACCAGGAA 










ric8 guanine nucleotide 















chromosome 6 open 











myosin xvb pseudogene CG008 CG008_MO1 AAATTTATTCACTTA
CCCATGAAGC 
slc43a3a solute carrier family 43, 
member 3  
CG040 CG040_MO3 ACCGCAGTCTAAAGA
GAAAAGCAGA 








tp53bp2 (2 of 
2) 
tumor protein p53 
binding protein, 2  
CG054 CG054_MO1 GTGTGTCAGCAGCAC
CTACCAGATC 
trak1 (2 of 3) trafficking protein, 
kinesin binding 1 
CG059 CG059_MO1 AGTCAGTAACACACA
CTCACGGTGT 
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ttll7 tubulin tyrosine ligase-
like family, member 7 
CG028 CG028_MO1 GAATCTGAAAACCCC
AATACCTGAT 
wdr27 wd repeat domain 27 CG016 CG016_MO1 GTACTATTAGTGCAC
AATAACCTCC 
zbbx zinc finger, b-box 
domain containing  
CG001 CG001_MO2 TCTGAGGAGAAAAG
ACTTACTCTGT 
zgc:153738 iq motif containing with 
aaa domain 1  
CG012 CG012_MO2 AAACACTCTATTGAA
ACTCACAGGG 
control mo n/a n/a Control_MO CCTCTTACCTCAGTT
ACAATTTATA 
 lrrc9  leucine-rich repeat 
containing 9 
 n/a lrrc9_SpMO1   GATCTTTCCTGTAAC
TTACATTCAA 
 
Table 4.3 Cut-off values for phenotypes 
Phenotype Cut-off percentage 






4.2.2 Microinjection of RNA 
To study ciliary motility, 200ng/µl of RNA encoding Arl13b-GFP was injected along 
with the relevant FIG-morpholino. 
For localization, lrrc9myc RNA (250ng/µl) was injected into 1-cell stage embryos. The 
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4.3 Whole mount immunohistochemistry on zebrafish embryos 
 
Embryos used for immunohistochemistry were fixed for 2hrs in Fish Fix (containing 4% 
paraformaldehyde, 4% sucrose and 120µm of CaCl2 dissolved in water) on a nutator at 
room temperature. After 2hrs, the fixed embryos were washed with PBS for 2hrs at 
30min intervals. After the last wash, PBS was removed 1 ml of absolute methanol was 
added and the embryos were stored in -20oC. Embryos stored in methanol can be kept for 
up to a year. For the staining, methanol was removed and embryos were re-hydrated in 
progression from 75%, 50% and 25% methanol to PBS. Embryos were finally washed in 
PBS at 2-min interval for 4 times. After last wash, PBS was removed and 1ml of ice-cold 
acetone was added to the embryos for 7mins in -20oC for cracking step. The acetone was 
removed and embryos were washed with PBS at 2min interval for 4 times. After last 
wash, PBS is removed and blocking solution consisting of 2% sheep serum diluted in 
PBDT (PBDT consist of 1% BSA, 1 % DMSO and 0.5% Triton-X100 diluted in PBS and 
stored at 4oC) is added to the embryos. Blocking is carried out for 1hr at room 
temperature in a glass cavity-dish on a nutator. Primary antibody is added and the dishes 
are incubated overnight in 4oC. Next day, the primary antibody is washed off with PBDT 
for 2hr at 30min interval. Secondary antibodies (1:500 dilution) are subsequently added 
(Alexa antibodies purchased from Invitrogen were used as secondary antibodies) and 
incubated at room temperature for 4 hrs. Secondary antibodies are then washed off by 
PBS washes for 2 hours at 30 min intervals. Stained embryos were mounted using 70% 
glycerol. DAPI was added during the third wash.  
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Table 4.4 List of antibodies used 
Name of antibody Company Dilution 
A4.1025 (myosin heavy 
chain) 
Developmental Studies 
Hybridoma Bank (DSHB) 
1:10 
Anti-GFP (rabbit, #TP401) Torrey Pines 1:500 
Anti-Myc #sc-789 Santa Cruz 1:200 
Acetylated tubulin (mouse, 
#T6793) 
SIGMA 1:500 





4.4 lefty2 in situ hybridization 
 
Plasmid containing cDNA of lefty2 was linearized by digestion with the restriction 
enzyme BamHI. Dig-labeled antisense RNA probe was transcribed using the T7 RNA 
polymerase (Roche #10881767001) and DIG RNA labeling mix (Roche #11277073910). 
To prepare the RNA probe, 1µg of linearized template was used with the transcription 
components and incubated for 2hrs at 37 oC. DNase1 was added for another 15mins to 
digest the DNA template. Reaction was stopped with 0.5mM EDTA pH 8, and further 
precipitated by 4mM LiCl and ice-cold ethanol for at least 1hr in -80 oC or overnight at -
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20 oC. Precipitated RNA pellets were washed with 70% ethanol air-dried and re-
constitute in 20µl of DEPC-treated water. The antisense probes were stored at -80 oC.  
Embryos for lefty2 in situ hybridization were fixed at 24hph overnight in fishfix at 4 oC, 
subsequently, the embryos were washed with PBS, and stored in 100% methanol at -80 
oC. The embryos were rehydrated through 50:50 Methanol:PBS (DEPC treated), followed 
by PBS (DEPC treated) containing 0.1% Tritin X-100 (PBT) for 30 min. The embryos 
were post fixed for 20 min at room temperature with fishfix and washed with PBT for 30 
minutes, three times. Proteinase K digestion (10U in 1ml PBT) was carried out for 3 min 
and the embryos were fixed for 20 min with fishfix and PBT washes for 45 min.  
Pre-hybridized of embryos was carried out in Hybe A containing 65%formamide, 6.5x 
DEPC-treated SSC - 975 mM sodium chloride, 97.5 mM sodium citrate, 0.1% TritonX-
100, 0.1 mg/ml yeast tRNA, 50 ug/ml heparin and 0.4 mg/ml of heat denatured salmon 
sperm DNA, adjusted to pH 5.5] for 4 hrs at 68°C. Subsequently, the digoxigenin (DIG) 
probe dissolved in Hybe A was added to the embryos at hybridized overnight in a water-
bath at 68°C. Next day, the probes are washed off by Hybe B (containing 65% 
formamide, 6.5x SSC, 0.1% TritonX-100, adjusted to pH 5.5) at 68°C for 4 rounds of 
30min washes. Following this, the embryos are washed for 30 min in PBT, and then in 
blocking buffer containing 0.5% Blocking reagent in PBT for 30 min. Anti-DIG antibody 
coupled to alkaline phosphatase (1:2000) in 0.5% blocking buffer was added to the 
embryos and incubated overnight at 68°C. Excess antibody was washed off by PBT 
washes for 30 min each, four times, and equilibrated for 20 min with in situ buffer 
containing 100mM Tris, pH 9.5, 50mM MgCl2, 100mM NaCl and 0.1% TritonX-100. 
Colour was developed by the addition of Nitro Blue Tetrazolium (NBT-250 mg/ml) and 
 Materials and methods  
 
77 
5-Bromo 4-chloro 3-indolyl phosphate (BCIP 125 mg/ml) for 1 hour. The reaction was 
stopped by PBT washes, and embryos were stored in fishfix at 4°C till observation under 
stereomicroscope.  
A minimum of 30 embryos for each morphant was scored for the expression of 
lefty2 and significance was calculated using Fisher’s Exact test (2*2 matrix, two-tailed) 
as compared to the wild-type.  
 
4.5 Molecular biology techniques 
 
4.5.1 Restriction enzyme digestion 
 
Restriction enzymes used in this study were purchased from New England Biolabs 
(NEB). In order to digest or linearize a particular vector or a construct, the following set 
up was used: 
Table 4.5 Components in a typical restriction digestion set up 
 
 Component Volume (µl) 
DNA for digestion  3ug 
10X BSA 5 
10X Buffer 5 
Restriction Enzyme 1 
Water Upto 50µl 




The reaction mixture was incubated at 37°C for 3 hours to overnight depending on the 
enzyme. Where double digestion was necessary, the total volume of the two enzymes did 
not exceed 3µl in a total volume of 50µl. NEB buffers were chosen in a manner 
compatible with both the enzymes. Following digestion, fragments were resolved on a 
1% agarose gel and the desired product was excised from the gel with the help of a gel 
cutter. Purification of the DNA fragments was performed with QIAquick Gel Extraction 
Kit (Qiagen, #28704) as specified by the manufacturer. 
 
4.5.2 Extraction of Plasmid DNA 
Depending on the purpose, either mini-prep or maxi-prep steps were followed as per the 
manufacturer’s protocol (QIAGEN,Valencia, CA, USA) from the appropriate volume of 
bacterial culture using relevant ion-exchange columns. 
 
4.5.3 Quantification of nucleic acid concentration 
NanoDrop® ND-1000 UV-Vis Spectrophotometer (ThermoScientific, Wilmington, DE, 
USA) was used for quantification of double stranded DNA or single stranded RNA. 
 
 
4.5.4 Extraction of RNA from zebrafish embryos  
Total RNA was extracted from zebrafish embryos using RNeasy Mini Kit (Qiagen, 
#74106). Approximately, 50 dechorionated zebrafish embryos were collected at desired 
developmental stages was washed with PBS and placed in 1.5 ml RNAse-free tube. 350 
µl of RLT buffer containing β-mercaptoethanol was added to the tube and the embryos 
were disintegrated using an RNAse-free mini pestle. Further disintegration was achieved 
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by passing the mixture through a 23G sterile needle for 6-8 times. The lysate was cleared 
of debris by spinning at 14000rpm for 5 min. 350 µl of the supernatant is mixed with 350 
µl of 70% ethanol (DEPC water) in an RNAse-free tube. Subsequently, the mixture was 
transferred to an RNeasy mini spin column and spun at 14000 rpm for 30s. The column 
was then washed with 350 µl of RW1 buffer and spun at 14000 rpm for 30s. To remove 
contamination from genomic DNA, an on-column DNAse treatment was carried out 
using diluted RNase-free DNAse for 20 min. The DNAse was washed out with 350 µl of 
RW1 buffer and spun at 14000 rpm for 30s. Subsequently, two rounds of washes with 
RPE buffer were carried out. Spinning for 2 minutes at 14000 rpm dried the column. 20 
µl of RNase-free water was added to the column and allowed to stand for 2 min. RNA 
was eluted by spinning the column at 14000 rpm for 2 min. Nanodrop 1000 
spectrophotometer (Thermo Scientific, US) was used to quantify the yield.   
 
4.5.5 First-strand cDNA synthesis 
First-strand cDNA was synthesized using the Superscript First Strand Synthesis Kit 
(Invitrogen, USA). 2 µg of purified RNA obtained from zebrafish embryos at the desired 
developmental stage was used for the synthesis of cDNA. The reaction was assembled as 
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Table 4.6 Components for First-strand synthesis of cDNA 
Component  Volume (µl) 
RNA 2 µg 
Random hexamer 1  
10 mM dNTP mix 1  
DEPC Water Up to 10 µl 
 
Subsequently, the mixture was incubated at 65°C for 5 min, followed by chilling on ice 
for 5 min. After this step, the reverse transcription (RT) was carried out by the addition of 
the following components listed below.  
  
Table 4.7 Components for reverse transcription  
Component  Volume (µl) 
10X First Strand buffer 2  
25mM MgCl2 4  
0.1M DTT 2  
RNase Out 1  
Superscript III reverse transcriptase 1 
 
The mixture was assembled, and kept at room temperature for 10 min. This was followed 
by incubation at 42°C for 1h. The reaction was terminated by a short incubation for 5 min 
at 85°C and subsequently chilled. RNA was removed by the addition of 1 µl of RNase H 
and incubation at 37°C for 20 min. Synthesized cDNA was stored at -20°C till further 
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applications. A no-RT library can be prepared by substituting water in place of 
Superscript III reverse transcriptase in the reaction scheme discussed above. 
 
4.5.6 Polymerase Chain Reaction (PCR) 
Primers for PCR were purchased from IDT (earlier1st-Base) Singapore. DNA was 
amplified either with Advantage 2 Polymerase Mix (clonetech) using PTC100 thermal 
cycler (MJ Research). The cycling conditions consisted of denaturation at 95°C for 30s, 
followed by annealing for 30s at a range of temperatures from 55°C to 65°C, and finally, 
an extension at 68°C. Extension time was set at the rate of 1minute per Kb.   
 
Table 4.8 Set up of a typical PCR  
Component Volume (µl) 
Template 1-2  
10X Advantage 2 buffer 2.5  
10X 10mM dNTP 0.5  
DMSO 0.5  
Advantage 2 enzyme 0.25  
Primers 2.5  




To check the efficacy of splicing, RT PCR was performed using cDNA library obtained 
from morphant embryos as well as wild type controls. In a typical reaction, primers were 
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designed to amplify approximately 300-500bp product in-between two successive exons. 
β-actin was used as the loading control. In addition, the use of β-actin primers helps to 
check for the presence of genomic DNA contamination, since the product size would 
increase from 300bp to above 500bp, leading to a shift in the size of the product on an 
agarose gel. 
 
Table 4.9 List of RT-PCR primers used 
Gene 
Symbol/Name Fwd Sequence (5'->3') Rev Sequence (5'->3') 
aftphb CCCTAAAAGACTTCAAGGAGGAA TGATTCCTAGGCAATTCAGAAGA 
ak9 GCAAATCCTCGGTGTTATCTTC TGGGAATATCCAGTATCCATCC 
arhgef18b GAAGGAGCAGCACAAAGAAAAG ACGTCTTCTGCGCTGAATCT 
bx470211.1 TGAGCTCCAGATACGCTTACTTT GGTGACAAATCTATAGCCAACCA 
c18h15orf26 GTCACCTGTTTTAGGCTCATTTG GTACAGTGAGTTCGCCTCTGTCT 
c20h6orf165 CAGGCTGAAGGAGTGATAAGAAA TTTCTGCACATCTTGCTTTGTAA 
c24h11orf65 GACTAATGTCATTCTTGTCCCACA ACCCAGCATTATTGTCCTCATTAT 




ces3 GGCAATATGTGAAAGCTAAAGGA GTCGATACTGAATGACAACCACA 
chia.4 TGTTACTTCACCAACTGGTCTCA AGCAAAGTGAATCTCTGCTTGTC 
clic6 GTAGCATGGCTTGGTTTGATGTA CATTGAAAATCACTCCTTTCAGC 
cma1 (1 of 29) GCAAACCACTAGTCTGCTGCTAC ATTATTGAATTTGGGATGTGGTGT 
cp GTTGGAGCGTATTACTCCACTGT GTGGAAGTGTGCTGTGTGTATGT 
ct573248.1 n/a n/a 
dlec1 AAACTGAACCAAAAGCACTAACG GACTTCTTCCAGGATTTTGTTGC 
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dr.81747 CTGTTCTTAAGTCTCGCGTGTTT GAGACCACAGGCTTTCATTTTC 
ect2l GTGGACAGACAGACAAAGGAAAG CTCATAATCTGATGGGCTGTAGG 
fank1 TGAACAACACAAAACACAGCTTTA AGCTCCACTTCATCAGTCTTGAG 
fgfbp2b n/a n/a 
hhipl1 TATGCAAGAGACCAAGAACTGAT ACCATTGTGATTAGAAGCAGGTT 
il1rapl2 AGAGTGAAGAGGGACTTTGCTTTA AACCTTGCTGCCATATTTAAGTTC 
illr4 GTGATCTTCACCACTGGACTGAT TTGTTCCCTGTTATATATGTGTTCG 
iqcg AAGCACTTCAAAATTCAGCAGAC GCGAATGTCAAGTAACTGCTTTT 
kcnip1a ACTCTCAGTTCTTTCCTCATGGA TGTATCCATCTCTGTTGATGTCG 
kif6 ACAGGAAGTGGGAAGACCTTTAC GGTTCTTGAGATGAATGTTCTGG 
lace1b  TGTTCAAAAAGACTAGGTTGTCG ATAATAACCTTGGGGTGGATGTG 
lrtomt GGATCTTCAGTGGACTTTTCATTT GCAATTCTTTGAGTTGAGTGAGAA 
magi3 (1 of 3) TAAAGAGCTGGATGTGTTCATCA CACTGAAAGCAGCACTTGTCC 
masp1 GTGGAGGAAAAGTCGAGTTCAG ATTGGAAAAGTCTGAACGGAAA 
mns1 CAACATCTCTCACAACCACCAT ATATCGCATCGCTTCTTTTTCT 
mustn1a TTTGATTGGAGCCAGAGATAAAC GGTTTGTTAAAGGCAGTCTCTGA 
plcxd2 AATGATTTCGTGGAGAAGAACAA GGCCGTGTATGAAGTATATCTCG 
s100a10a ATCATGGTTTTCCACCGATATG ACCAAAGACACAAACTCCTCAAA 
scg5 CAAATGAAGCGTAGAGGAGGAG CTGAAATCTTTGGGAACACTGTC 
si:ch211-
195b15.7 TGTGGAAGAAAGGGAGAGAAAA ATCTGGAAGTGTGTCAGTCTCGT 
si:ch211-





242m19.1 AGAAACTTGGATCAACACCTCAA TCATCAGCGGGTGATAATCTAGT 
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si:dkey-26i13.8 ATGAAGGATTTGCCAGGAGAA AGTGTAATCAAATGCCAGATCAAA 
si:dkeyp-67e6.5 GCTGAAATCAACACATCAACAAA TTCTTCATAGGCTGATCCAACAT 
slc43a3a CCTCAAGACAGATGGTTACTTCG ATGTGCCGGTGGTATAAAGAAAT 






tp53bp2 (2 of 2) GTTCCTAACGGTGTACCTGAGC GCTGCAGCACTTCAATGATTC 
trak1 (2 of 3) CTTGGAGAATCCTGATGATGAAG CTTGACTATCTGCAGTTTGTTGG 
ttll7 ATCAGAATGGCGTAAAGAGGAA ATTCCTGGGAAATGGTTTATCC 
wdr27 ACACTATCACAGACGCCACAAG ACACCATAGCAGACACATCACC 
zbbx GAAGATGGGAGCATCTCGTTG CTCTAATCTTCATCTTGCCTGGA 
zgc:153738 GGAAAAGGAATTTTCAGAGTACC CCATTTGGTTTAATATAGCAGCA 
lrrc9  AGACTGTCCAGCCTTACAATT  CGTATCTTCTCCTCCGGTAACTG 
actb1 CATGGGACAGAAAGACTCCTATG GGAAGAGCGTAACCCTCATAGAT 
 
   
4.5.8 Gel extraction to obtain the desired DNA fragments.  
 
Qiagen gel extraction kit was used for this purpose. The band that corresponded to the 
desired DNA fragment size was excised from 1% agarose gel under a UV trans 
illuminator and placed in a 1.5ml Ependorf tube. 500 µl of buffer QG (Qiagen, USA) was 
added to dissolve the gel fragment. The dissolved gel pieces were transferred to the DNA 
purification column (Qiagen, USA) and centrifuged for 1 minute. The flow-through was 
passed through the column again. After centrifuging the mixture for a minute, the flow 
through was discarded. 750 µl of was buffer PE was added. The flow through was 
discarded and the column was spun again to dry for 2 minutes. The column was 
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transferred to properly labeled Ependorf tubes. 15 µl of water was added and left on the 
bench for 2 minutes. It was spun down for 1 minute and the DNA was eluted as the flow 
through. 
  
4.5.9 DNA Sequencing 
The DNA Sequencing Facility at IMCB performed DNA sequencing. Sequencing was 
performed using Big Dye Terminator v3.1 Cycle Sequencing Kit and the reaction was 
assembled as listed below.  
Table 4.10 Components for DNA sequencing 
Components Volume (µl) 
Water 4 
Primers 1 
V3.1 Sequencing Mix 4 
DNA 1 





The cycling conditions are as shown in table 4.11 below. 
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Table 4.11 DNA sequencing PCR-cycles 
 Process Temperature (oC) Time (m:sec) Remarks 
1 Denaturation 95 1:00  
2 Denaturation 95 0:30 
30 cycles  Annealing 53 0:30 
 Extension 68 0:30 
3 Extension 68 10:00  
4 Maintenance 16   
 
Results were viewed using the commercial software Finch TV. 
 
4.5.10 Synthesis of sense mRNA 
mRNA were synthesized with mMESSAGE mMACHINE SP6 or T7 kit (Ambion) 
according to manufacturer’s protocol. In brief, about 1µg of DNA template linearized at 
3’ end was mixed with transcription components for 2hrs at 37 oC. DNase1 was added for 
another 15mins to remove the DNA template, followed by lithium chloride precipitation 
at -20 oC. Centrifuge sample at max speed for 30mins, washed pellets with 70% ethanol, 
air-dried and re-constitute in 20µl of DEPC-treated water. The synthesized mRNA was 
stored at -80 oC. 
 
4.5.11 Quantitative PCR 
For zebrafish qPCR, embryos were collected under the same conditions as for the 
microarray analysis. Total RNA (2 µg) was used for cDNA synthesis by Superscript III 
(Invitrogen, #18080-051). Quantitative PCR was performed on a Fast 7900HT real time 
 Materials and methods  
 
87 
machine (Applied Biosystems) using a Fast SYBR green master mix (Applied 
Biosystems, #4385612). Primers for qPCR were designed to flank exon-intron junctions 
to also test for genomic DNA contamination. Three to six biological replicates were 
measured for each gene. Significance was determined by using a Student’s t-test, with p-
values < 0.05 deemed highly significant, and 0.05 ≤ p< 0.09 deemed significant [112].  
Primers for qPCR used in this thesis are listed in table 4.1below. 
 
Table 4.12 qPCR primers used in the thesis 
Gene 
Symbol 
Gene Description  Fwd Primer (Sequence) Rev Primer (Sequence) 








arhgef18b rho/rac guanine 
nucleotide 
exchange factor 









c18h15orf26 chromosome 15 






c20h6orf165 chromosome 6 open 





c24h11orf65 chromosome 11 






c6h3orf67 chromosome 3 open 





ccdc78 coiled-coil domain 























cma1 (1 of 
29) 
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dr.81747 galactosidase, beta 













fank1 fibronectin type iii 
and ankyrin repeat 





fgfbp2b fibroblast growth 
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4.5.12 TOPO-TA cloning  
Following PCR of a particular gene/ fragment of a gene of interest, the purified product 
was used for TOPO cloning. The cloning reaction consists of mixing the following 
reagents:  
Table 4.13 reagents for TOPO cloning 
Component  Volume (µl) 
DNA 2 
TOPO Vector 0.5 
Salt Solution 0.5 
 
The above reagents are mixed and incubated at room temperature for 10 minutes. 
Following this, reaction was stopped by transferring the tubes to ice, and incubated on ice 
for 10 min. Subsequently; inoculating competent E.coli cells with the mixture was carried 
out for transformation. The culture was then plated on an antibiotic containing LB agar 
plate with 50 µl X-GAL and incubated overnight at 37°C. White colonies from the plate 
were picked for miniprep. EcoR1 digestion of the mini prep DNA was carried out, and 
the products resolved on a 1% agarose gel to verify the presence of the insert. DNA 
sequencing using M13 forward, M13 reverse or gene-specific primers, verified the 
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4.5.13 Cloning and sub-cloning  
Primers were designed to incorporate appropriate restriction enzyme sites at the 
beginning of the forward and reverse primers. PCR was carried out and the product 
purified. Both the vector and insert were digested with the same restriction enzymes for 3 
hrs at 37°C. To prevent self-ligation, the ends of the vector DNA were dephosphorylated 
by treatment with Antarctic phosphatase (NEB, #M0289S). The reaction was assembled 
as indicated in table 2.3.  
Table 4.14 Reaction set up for dephosphorylating vector DNA 
Component Volume (µl) 
Vector DNA Up to 1 µg  
10X Antarctic phosphatase buffer 2  
Antarctic phosphatase 1  
Water Up to 20 µl 
 
The reaction is stopped by heat inactivation at 70°C for 7 minutes.  
The vector (V) and the insert (I) were mixed in a 1:3 molar ratio (indicated in table 4.15) 
and ligation was carried out using Rapid Ligation Kit (Roche, #11 635 379 001) at room 
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Table 4.15 Reaction set up for regular cloning 
Component Control (µl) Test (V+I) (µl) 
Insert (50 ng) -  3  
Vector (50 ng) 1  1  
2 X T4 DNA Ligation Buffer 10  10  
T4 DNA ligase 1  1  
Water Up to 20 µl Up to 20 µl 
 
6µl of the ligation mixture was mixed with 50 µl of competent cells; heat shocked at 
42°C for 1 min, transformed and plated on LB agar plates containing the selection 
antibiotic and left overnight at 37°C. Colonies were screened using colony PCR for the 
presence of insert. Positive clones were selected and DNA was obtained by mini prep.  
  
4.5.14 Colony PCR 
To facilitate rapid identification of positive clones from a plate containing colonies from 
a cloning experiment, colony PCR was carried out. In this method, a single colony is 
picked with a pipette tip, dipped into a PCR master mix, and, later the tip is inoculated in 
a pre-labeled tube with 2 ml of LB broth containing the selection antibiotic. PCR is 
carried out as per cycling conditions used for the specific gene. Initial denaturation step is 
usually longer and about 5 minutes.  The products are resolved on a 1% agarose gel, and 
a lane with amplicon of the correct size is considered to represent a positive clone. The 
corresponding tube is then allowed to grow overnight and DNA extracted by miniprep. 
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Full-length sequence of the insert is confirmed by sequencing it with flanking primers 
and then assembling the sequence.  
 
4.5.14 Extraction of protein and western-blot 
100 embryos expressing Lrrc9Myc were manually dechorionated at 8-10 som stage and 
washed with PBS. Subsequently, the embryos were homogenized in 100 µl of SDS 
loading buffer and denatured at 95°C for 10 minutes. 30 µl of this extract was run on a 
4% SDS Polyacrylamide Gel. Gels were run at a voltage of 130V for 45mins to 1 hr. 
Trans-Blot SD Semi-dry transfer cell (Bio-rad) was used to transfer the gel to Hybond 
nitrocellulose membrane (GE Healthcare). Following the transfer, membranes were 
blocked in 5% non-fat milk (Anlene) dissolved in PBST (PBS containing 0.1% v/v 
Tween20) for 1hr at room temperature. Primary antibodies diluted in the same blocking 
solution were added to the membranes for at least 1hr at room temperature. The primary 
antibodies were washed off with PBST at 10mins interval for 3 times. Appropriate 
secondary antibodies were added for 45mins at room temperature, followed by vigorous 
4X PBST washes at 10mins interval. Enhanced chemiluminescent (ECL) substrate (GE 
Healthcare) was used to detect the signal and Hyperfilm ECL (Amersham) for exposure 
to develop the film. 
 
 
4.6 Genomics and Molecular biology 
4.6.1 Microarray 
Microarray was carried out as described in [112]. In order to carry out the microarray, 50 
wild-type and 50 hsp70::foxj1a embryos were dechorionated at 22 hpf and RNA was 
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extracted using the RNeasy Mini Kit (Qiagen, #74106). From the total RNA, 10 µg was 
used to make double stranded cDNA using the Superscript III Double-Stranded cDNA 
Synthesis Kit (Invitrogen, #11917-020). The cDNA was then labeled with the Nimblegen 
Labeling kit and hybridized to Nimblegen Zebrafish whole genome 60-mer 
oligonucleotide 12 x 135k arrays (Roche, #071105) at the Biopolis shared facility (BSF). 
Hybridization was carried out overnight at 42°C in a Maui Hybridization System 
(BioMicro Systems) and arrays were scanned with a GenePix 4000B scanner (Molecular 
Devices), with a pixel size of 5 µm [112]. 
 
4.6.2 Microarray analysis  
Microarray analysis was performed using the commercial ArrayStar software (DNAStar). 
Robust Multiarray Average (RMA) analysis was used to normalize the array. Six 
biological replicates were averaged for each sample. Probes greater than 2-fold 
upregulated in the hsp70::foxj1a sample with a p-value of < 0.01 were deemed to 
represent Foxj1 target genes (Student’s t-test, corrected for Multiple Hypothesis Testing 
by Benjamini Hochberg False Discovery Rate correction). The data is available at Array 
express under accession number E-MTAB-2815 [112]. 
 
4.6.3 Microarray annotation and gene analysis 
Probes were mapped against version 9 of the zebrafish genome using BLAST. Probes 
with 2 or fewer mismatches to the database sequence were accepted. Ensembl gene 
models were used in most instances; if unavailable, Unigene gene models and IDs were 
used instead. Orthology was determined using Ensembl human or mouse ortholog or 
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predicted ortholog. When two or more orthologs were predicted, only the vertebrate gene 
with the highest level of identity was used. For genes without an Ensembl ortholog, 
Unigene, OrthoDB or InParanoid-predicted orthologs were used [112].  
 
4.6.4 Gene ontology (GO) analysis 
GO analysis was performed on the human orthologs of the Foxj1 targets, with a 
background of the entire human genome using DAVID (http://david.abcc.ncifcrf.gov/). 
GO Biological Process was investigated, and GO categories with a minimum of 5 genes, 
at least a 2.5-fold enrichment, and a p-value ≤0.02 were reported (Fisher’s Exact Test). 
Any redundant categories, defined as a category with more than 80% overlap with 
another category, were removed for clarity [112].  
 
 4.7 Yeast-2-hybrid (Y2H) 
To uncover interactors of Lrrc9, full-length Lrrc9 was used as a bait to identify potential 
hits. Plasmid encoding the full-length cDNA of lrrc9 was sent to a commercial service 
provider-Hybrigenics. The library used in this assay was from Danio rerio embryos 
(stages 18-20 hpf).  
 
4.8 Microscopy  
In the case of immunofluorescence analysis, the stained embryos were mounted in 70% 
glycerol on a glass slide. These were then subjected to high-resolution imaging using an 
Olympus Fluoview laser scanning confocal microscope. Confocal imaging was done 
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using PlanApo 60X and 100X lenses with NA of 1.42 and 1.45, respectively. Image-J 
software was used to quantify ciliary length. 
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Chapter 5 : Identification and characterization of novel Foxj1-





As discussed in chapter 1, Foxj1 is the master regulator of motile ciliogenesis. Therefore, 
Foxj1 may transcriptionally control a suite of genes necessary for the form and function 
of a motile cilium. Also, as discussed in section 1.7, there is a pressing need to identify 
novel PCD genes. In this background, we hypothesized that identifying and 
characterizing genes induced by Foxj1 would lead to the identification of novel genes 
with potential roles in the formation and function of motile cilia. To test and validate this 
hypothesis, we designed a screen to identify as well as characterize Foxj1 induced genes 
using zebrafish as a model system. This chapter details the work done in order to discover 
and characterize genes induced by Foxj1. This work was jointly done with a postdoctoral 
fellow, Dr. Semil Choksi and has been published in Development [112].   
 
5.2 Microarray screen identifies targets of Foxj1a 
Given that Foxj1 is a transcriptional activator that regulates a host of genes that are 
necessary and sufficient for the structure and function of motile cilia, our first goal was to 
identify Foxj1-induced genes (FIGs). To do this, we carried out a whole-genome 
microarray analysis and compared the transcriptomes of zebrafish embryos 
overexpressing Foxj1 with that of wild-type embryos. Zebrafish has two paralogs of 
foxj1, namely foxj1a and foxj1b. As detailed in chapter 1, our group and others have 
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identified foxj1a as the master regulator of motile ciliogenesis [157, 158]. Hence, 
foxj1/Foxj1, as reported in this thesis refers to foxj1a/Foxj1a.  
In order to get a consistent overexpression, Dr. Xianwen Yu, a postdoc in the lab 
generated a transgenic line that could overexpress Foxj1 in a stable manner. The line 
hsp70::foxj1 thus generated can temporally overexpress Foxj1 upon heat shock. With this 
tool in place, we set out to identify transcripts that are induced by overexpression of 
Foxj1. Experimentally, Xianwen obtained embryos from six pairs of transgenic 
hsp70::foxj1 fish and subjected them to two rounds of heat shock for one hour at 380C, at 
10-12 hpf and 18 hpf to induce the overexpression of Foxj1. Embryos expressing GFP 
were screened and sorted under a stereomicroscope and RNA was extracted for 
preparation of cDNA from 50 embryos (test sample). Likewise, cDNA prepared from 
RNA extracted from embryos from six pairs of wild-type (AB) fish treated in an identical 
manner formed the control. Semil and I did the cDNA synthesis and subsequent 
downstream experiments to generate cDNA for the microarray.  
Based on the reported observation that Foxj1 is a potent activator (discussed in 
section 1.10), we should expect an upregulation of target genes upon overexpression of 
Foxj1. This was indeed the case as we observed that 662 genes were significantly 
upregulated upon overexpression of Foxj1 as shown in figure 5.1. Each spot on the 
scatter plot in figure 5.1 represents a particular probe. Changes in the transcript level 
either in the test or the control correspond to a change in expression level in figure 5.1 
Thus, if a transcript is upregulated upon overexpression of Foxj1, the probe 
corresponding to the transcript would be found on the Y axis and vice versa. Visual 
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inspection of the plot revealed a striking upregulation of several probes and, thus, 
confirms the previous observation that Foxj1 is a potent activator of transcription. 
These probes that are upregulated in the array correspond to 662 zebrafish genes. 
Since we set out to discover genes with potential roles in PCD, the task ahead was to 
filter out fish-specific genes from the list. In order to do that, we performed a homology 
search using databases such as ENSEMBL and DAVID (Database for Annotation, 
Visualization and Integrated Discovery) to identify genes from our list that are conserved 
in mammals. At the end of the homology search, we filtered out 66 fish-specific genes 
from the list of 662 zebrafish genes to obtain a total of 596 zebrafish genes corresponding 
to 573 genes with a mammalian ortholog. This list of Foxj1-induced genes, which is a 
combination of direct as well as indirect targets of Foxj1, was termed as FIGs (Foxj1-
induced genes) as shown in supplementary table1.  




Figure 5.1: Foxj1 overexpression leads to upregulation of several genes as seen on 
the microarray.  
Each spot on this scatter plot corresponds to a particular probe and its upregulation or 
downregulation upon Foxj1 overexpression. The X-axis represents the expression levels 
of genes in the wild-type control embryos while the Y-axis represents the expression of 
genes in Foxj1 overexpression embryos. Red dots correspond to genes upregulated in 
Foxj1 overexpression embryos while blue dots correspond to genes downregulated in 
Foxj1 overexpression embryos. Yellow dots represent genes that are expressed at 
identical levels in wild-type as well as Foxj1 overexpression embryos. Expression levels 
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5.3 Logic and design of the screen 
A microarray screen generates a long list of genes. Hence, in order to validate the 
microarray results and to explore the functional significance of our FIGs, we wished to 
design a screen that would suitably evaluate the strength of our list and aid in identifying 
novel FIGs with ciliary roles (figure 5.2). Previous genomics-based screens that have 
identified lists of genes fail to provide detailed functional analyses, thereby, resulting in 
an inability to generalize findings to the whole list (section 1.9). Here, we selected a 
subset of genes in an unbiased manner to validate the screen. Since we wanted to carry 
out a more comprehensive analysis, we reasoned that creating and evaluating a random 
list would enable us to extrapolate our findings to the entire list in addition to uncovering 
large numbers of genes with roles in the motile cilium.   




Figure 5.2: Schematic representation of the design of our screen to identify and 
characterize Foxj1-induced genes.   
 
5.4 Validation of FIGs 
To gain an initial insight about the list of FIGs, we performed the gene ontology (GO) 
analysis to identify over-represented classes of genes in our list of FIGs. GO analysis 
revealed that four out of the top five over-represented classes of genes were directly 
linked to cilia as shown in figure 5.3. The top four enriched class of genes include those 
relating to ciliary or flagellar motility, cilium morphogenesis, determination of left/right 
asymmetry and spermatogenesis as shown in figure 5.3. 




Figure 5.3: GO annotation enrichment of classes of genes in targets of Foxj1.  
The classes of genes are listed on the left side and the corresponding fold-enrichment 
relative to the human genome is indicated by the bars. Four of the top five categories are 
directly related to cilia and are represented by the red bars.    
 
 
As an initial evaluation tool, the GO analysis revealed that the function of the majority of 
genes present in the list of FIGs would most likely be related to motile cilia.  
 Encouraged by the GO enrichment results, we next sought to identify known 
ciliary genes from our list of FIGs. To do that, we manually annotated the list of FIGs 
and found 83 known genes with ciliary functions as shown in supplementary table 1. 
Some of these known regulators can be further classified on the type of functions 
performed. We were able to identify eight major classes of genes from the subset of 
previously known regulators of ciliary development and function as shown in figure 5.4. 
They include genes that encode for structural components of the motile cilium, for 
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example, genes encoding axonemal dyneins like DYNEIN AXONEMAL HEAVY 
CHAIN - DNAH1, RADIAL SPOKE HEAD PROTEINS like RSPH1 and components of 
the nexin-dynein regulatory complex like COILED COIL CONTAINING DOMAIN 65 - 
CCDC65. I had discussed the importance of intraflagellar transport (IFT) and dynein 
axonemal assembly factors (DNAAFs) in the construction of a motile cilium in chapter 1. 
We found that our list of FIGs contains known components of the IFT, for example- 
IFT27 and IFT80, dynein assembly factors, for example, DNAAF1, DNAAF2, and 
DNAAF3. We also found tubulin-modifying enzymes like TUBULIN TYROSINE 
LIGASE LIKE 6 - TTLL6 and TTLL9 in the list of FIGs. Foxj1 upregulates another 
ciliary transcription factor - rfx2, thereby, placing Foxj1 higher in the transcriptional 
hierarchy in ciliogenesis. 




Figure 5.4: Classes of known cilia genes regulated by Foxj1.  
The list of FIGs contains numerous known regulators of ciliary development and 
function. These have been categorized into eight major classes. Boxes contain known 
genes for each class. 
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After removing 83 known ciliary genes (listed in supplementary table 2), we were left 
with 513 novel genes. We randomized the list of genes so as to prevent experimental bias 
in the selection of candidate genes for further validation. In order to validate this list of 
genes, we selected the first 53 genes from our random list of targets and carried out qRT-
PCR to confirm the upregulation of these genes following overexpression of Foxj1.  
We observed that 50 out of 53 genes were upregulated on overexpression of 
Foxj1, giving a 94.4% positive rate, (P<0.05). The 50 genes and their fold change are 
shown in figure 5.5 and supplementary table 3.  
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Figure 5.5: Verification of FIGs using qRT-PCR 
Fold change for a particular gene with relative to wild-type as observed by microarray 
and qPCR are shown in blue and red bars respectively. Three to six biological replicates 
for qPCR was done. Error bars represent standard error of the mean (SEM) for each fold 
change. The figure shows all 50 of the verified FIGS.  
 
 
In summary, we have identified a number of downstream targets of Foxj1 and 
validated a random subset corresponding to 1/10th of our list of genes. The next stage of 
validation is to functionally dissect these targets. We chose 50 random qPCR validated 
genes for functional validation. 
  
5.5 Analysis of FIGs - generating and validating the tools 
To determine whether genes have a role in cilia, it is important to create a loss of function 
and then assess the outcome of this knockdown on the structure and function of cilia. 
Therefore, we embarked on a second screen to assay the functional importance of these 
genes in cilia. Here, the objective was to knock down all the 50 qPCR verified genes and 
evaluate the result of this knockdown on the form and function of motile cilia. As 
discussed earlier in section 1.8.1, MOs provide a versatile tool to achieve transient 
knockdown of genes in zebrafish. Hence, I designed MOs targeting each of the fifty 
genes. The strategy was to use splice MOs since the efficacy of the MO can be readily 
assessed by RT-PCR. The exon-intron junction ahead of the predicted domains in the 
protein encoded by the FIG was the usual target site for the MO. In the case of genes with 
splice variants, an exon-intron junction common to multiple transcripts was the choice 
since the MO could target all the splice forms of the gene. Preferably, the first exon was 
spared, for ease of RT-PCR. However, in case a gene had domain starting from the first 
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exon, then the first exon-intron junction was selected as a suitable target. In two 
situations, I had to design translation-blocking MO (start MOs) since these genes had 
only a single exon. 
Following the reconstitution of the MO, I determined the optimal dose for each of 
the MO. In order to do that, zebrafish embryos at one cell stage were injected with 
increasing concentrations of the MO and the outcome of the injection was scored at 24 
hpf and 48 hpf. The optimum dose was experimentally determined to be the maximum 
dose at which >80% of the embryos survive and do not show signs of necrosis, 
developmental delays, and lethality. At the standardized dose, phenotypes arising due to 
knockdown were scored. At this dose, I extracted RNA from approximately 50 embryos 
and reverse transcribed to obtain cDNA for RT-PCR analysis. A working MO is defined 
as the one, which has been determined to cause defects in splicing as evidenced by the 
presence of aberrant splice products when resolved on a 2% agarose gel as shown in 
figure 5.6. I TOPO cloned and sequenced the products from an RT-PCR reaction to 
uncover the precise nature of the defect. MOs that did not cause any splicing errors were 
discarded and fresh MOs were ordered for those genes. I continued the testing round till I 
had 48 verified working splice MOs and 2 start MOs against 50 genes.  
 
 




Figure 5.6: Verification of splicing due to morpholinos by RT-PCR.  
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Products from an RT-PCR reaction for knockdown of each of the 48 genes using a splice 
MO. Several aberrations can be seen in the morphant bands (highlighted by a red 
asterisk) as compared to the wild-type product in lane 1 for a particular gene. Sizes of 
morphant bands are highly variable ranging from greater than wild-type, lesser than wild-
type, complete disappearance of morphant band and presence of multiple bands. Each of 
these bands was cloned and sequenced. No RT controls (lane 3 and lane 4) served to 
check for genomic DNA contamination. β -actin was used as the loading control (LC) in 
lanes 5 and 6. Summary of the RT-PCR results are shown in supplementary table 5. 
 
5.6 Functional analysis of FIGs 
Once the tool to achieve knockdown was in place, the next task ahead was to test the 
effect of loss of function of these genes on motile ciliary form and function. How do we 
assay these features in zebrafish embryos?   
 As discussed in section1.8, the zebrafish model is incredibly powerful and well 
suited to the analysis of cilia. I have already explained the various tissues that 
differentiate motile cilia, and the basis for phenotypes that arise as a consequence of 
impaired ciliary form and function. Hence taking advantage of the zebrafish model, I 
injected the standardized dose of MO and scored the effects arising due to the knockdown 
at various developmental stages. Broadly, I scored for two categories of phenotypes- 
gross morphological and microscopic to cover a broad range of ciliary functions. The 
phenotypes I scored included:  
i. Presence of otolith defects 
ii. Presence of curved body axis 
iii. Presence of hydrocephalus 
iv. Presence of kidney cysts 
Additionally, the following phenotypes were scored at the microscopic level following 
fixation of the embryos for in situ hybridization and immunofluorescence. 
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Videomicroscopic recording of KV in live morphant embryos was performed for the 
analysis of ciliary motility.  
i. Analysis of LR symmetry 
ii. Analysis of ciliary organization and ciliary length  
iii. Analysis of ciliary beat frequency (motility profile) 
To bolster the statistical significance of the observation, two independent trials of MO 
injections were conducted and observations were noted and analyzed in each independent 
trial. To be called as a hit, MO-injected embryos must display at least two phenotypes 
above a selected cut-off. I have discussed the individual cut-off values and the rationale 
behind choosing them in the following sub-sections. 
I observed that MO-mediated knockdown of 31 out of 50 genes led to the formation of at 
least two phenotypes. In the following sub-sections, I have presented the detailed results 
from MO-knockdown as observed for each of the phenotypes for all 31 FIGs.  
5.6.1 Defects in otoliths are present upon ciliary dysfunction in the morphants 
As discussed earlier in section 1.8.2, altered ciliary beating of motile cilia lining the otic 
vesicle of the zebrafish embryo leads to the formation of abnormal numbers of otoliths in 
the otic vesicle as observed by the direct visual inspection of the otic vesicle under a 
stereomicroscope. Defective ciliary beating in the otic vesicle leads to defective otolith 
numbers either multiple otoliths or in rare cases, fused otoliths. Since this phenotype 
manifests as early as 24 hpf, it was the first phenotype I scored for in the MO-injected 
embryos as well as in the control MO-injected and wild-type embryos.  
For a morphant phenotype to be scored positive for otolith defects, at least 20% of 
the morphant embryos from two independent injections of the MO must exhibit the 
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phenotype (P<4.0 * 10-7). This cut-off is based on the observations from several trials 
that in the wild-type as well as in control-MO injected embryos, the incidence of otolith 
defects is never more than 10% as shown in figure 5.8. However, to further increase the 
stringency, a 20% cut-off was decided as a threshold above which incidence of otolith 
defects is termed as being positive for the phenotype. I observed the presence of multiple 
as well as fused otoliths as shown in figure 5.7. Further, I observed that 20 out of 31 
morphant embryos had a greater than 20% defects in otoliths while the remaining 11 
morphants had less than 20% defects in otoliths and did not meet the 20% cutoff as 
shown in figure 5.8. I have shown the distribution of otolith defects in the form of a pie 
chart in figure 5.9 and table 5.1. 
 
 
Figure 5.7: Otolith defects seen upon knockdown of FIGs.  
Otolith defects observed in morphants (B) and (C) as compared to wild-type (A). Note 
the presence of 2 distinct otoliths in A, while multiple otoliths are present in B and a 
single fused otolith in C. Scale bar = 20 µm 





Figure 5.8: Graph showing percentage defects observed in each of the 31 morphants 
Red dotted line indicates the cut-off value at 20%. Morphants exhibiting greater than 
20% otolith defects are considered to be positive for the phenotype. Y-axis shows the 
percentage of occurrence of the phenotype. 
 
 It is interesting to note that some morphants, for example arhgef18 morphants, 
display close to 100% fusion of otoliths. The mechanisms that distinguish the production 
of single vs clumped otoliths are unknown. But defective otolith count points to potential 
problems in ciliary motility in the ear.  




Figure 5.9: Distribution of otolith defects in FIG morphants shown by a Pie chart. 
 
Table 5.1 Distribution of morphants based on percentage of otolith defects observed. 
Category  Number of morphants 
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5.6.2 Analysis of hydrocephalus in the morphants 
As discussed in chapter 1, ciliary motility in the spinal canal is critical for the circulation 
of the cerebrospinal fluid (CSF). Consequently, altered ciliary motility in the spinal canal 
would result in altered circulation of the CSF eventually leading to the swelling in the 
brain ventricles and manifest as hydrocephalus.  
Hydrocephalus is visually discernible in zebrafish embryos by 48 hpf. Hence, this 
phenotype was scored by live observation of at least 30 embryos for each trial under a 
stereomicroscope. Hydrocephalus was not encountered in the wild-type as well as in the 
control-MO injected embryos as shown in figure 5.10 as well as figure 5.11. Hence, a 
threshold of 10% incidence was decided as being positive for hydrocephalus. Therefore, 
morphant embryos presenting with hydrocephalus in greater than 10% of the population 
(P<3.0 * 10-11), was scored as positive for hydrocephalus. The results were compared to 
observations made from wild-type as well as control MO-injected embryos.  
 
Figure 5.10: Presence of hydrocephalus in morphants.  
Deficient ciliary activity in the spinal canal leads to the development of hydrocephalus in 
morphant embryo at 48hpf (B) as compared to wild-type embryo at 48hpf (A). Scale bar 
= 100 µm 




Figure 5.11: Occurrence of hydrocephalus in FIG morphants.  
Red dotted line indicates the cut-off at 10%. The incidence of hydrocephalus above the 
cut-off value is considered to be positive for the phenotype. Y-axis shows the percentage 
of occurrence of the phenotype. 
 
 
I observed that 26 out of 31 morphants embryos showed an incidence of 
hydrocephaly above 10% while knockdown of 4 genes did not produce significant 
hydrocephaly and in one of the morphant, no hydrocephaly was observed. 19 out of 31 
morphants showed >20% instance of hydrocephalus as shown in figure 5.12 and table 
5.2). The majority of morphants (11 out of 31) fell in the category of 10% to 30% 
incidence of hydrocephaly as shown in figure 5.10. The most severe incidence of 
hydrocephaly was noticed upon knockdown of zbbx, which encodes a novel Z box 
containing protein. Knockdown of zbbx led to a significantly high occurrence of 
hydrocephaly in 93% of morphant embryos. 




Figure 5.12: Pie chart showing distribution of 31 morphants into different categories 
depending on the occurrence of hydrocephalus. 
 
 
Table 5.2 Distribution of hydrocephalus 
Category  Number 
No hydrocephalus  1 
< 10%  4 
10-30%  11 
30-50%  7 
50-70%  3 



















5.6.3 Analysis of curved body axis (CBA) in the morphants  
The presence of CBA is a morphological feature of ciliary dysfunction as elaborated in 
chapter 1. CBA is visually apparent from 30 hpf onwards and is distinct at 48 hpf as 
shown in figure 5.13. Hence, I scored this phenotype by live observation of morphant 
embryos under a stereomicroscope at 48 hpf. A minimum of 30 embryos from two 
independent trials was scored for the presence of CBA. Observations revealed a low 
incidence (less than 2%) of CBA in wild-type as well as control MO-injected embryos. 
Hence, a threshold of above 15% would be sufficiently stringent in deciding the 
phenotype as being positive. Hence, morphant embryos presenting with greater than 15% 
CBA (P<3.0 * 10-10) were considered to be positive for the phenotype as seen in figure 
5.14.  
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Figure 5.13: Presence of CBA upon knockdown of FIGs. 
CBA is present in the morphant embryo (B) as compared to wild-type embryo (A) at 
48hpf. Scale bar = 100 µm 
 
Strikingly, independent knockdown of each of the 31 genes led to the development of 
CBA as shown in figure 5.14. Further, knockdown of 4 genes encoding carboxylesterase 
3 (ces3), Kv channel interacting protein 1 (kcnip1a), ortholog of galactosidase, beta 1-
like 2 (Dr.81747) and a novel gene BX470211.1, led to the formation of CBA in 100% of 
the morphant embryos as shown in figure 5.14. I observed an incidence of greater than 
50% CBA in case of embryos from 27 out of 31 morphants as shown in figure 5.15 and 
table 5.3.  
 
Figure 5.14: Percentage of CBA found in 31 morphants from the screen.  
The red dotted line indicates the cut-off at 15% for the phenotype to scored as being 








Figure 5.15: Pie chart showing the distribution of percentage of morphants 
exhibiting CBA into various categories.  
Categories are indicated by the respective colour bars on the right-side. 
 
Table 5.3 Distribution of CBA 
Category Number 





















5.6.4 Analysis of Kidney cysts in the morphants 
In the zebrafish embryo, motile cilia lining the pronephric duct beat to clear fluid wastes 
from the duct. Consequently, defective ciliary motility leads to the appearance of cysts in 
the pronephric duct due to aberrant clearance of fluids. These cysts can be observed 
microscopically from 3 dpf and becomes prominent by 4 dpf. I scored for the 
development of cysts in the morphants on 4 dpf. No kidney cysts were observed in wild-
type embryos as shown in figure 5.16. Hence, for the phenotype to be scored as positive, 




Figure 5.16: Kidney cyst seen upon knockdown of FIGs. 
Presence of kidney cysts indicated by red arrowhead in morphant embryo (B) as 
compared to wild-type embryo (A) at 4 dpf. Scale bar = 100 µm 
 
 
Overall, the incidence of cysts in the pronephric duct was low, with 16 out of 31 
morphants displaying no cysts while the percentage of cysts in 7 morphants was less than 
10% as shown in figure 5.17, figure 5.18 and table 5.4. Knockdown of four genes led to 
greater than 30% cysts in the MO-injected embryos as seen in figure 5.17 and table 5.4. 
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The maximum percentage of cysts was observed upon knockdown of a novel gene 
Dr.81747.   
 
Figure 5.17: Percentage of kidney cysts found in 31 morphants from the screen.  
The red dotted line indicates the cut-off at 10% for the phenotype to scored as being 








Figure 5.18: Pie chart showing the distribution of kidney cysts found in 31 
morphants from the screen classified into various categories (right-side).  
 
Table 5.4 Distribution of occurrence of kidney cysts in the morphants 
Category Number 
No cysts 16 
< 10% 7 
10-30% 4 















5.6.5 Analysis of Left-right asymmetry (LRA) in the morphants 
As discussed in section 1.8.2, motile cilia in KV beat to institute symmetry breaking in 
zebrafish embryos. Hence, LRA would be altered in case of defective ciliary beating. I 
scored for LRA by scoring for sidedness of lefty2 expression at 24 hpf. As discussed in 
section 1.6, expression of lefty2 is restricted to left-sided of the embryo. In case of altered 
ciliary beating in the node, this expression pattern can be aberrant and consequently lefty2 
expression can be shifted from left side to right side or bilateral.  
 I carried out in situ hybridization on fixed embryos of all the 31 morphants and 
scored for the sidedness of lefty2 expression. I scored a minimum of 30 embryos for each 
of the 31morphants as well as for wild-type and control MO-injected embryos. I observed 
that in wild-type as well as in control MO-injected embryos, the incidence of LRA was 
between 5-7% as shown in figure 5.20. Therefore, I chose a cut-off at 20% LRA, (P<2.0 
* 10-3) above which incidence of LRA was scored as being positive for the phenotype. 
I observed alterations of lefty2 expression in the morphant embryos as shown in figure 
5.19. lefty2 expression was found on the right side or present on both sides in morphant 
embryos as shown in figure 5.19. 
 
Figure 5.19: Presence of LRA in morphants for FIGs.  
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In wild-type embryo, lefty2 expression is restricted to the left side. However, in the 
morphant embryo, expression of lefty2 is found on the right side (B) or bilateral (C) 





Figure 5.20: Graph showing the incidence in percentage for the occurrence of LRA 
in FIG morphants.  
Percentage of MO-injected embryos with defective LRA (right and bilateral). The red-




I observed that 28 out of 31 morphants had altered LRA as shown in figure 5.20. 19 
morphants fell into the major category with 40-60% of defects in LRA as seen in figure 
5.21 and table 5.5.  




Figure 5.21: Pie chart showing the distribution of percentage of occurrence of LRA 
in FIG morphants.  
 
 
Table 5.5 Classification of occurrence of LRA and the corresponding number of 
morphants in each category. 
Category  Number 
< 20%  3 
20-40%  5 
40-60%  19 
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5.6.6 Ciliary length, organization and ciliary beating is altered in FIG morphants 
In order to examine the ciliary structure, I collected and fixed batches of embryos from 
all the 31 different FIG morphants at 24 hpf, and immunolabelled with antibodies to mark 
cilia as well as the basal bodies. The embryos were mounted and observed under a 
confocal microscope for any alterations in length as well as position of basal bodies in the 
pronephric duct. Ciliary length was quantified from the images obtained using Image J 
software. This experiment was jointly done with Semil Choksi. I injected, fixed and 
stained the batches of embryos from all 31 morphants. Semil Choksi did confocal 
imaging of the cilia and quantification of ciliary length. 
We observed that knockdown of six genes led to a significant reduction in length 
of motile cilia in the pronephric duct as shown in figure 5.22 and 5.23 indicating a 
potential role for these proteins in the formation of motile cilia. Interestingly, we found 
that knockdown of mustn1a, encoding a transcription factor, led to abnormalities in the 
organization of motile cilia and basal bodies. In contrast to wild-type, mustn1a morphants 
exhibited curled cilia and disorganized gamma tubulin expression (as indicated by the 
arrowheads in figure 5.22, pointing to aberrant organization of basal bodies upon loss of 
Mustn1.  




Figure 5.22: Examination of ciliary length in FIG morphants at 24 hpf.  
Cilia in the pronephric ducts of 24 hpf zebrafish embryos are labelled by Anti-Arl13b 
antibody (green) while basal bodies are labelled by gamma tubulin antibody (red). There 
is reduction in ciliary length in case of morphants (B, C, D, E, F, G) as compared to wild-
type (A).  Curling of cilia indicated by white arrow and disorganization of basal bodies as 
indicated by white arrowhead are seen upon loss of Mustn1a (H). Scale bar = 10 µm   
 




Figure 5.23: Shortening of ciliary length as seen in 6 morphants (blue bars) as 
compared to wild-type (green bar).    
 
Thus, we show that loss of seven genes led to deficiencies either in the structure or 
organization of motile cilia. This brings us to the question regarding the role of remaining 
FIGs. We hypothesized that the remaining FIGs would be required for ciliary motility. 
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We tested this hypothesis by observing the ciliary motility profile of wild-type as well as 
morphant embryos during development. In other words, a high-speed live 
videomicroscopy based assay was employed to study aspects of ciliary motility in real 
time.  
To perform this assay, we chose ten genes whose knockdown resulted in severe 
defects in LR asymmetry to assay ciliary motility in KV. From this group, genes whose 
knockdown produced ciliary shortening were excluded. I co-injected the standardized 
dose of the relevant morpholino along with mRNA encoding Arl13b GFP to label cilia. 
AB embryos injected with arl13 GFP mRNA served as the wild-type, while a standard 
control MO co-injected with arl13 GFP mRNA served as the control. Semil imaged KV 
of wild-type, control MO-injected as well as morpholino injected embryos at 14-15hpf at 
high speed (up to 500 frames/s) and analyzed for: 
1. Percentage of motile cilia 
2. Beat frequency of motile cilia 
 Analysis of the movies revealed that in wild-type as well as in control MO-injected 
embryos, approximately 60-70% of KV cilia were motile as shown in figure 5.24. 
However, in nine out of ten morphants, the percentage of motile cilia was drastically 
decreased to 2% as shown in figure 5.24. Further, the average beat frequency in wild-type 
as well as control was estimated to be around 30Hz. In contrast, beat frequencies were 
significantly lower in four of the morphants as compared to wild-type and control 
morphants as shown in figure 5.24 (C).  
 




Figure 5.24: Ciliary motility and ciliary beat frequency is altered in FIG morphants.  
Live imaging of KV cilia from control MO-arl13bgfp RNA co-injected embryo (A) 
shows 4 motile cilia in contrast to non-motile cilia seen in a MO-injected embryo (B). 
The green bars correspond to percentage of motile cilia while blue bars indicate ciliary 
beat frequency. Black arrows indicate motile cilia in (A) whereas black arrows in (B) 















The motile cilium is a complex organelle that can multitask functions as disparate as 
motility as well as being able to sense extracellular signals. Hence, it is not surprising that 
abnormality in ciliary structure or functions leads to disease pathologies in humans. 
Therefore, it is vital to understand this organelle in order to pave the way for better 
understanding of the disease and its management.  
 A good starting point would be to decipher the components a cilium is made of. 
Given its complex architecture, this task it is far from easy to do. Therefore, a few years 
back, investigators from several labs undertook laborious screens employing approaches 
that were either proteomic or genomic-based. The initial results from these screens 
(ciliary proteome and ciliome) have been vital in defining a structural signature of the 
motile cilium. However, these approaches have their inherent limitations based on the 
tool employed (details in chapter 1). There always seems to be a problem- one that is of 
breadth and depth. Proteomics-based screens usually have good depth but lack breadth 
(refer to section 1.9). On the other hand, bioinformatics as well as genomics-based 
screens are broad and suffer from the lack of depth. Thus at the moment we stand at a 
point, where no dedicated large-scale vertebrate ciliary screen has been done at the 
resolving limit of a whole organism. This is the shortcoming my thesis attempts to 
address.  
Previous discovery from our lab as well as Kintner’s group ascribed a master 
regulatory role for Foxj1 in motile ciliogenesis (discussed in section 1.10). This finding 
opens up a whole new vista to identify and characterize Foxj1 induced genes with 
relevance to motile cilia.  We have thus exploited this knowledge to carry out a whole 
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genome analysis of genes upregulated by Foxj1. As a starting point, results from Foxj1 
microarray revealed that 662 genes are upregulated in response to Foxj1. Of these, 
removal of zebrafish-specific genes resulted in 573 genes with a mouse or human 
ortholog in our collection. This collection is termed as FIGs (Foxj1-induced genes). 
We hypothesized that this collection would help to uncover several new genes 
with functions in motile cilia. To test the hypothesis, we used the zebrafish as a vertebrate 
model to carry out large-scale functional analysis of Foxj1 targets. This becomes 
important when we consider the fact that there are several complex cellular decisions in 
which cilia are involved, some of which cannot be recapitulated in cell culture based 
screens. Also, screens involving single-celled organisms like Chlamydomonas cannot be 
used as read outs for complex ciliary functions. For example, single-celled as well as 
invertebrate model systems would not be suitable for uncovering ciliary functions like in 
the determination of left-right asymmetry, which is a largely conserved feature of 
vertebrate development. Hence, it is obvious that vertebrate models are indispensable to 
the analysis of novel genes with suspected roles in motile cilia. Therefore, our study 
assumes greater significance in light of the fact that it is the first vertebrate screen to 
analyze targets of Foxj1 at a functional resolution. 
After removing known ciliary genes from our list of FIGs, we were left with 513 
genes. At this point, we chose to generate a random list of genes from our list of FIGs. 
This was done to prevent bias in the selection of candidates for the knockdown. We chose 
to verify approximately 10% of our list (53 genes out of 513 genes) by qPCR and found 
that approximately 94% of the candidates (50 out of 53 genes) in the list are upregulated 
by Foxj1. I designed MOs against all the 50 genes and performed a knockdown screen. 
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The read out of assay was based on the development of phenotypic features that are 
expected to occur in the case of ciliary dysfunction, for example, presence of multiple 
otoliths, development of CBA, presence of hydrocephaly and kidney cysts, alterations of 
LRA, perturbations in ciliary length, organization, and ciliary length.  
Interestingly, 31 out of 50 genes when knocked down led to the development of at 
least two phenotypes associated with ciliary dysfunction as shown in figure 5.25. Thus, 
the hit rate of the screen is 62%, indicating the success of the screen and further, lending 
support to our hypothesis that identification of targets of Foxj1 would help to uncover 
genes with potential roles in motile cilia. Knockdown of 6 genes led to the development 
of all the phenotypes and might represent core motile ciliary genes. The broad choice of 
phenotypes spanning multiple tissues is important because it will help us to uncover the 
functions of genes whose proteins function may be restricted to a particular tissue. In 
such a situation, we should expect to see the consequence of altered ciliary activity 
restricted to that specific tissue in which the protein functions, upon knockdown of that 
particular gene. For instance, knockdown of two genes - guanine nucleotide exchange 
factor - arhgef18b and epithelial cell transforming 2 like - ect2l identified from the screen 
produced defects in otoliths and defective LRA indicating that they are needed for the 
function of motile cilia in KV and otic vesicle. In contrast, knockdown of a novel gene 
si:ch211-71m22.1 produced other phenotypes but does not produce any defects in 
otoliths, suggesting a limited or no role for the protein in the otic vesicle. 
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Figure 5.25: Summary of phenotypes seen in the hits obtained from the knockdown 
screen.  
Red box indicates that the phenotype is present when the gene is knocked down 
while the white box indicates absence of a particular phenotype.  
 
Further, based on our hit rate of 62%, we can extrapolate that our collection of 
FIGs contains between 252 to 383 genes at 95% confidence interval. This feature makes 
it a unique collection of novel genes with potential ciliary roles.  This extrapolation is 
possible only because we chose to randomize our list and then screen 10% of the list in 
an unbiased manner.  As a result, our collection of FIGs represents the best functionally 
characterized list of ciliary genes till date unlike lists from other genomics-based studies 
where the power of the collection has not been demonstrated.  
As mentioned in section 1.7 of chapter1, identification of PCD genes remains a 
big goal in the field of ciliary biology. At the time of this study, mutations in 26 genes 
have been identified to be the molecular basis of PCD. In section 1.9 of Chapter1, I had 
discussed previous ciliary screens and the integration of the data from these screens into 
two databases- ciliome and ciliary proteome. Together, these databases contain 4049 
genes. Upon manual screening for the presence of these PCD genes in the databases, we 
found that 22 out of 26 PCD genes (22/26=84.6%) were present in these databases. We 
next probed for the presence of these 26 PCD genes in our collection of FIGs, and 
interestingly, found that our modest list of 573 genes identified 22 out of the 26 
(22/26=84.6%) genes as shown in figure 5.26 and table 5.6. This remarkable finding 
indicates that the FIGs have a high predictive capability for new PCD genes with a much 
lesser false-positive rate.  
  




Figure 5.26: Similar identification of PCD-causing genes in the list of FIGs vs the 
ciliome and the ciliary proteome combined.   
The ciliary proteome and the ciliome containing 4049 genes shown by the blue circle 
identified 22/26 PCD-causing genes (84.6%). In a sharp contrast, the list of FIGs 
containing a much smaller number of 573 genes (shown as a red circle) was able to 
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Gene Description (Vertebrate Ortholog) Reference 
DNAI1 DYNEIN, AXONEMAL, INTERMEDIATE 
CHAIN 1  
Zariwala et al., Am J Respir Crit Care 
Med, 2006 
DNAAF3 DYNEIN, AXONEMAL, ASSEMBLY 
FACTOR 3  
Mitchison et al., Nat Genetics, 2012 
DNAH5 DYNEIN, AXONEMAL, HEAVY CHAIN 5  Olbrich et al., Nature Genet., 2002 
HYDIN HYDIN Lechtreck et al., JCB, 2008 
DNAH11 DYNEIN, AXONEMAL, HEAVY CHAIN 
11  
Schwabe GC et al., Hum Mutat, 2008 
DNAAF2 DYNEIN, AXONEMAL, ASSEMBLY 
FACTOR 2  
Omran et al., Nature, 2008 
RSPH4A RADIAL SPOKE HEAD 4 HOMOLOG A  Castleman et al., Am J Hum Genet, 
2009 
RSPH9 RADIAL SPOKE HEAD 9 HOMOLOG   Castleman et al., Am J Hum Genet, 
2009 
DNAAF1 DYNEIN, AXONEMAL, ASSEMBLY 
FACTOR 1  
Loges et al., Am J Hum Genet, 2009 
CCDC39 COILED-COIL DOMAIN CONTAINING 
39  
Merveille et al., 2010 
CCDC40 COILED-COIL DOMAIN CONTAINING 
40  
Becker-Heck et al., 2010 
CCDC103 COILED-COIL DOMAIN CONTAINING 
103  
Panizzi JR et al., Nat Genet, 2012 
LRRC6 LEUCINE RICH REPEAT CONTAINING 
6  
Kott et al., Am J Hum Genet, 2012 
CCDC114 COILED-COIL DOMAIN CONTAINING 
114  
Knowles MR et al., Am J Hum 
Genet, 2013 and Onoufriadis A et al., 
Am J Hum Genet, 2013 
ZMYND10 ZINC FINGER, MYND-TYPE 
CONTAINING 10  
Zariwala et al., Am J Hum Genet, 
2013 and Moore et al., Am J Hum 
Genet, 2013 
ARMC4 ARMADILLO REPEAT CONTAINING 4  Hjeij R et al., Am J Hum Genet, 2013 
and Onoufriadis A et al., J Med 
Genet, 2014 
RSPH1 RADIAL SPOKE HEAD 1 HOMOLOG  Kott et al., Am J Hum Genet, 2013 
DYX1C1 DYSLEXIA SUSCEPTIBILITY 1 
CANDIDATE 1  
Chandrasekar G et al., Plos One, 
2013 and Tarkar A et al., Nat Genet, 
2013 
C21orf59 CHROMOSOME 21 OPEN READING 
FRAME 59  
Austin-Tse C et al., Am J Hum 
Genet, 2013 
CCDC65 COILED-COIL DOMAIN CONTAINING 
65  
Horani A et al., Plos One, 2013 and 
Austin-Tse C et al., Am J Hum 
Genet, 2013 
SPAG1 SPERM ASSOCIATED ANTIGEN 1  Knowles et al., Am J Hum Genet, 
2013 
CCDC164 COILED-COIL DOMAIN CONTAINING 
164  
Wirschell M et al., Nat Genet, 2013 
 
GAS8 GROWTH ARREST SPECIFIC 8 Olbrich H et al., Am J Hum Genet, 
2015 
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Finally, comparison of the list of FIGs to that of the ciliary proteome as well as the 
ciliome indicates an overlap of 38% of genes with the combined proteome and ciliome as 
shown in figure 5.27.  
 
 
Figure 5.27: Comparison of FIGs to other ciliary screens.   
Pie chart showing the overlap of FIGs to the other ciliary screens, combined into the 
ciliome as well as the ciliary proteome.  
 
 
This modest overlap, combined with the enrichment of cilia GO term and the predictive 
ability of FIGs in identifying PCD-causing genes make a strong case to argue that the list 
of FIGs contain many novel ciliary genes. This is further strengthened when the 62% hit 
rate from the knockdown screen is also considered, thereby, making a compelling case 
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that identification of targets of Foxj1 would lead to the identification of novel ciliary 
genes as has been experimentally shown in this chapter. 
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In the previous chapter, I presented results that identified and functionally characterized 
targets of Foxj1 in an unbiased manner. In other words, the choice of target genes to 
screen was randomized. This is a powerful approach in that it gives an estimate of the 
power of the screen since the results from a pilot screen can then be extrapolated to the 
entire list as seen in chapter 5. However, a potential drawback of this approach is that it 
does not look at the roles of specific classes of genes in the biology of motile cilia. To 
address this shortcoming, we classified the list of Foxj1 targets into specific sub-groups 
and then proceeded to characterize a particular group further. The results of such an 
approach are discussed in this chapter. Here, we grouped Foxj1-induced genes (FIGs) 
obtained from the Foxj1 microarray (discussed in chapter 5) based on domains in the 
proteins that they encode. When this was done, it became clear that certain domains are 
enriched as compared to the others. To make further sense of these data, we asked if a 
certain category of genes are overrepresented in the FIGs as compared to the genome. 
Indeed, it turns out that certain families of genes were enriched in the FIGs. This is 
exciting as it provides another handle to explore the FIGs. The group I chose to study 
further was the Lrr encoding genes. As discussed in chapter 2, LRR members play crucial 
roles in protein-protein interactions. Also, mutations in two LRR encoding genes have 
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been found to be the genetic basis of PCD.  Surprisingly, our understanding of the 
molecular functions of genes with Lrr is inadequate and warrants a thorough evaluation. 
Hence, I decided to perform an evaluation of genes encoding Lrr proteins and to further 
study one such member-lrrc9 in greater detail. The result of this investigation forms the 
basis of chapter 6.  
6.2 Genes encoding Lrr proteins are enriched in the FIGs 
The first question I asked was if specific class of genes encoding proteins with certain 
domains were enriched in our list of FIGs. To answer that question, we used the Interpro 
database (https://www.ebi.ac.uk/interpro/) and identified eight different protein domains: 
Dynein heavy chain domains, IQ calmodulin-binding region, EF-Hand type, Armadillo-
like helical domains, EF-hand1, Tetratricopeptide-like helical domains, Leucine-rich 
repeats and WD40 repeat that were enriched in the human orthologs of FIGs as compared 
that of the human genome. Analysis of the gene list (FIGs) obtained from Foxj1 
microarray revealed greater than two-fold enrichment of Lrr encoding genes in the FIGs 
as compared to the human genome as shown in figure 6.1. This finding led me to 
question the significance of this enrichment and to further evaluate the roles played by 
Lrr proteins in motile cilia, and thus, became the starting point of my investigations into 















Figure 6.1: Enrichment of Lrr proteins in the list of FIGs as compared to human 
genome. 
There is greater than two-fold enrichment of genes encoding Lrr proteins with respect to 
the genome as indicated by the red bar.  
 
6.3 Evaluation of the roles of Lrr encoding genes in cilia 
The Foxj1 screen identified 19 Lrr encoding genes as shown in table 6.1. Of these, the 
function of two genes - lrrc6 and lrrc50 are already known (discussed in detail in chapter 
2). Therefore, we have 17 novel Lrr-encoding genes to focus on. To evaluate the role of 
these genes in cilia, I designed a MO-based screen to knockdown these genes and assay 
for the development of cilia-related phenotypes. And further, candidate genes whose 
knockdown led to the development of ciliary phenotypes would then be chosen for a 
detailed evaluation. I have elaborated on the types of phenotypes as well as the rationale 










Table 6.1 lrr encoding genes identified from the Foxj1 microarray screen. 





lrrc23 leucine rich repeat containing 23   19.650 up 
lrrc50 leucine-rich repeat-containing protein 50   7.862 up 
lrrc45 leucine rich repeat containing 45  3.381up 
lrriq4 leucine-rich repeats and iq motif containing 4   11.846 up 
b0s5f3_danre 
novel protein similar to vertebrate leucine rich repeat containing 8 
family   11.846 up 
lrit1a 
leucine-rich repeat, immunoglobulin-like and transmembrane 
domains 1  2.360 up 
lrrc71 leucine rich repeat containing 71   9.198 up 
si:ch211-81a5.5 hypothetical protein loc558774   9.198 up 
lrtomt 
leucine rich transmembrane and o-methyltransferase domain 
containing   11.810 up 
lrrc48 leucine rich repeat containing 48   13.645 up 
lrrc6 leucine rich repeat containing 6   8.168 up 
lrrc9 leucine rich repeat containing 9   4.270 up 
lrrc67 leucine-rich repeat-containing protein 67   8.356 up 
lrrc34 leucine rich repeat containing 34   6.912 up 
lrrc10b leucine rich repeat containing 10b   2.232 up 
lrguk leucine-rich repeats and guanylate kinase domain containing  6.952 up 
lrriq3 leucine-rich repeats and iq motif containing 3   5.133 up 
lrrc56 (1 of 2) leucine rich repeat containing 56  4.231 up 
lrriq1 leucine-rich repeats and iq motif containing 1   4.149 up 
 
 
As a first-pass, I designed and injected MOs to knock down 5 of these genes as 
highlighted in table 6.1. I observed that knockdown of three out of the five genes, led to 









Table 6.2 Phenotypes observed upon knockdown of lrr targets.  
Red shaded box indicates the presence of the particular phenotype, whereas white boxes 
indicate that the phenotype is not produced upon knockdown. 
 





lrrc9         
lrguk         
lrriq1         
 
As shown in the above table, knockdown of three Lrr encoding genes led to the 
development of at least two ciliary phenotypes. Of these, knockdown of lrrc9 produced 
larger numbers of ciliary phenotypes than those arising due to knockdown of genes 
encoding leucine-rich repeats and guanylate kinase domain containing - lrguk and 
leucine-rich repeats and iq motif containing - lrriq1. Based on this first-pass knockdown 
result, I reasoned that Lrrc9 is a good candidate to evaluate in terms of its role in cilia. 
Therefore, I pursued a detailed characterization of Lrrc9 in structure and functions of 
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6.4 lrrc9 is upregulated by Foxj1 
The Foxj1 microarray indicated that lrrc9 transcript was upregulated by Foxj1 (4.2-fold). 
I further validated this result by qRT-PCR and found that lrrc9 was greater than 9-fold 
upregulated by Foxj1 as shown in figure 6.2. cDNA used in this experiment is the same 
cDNA used in chapter 5 to validate FIGs through qRT-PCR.  
 
 
Figure 6.2: lrrc9 is upregulated by Foxj1.  
qPCR results indicate that Foxj1 upregulates lrrc9 by greater than 9-folds relative to 
wild-type. The Y-axis represents the fold upregulation. Six biological replicates of 
hs::Foxj1 and six biological replicates of identical wild-type embryos were used for the 
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6.5 Domain architecture of Lrrc9 
The coding sequence of lrrc9 comprises 4,500bp and encodes a predicted protein 
containing 1500 amino acids. I used the SMART protein domain prediction tool to 
determine the domain structure of Lrrc9, and found that Lrrc9 has nineteen Lr repeats 
arranged in four major clusters in the protein as shown in figure 6.3. Each of the clusters 
has at least 4 Lrr within the cluster. The program also predicted the presence of a coiled-
coil domain as indicated by a green box in figure 6.3. Lrr are distributed in the protein in 
a non-uniform manner with more clusters towards the C-terminus of the protein as 
compared to the N-terminus.  
 
Figure 6.3: Domain structure of Lrrc9 
The large green boxes indicate Lrr while the small light green box indicates the presence 
of a coiled-coil domain. Pink boxes represent low-complexity regions. 
 
6.6 Achieving efficient knockdown of lrrc9 using splice MO 
lrrc9 splice MO (spMO) targeted the splice junction of exon 2-intron 2 of lrrc9 
transcript. I carried out a dose titration and determined the optimal dose and found that 
the spMO works best at a concentration of 1 mM and an injection volume of 0.75 nl. I 
carried out a RT-qPCR and verified the efficacy of the splicing process using cDNA from 
morphant embryos at 24 hpf, while uninjected wild type embryos served as the control. 
The products of the PCR were resolved on an agarose gel and revealed an increase in the 
size of the PCR product in case of the cDNA obtained from MO-injected embryos as 
shown in lane 2 as shown in figure 6.4. The wild type and morphant bands were 
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subsequently cloned and sequenced. Sequence analysis indicated retention of a part of 
intron 2 in the product.  Inclusion of the intron leads to the introduction of a stop codon in 
the reading frame of lrrc9, leading to a premature truncation of the protein. In this 
manner, the spMO consistently achieves knockdown of lrrc9. Thus, I was able to validate 
that lrrc9 spMO can reliably induce errors in splicing of the lrrc9 transcript.  





Figure 6.4: lrrc9 spMO induces error in splicing of lrrc9 transcript.  
This is seen as the higher band in lane 2 due to a partial inclusion of intron 2, highlighted 
by yellow arrow as compared to a lower wild-type band. As expected, no bands are seen 
in the No RT controls to indicate the absence of genomic DNA contamination. β-actin 
A 
B 
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was used as the loading control (LC) in lanes 5 and 6. Results of sequence alignment 
showing the inclusion of the intron in the case of the MO band is shown in panel B.  
 
 
6.7 lrrc9 morphants display ciliopathy phenotypes 
After validating lrrc9 spMO, I injected the lrrc9 spMO and assayed for various 
phenotypes arising due to loss of Lrrc9. Data for the phenotypes was obtained from 
analysis of morphants as well as controls from two independent trials.  
 
 
6.7.1 Presence of otolith defects in lrrc9 morphants 
 The first feature I scored for is the presence of two otoliths in the otic vesicle of lrrc9 
morphant embryos at 24-30 hpf. By this time, in the wild-type as well as in the control 
MO-injected embryos, 80% of embryos have two distinct otoliths. However, in case of 
lrrc9 morphants, >70% of the morphants have multiple otoliths as shown in figure 6.5 
and less than 30% of lrrc9 morphants embryos have 2 distinct otoliths. Thus, otolith 
defects are significant in lrrc9 morphants (P<0.001). Exact counts for the phenotype have 

























Figure 6.5: Loss of Lrrc9 leads to defective otoliths.  
In wild-type embryos at 24 hpf (A), two distinct otoliths are visible. However, in the case 
of lrrc9 morphant (B), multiple otoliths are seen. Y-axis in graph shows the percentage of 
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Table 6.3 Quantification of otolith defects observed in wild-type, control MO-
injected and lrrc9 morphant embryos. 
 
 Normal Defective Total % Normal % Defective 
WT 140 26 166 84.3 15.7 
Control MO 85 19 104 81.8 18.2 
lrrc9 MO 53 125 178 29.8 70.2 
 
 
6.7.2 lrrc9 morphants display curved body axis 
When embryos were examined at 48 hpf for the presence of CBA, it was observed that 
100% of lrrc9 morphants displayed a strong curvature in the body axis (P<0.001) as 
shown in figure 6.6 and table 6.4. The presence of CBA is significant considering the fact 
that neither the wild-type embryos, nor the control MO-injected embryos displayed any 
























Figure 6.6: Presence of CBA in lrrc9 morphant embryos as compared to wild-type.  
CBA is seen in 100% of the morphant embryos. Scale bar = 100 µm. The Y-axis shows 
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Table 6.4 Quantification of CBA as seen in wild-type, control MO-injected as well as 
in lrrc9 morphants. 
 Normal CBA Total % Normal % CBA 
WT 140 0 140 100 0 
Control MO 140 0 140 100 0 
lrrc9 MO 0 169 169 0 100 
 
6.7.3 lrrc9 morphants display cysts in kidney 
The presence of kidney cyst is a strong indicator of ciliary dysfunction (in situations 
where the development of PND is normal) as discussed in chapter 1. In the context of 
cilia, presence of kidney cysts is an indication of ciliary dysfunction leading to impaired 
fluid clearance in the PND and subsequent development of cysts. Examination of lrrc9 
morphant embryos at 4 dpf revealed the presence of large and bilateral kidney cysts, 
while no cysts were detected in the wild-type as well as control MO-injected embryos as 
shown in figure 6.7.  
In wild-type Foxj1::GFP embryos, GFP can be visualized live in tissues 
expressing Foxj1. Injection of lrrc9 spMO in Foxj1::GFP line revealed dilation of the 
PND at 4 dpf as against the unaffected PND in case of wild-type Foxj1::GFP embryos as 
shown in figure 6.7. This was seen in 100% of lrrc9 morphant embryos (P<0.001) as 
shown in the graph in figure 6.7 and table 6.5. Taken together with other phenotypic 
 Lrrc9 as a novel regulator of motile ciliary structure and function  
 
157 
observations, I have built a strong case to argue that Lrrc9 is required for motile ciliary 
function.  
 
Figure 6.7: Ciliary dysfunction in the PND upon loss of Lrrc9.  
Dilation of PND as pointed out by black arrow is seen on injection of lrrc9 MO in 
Foxj1::GFP zebrafish embryo, visualized by live imaging at 4 dpf. This is in contrast to 
wild-type embryo on the left side, where the dilation of PND was not observed. The 
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black arrow in the wild-type shows normal PND. Cysts were observed in 100% of lrrc9 
morphant embryos as seen in the graph. Scale bar = 100 µm. Y-axis shows the percentage 
of occurrence of kidney cysts. 
 
 
Table 6.5 Quantification of kidney cysts in wild-type, control MO and lrrc9 
morphant embryos at 4 dpf. 
 Normal Cysts Total % Normal % Cysts 
WT 140 0 140 100 0 
Control MO 140 0 140 100 0 
lrrc9 MO 0 169 169 0 100 
 
 
6.7.4 Knockdown of lrrc9 leads to a drastic reduction in ciliary length   
So far, I have discussed morphological features arising due to loss of lrrc9. From the 
phenotypes described so far, it appears that ciliary function is severely affected in lrrc9 
morphants. The next obvious question to ask is if loss of Lrrc9 leads to any alteration of 
ciliary length. To address this question, I visualized cilia in the PND of lrrc9 morphant 
embryos at 24 hpf, and at 52 hpf by immunolabelling cilia with an antibody against 
acetylated tubulin. Cilia in PND of wild-type and lrrc9 morphant embryos at 
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developmental stages of 24 hpf and 48 hpf were imaged and analyzed for ciliary length. 
Interestingly, I observed that ciliary length was significantly reduced in lrrc9 morphants. 
As shown in figure 6.8, wild-type cilia appear long and continuous throughout the duct. 
However, in case of lrrc9 morphant embryos, cilia appear to be short and stubble-like.  
 
Figure 6.8: Ciliary length is reduced in lrrc9 morphants 
A: In wild-type, cilia labeled by anti-acetylated tubulin antibody appear long and 
continuous. Loss of Lrrc9 led to significant reduction in ciliary length as seen in lrrc9 
morphants at 24 hpf. Basal bodies are marked by gamma tubulin in red. DAPI marks the 
nuclei in blue. Scale bar = 5 µm 
B: Measurement of ciliary length in pronephric duct revealed a significant reduction in 
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Quantification of length and statistical analysis revealed that the mean ciliary length in 
PND of wild-type embryos is 7.5 µm. Strikingly, the mean ciliary length in the case of 
lrrc9 morphants was 3 µm as shown in figure 6.8 (B). Thus, I observed that there is 
greater than 2-fold reduction in ciliary length in the case of lrrc9 morphant embryos. This 
finding was exciting since this is the first instance where the knockdown of an lrr 
encoding gene led to ciliary shortening. Thus, through the pursuit of lrrc9, I have 
identified the first Lrr candidate whose loss led to ciliary shortening. In chapter 2, I had 
discussed that in case of mutants for Lrr encoding genes- Lrrc6 and Lrrc50, there is no 
reduction in ciliary length unlike what I have observed in case of lrrc9 morphants. This 
reduced length is likely to lead to defective fluid clearance, eventually leading to the 
development of cysts in the PND. 
 
6.7.5 Cilia in KV are shortened in lrrc9 morphants 
In the previous section, I showed that cilia are dramatically shortened in PND of lrrc9 
morphant embryos. It is therefore natural to ask if the ciliary shortening is restricted only 
to PND. To test this, I examined another tissue- KV, which is the first tissue, where 
motile cilia are differentiated. Examination of cilia in KV of 8-10 som embryos revealed 
shortening of cilia in lrrc9 morphants as shown in figure 6.9. 
 




Figure 6.9: Reduction of ciliary length in KV in lrrc9 morphant embryos 
Cilia are labeled by anti-acetylated tubulin antibody in red. As compared to wild-type 
(WT), ciliary length of KV cilia is reduced in lrrc9 morphants. Scale bar = 5 µm 
 
6.7.6 Left-right asymmetry (LRA) is altered in lrrc9 morphants 
KV cilia as elaborated in chapter 1 are crucial for instituting LRA. Hence, I hypothesized 
that shortening of cilia in KV of lrrc9 morphant embryos should impair fluid-flow in KV 
and consequently lead to an altered LRA. To test this hypothesis, wild-type and lrrc9 
morphant embryos fixed at 50 hpf were stained with an antibody against myosin heavy 
chain (A4.1025 antibody) to visualize the looping of the heart. In the wild-type zebrafish 
embryos, heart is always looped to the left. However, this looping was affected in lrrc9 
morphants where only 70% of the embryos had left-looped heart as shown in table 6.6 
and figure 6.10. In the remaining 30% of the morphant embryos, the heart looped to right 
side or no looping (bilateral heart tube) was observed. Thus lrrc9 morphant embryos have 
significant (P<0.001) alteration of LRA.   
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Table 6.6 Looping of heart in wild-type as well as lrrc9 morphant embryos counted 
following immunolabelling with A4.1025 antibody.  
The counts (number of embryos) for each category are indicated in the respective 
columns. Total indicates the total number of embryos scored.  
 






   WT 80 1 81 98.8 1.2 





Figure 6.10: Presence of aberrant LRA upon loss of Lrrc9.  
In wild-type embryos, nearly 100% of the heart looping occurs to the left side. However, 
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morphant embryos had either right-looped or straight heart (P<0.001). N=60 for lrrc9 
morphants, N=81 for wild-type. Blue bars represent wild-type while red bars represent 
lrrc9 morphants. The Y axis shows percentage of occurrence of LRA. 
 
6.8 Axonemal organization is severely disrupted in lrrc9 morphants   
In the previous sections, I presented the phenotypes arising from the loss of Lrrc9 in 
terms of gross ciliary phenotypes as well as a severe reduction of ciliary length. Next, I 
asked if the observed ciliary dysfunctions could arise due to disruptions in ciliary 
architecture upon loss of Lrrc9. To address this question, transmission electron 
micrographs of sections from the PND of lrrc9 morphant embryos at 48 hpf were 
obtained at the IMCB-IMB electron microscopy facility. This was then compared to data 
obtained from wild-type embryos. For the analysis, I compared single sections from N=3 
for lrrc9 morphant embryos and N=2 for wild-type embryos. Comparison of the 
micrographs of lrrc9 morphants and wild-type embryos revealed striking defects in the 
ultrastructure of the cilium in lrrc9 morphants. The 9+2 arrangement of microtubules 
(indicated by the white arrow) in the periphery is perturbed in two of the three lrrc9 
morphants as shown in figure 6.11, panel B. Also, in these lrrc9 morphants, there is an 
8+2 arrangement of the microtubule doublets, with a pair of doublet being pushed interior 
from its peripheral location as indicated by the yellow arrow in panel B. In wild-type 
cilia, the central pair occupies the central region as pointed by green arrow in panel A. 
However, in the case of lrrc9 morphants, the position of the central pair is misplaced as 
indicated by the green arrow in panels B and C. I have summarized the defects observed 
in table 6.7. 




Figure 6.11: Ciliary ultrastructure is affected by loss of Lrrc9.  
TEM of transverse sections of the ciliary axoneme of lrrc9 morphants as compared to 
wild-type. 9+2 arrangement of microtubule doublets shown by white arrow is perturbed 
in lrrc9 morphants. Green arrow indicates the central pair, which is seen in a central 
position in wild-type cilia (A). Note the delocalization of central pair in lrrc9 morphant 
(B) and (C). Yellow arrow in (B) shows the inward positioning of one of the microtubule 




Table 6.7 Quantification of ultrastructural defects in lrrc9 morphant embryos 
Feature Wild-type lrrc9 morphant 
Presence of 9+2 doublets at 
the periphery 
2/2 (100%) 1/3 (33.3%) 
Presence of ectopic/shifted 
doublets 
0 2/3 (66.7%) 
Delocalized central-pair 0 3/3 (100%) 
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Thus, in addition to reduced ciliary length, ciliary ultrastructure is also perturbed 
in case of loss of Lrrc9. 
 
6.9 Lrrc9 localizes to the cytoplasm   
In order to decipher the function of Lrrc9, a good starting point would be to determine the 
subcellular localization of Lrrc9. Ideally, an antibody directed against Lrrc9 could be 
used to determine the subcellular localization. However, no such commercial antibodies 
existed at the time this study was undertaken. Subsequently, SIGMA generated an Lrrc9 
antibody. However, on the western blot, the antibody failed to recognize the correct sized 
band of Lrrc9. Hence, I decided to employ an alternate strategy- to use tagged version of 
Lrrc9 to determine subcellular localization.  In order to determine subcellular localization 
of Lrrc9, I injected mRNA encoding Lrrc9Myc into 1-cell stage embryos. 
Immunohistochemistry performed by double labeling embryos with anti-acetylated and 
















Figure 6.12: Lrrc9 localizes to the cytoplasm.  
Panel A: Schematic of Lrrc9Myc protein expressed in zebrafish embryos. Lrrc9 is 
downstream of a Myc tag that is present at the N-terminus of the fusion protein. 
Panel B: Western blot from zebrafish embryos at 8 som to show the expression of full 
length Lrrc9Myc, indicated by the red arrow. Expected band size is approximately 
170KDa. Ladder positions corresponding to 150 KDa and 250 KDa are shown by black 
lines on the blot. 
Panel C: Immunohistochemistry with anti-acetylated tubulin, anti-myc antibody and a 
merge of both the antibodies. Cilia in KV are labeled in green by anti-acetylated tubulin 
antibody while Lrrc9Myc is labeled in red by an anti-Myc antibody. DAPI marks the 
nucleus in blue. Localization of Lrrc9 is cytoplasmic as pointed out by white arrows in 
the merge. Scale bar = 10 µm 
 
I performed Western blot analysis on the protein extract obtained from injected 
embryos to verify that full-length Lrrc9 was expressed in the embryos as shown in Figure 
6.12 panel B. No signal was detected in the axonemes of the motile cilium. This result is 
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in agreement to the localization of other Lrr proteins like Lrrc50 and Lrrc6 (as discussed 
in chapter 2). This brings us to the next question: How does Lrrc9 function at the 
molecular level.  
 
6.10 Determining the interactors of Lrrc9 
In order to determine the molecular functions of Lrrc9, it is imperative to determine the 
protein partners that interact with Lrrc9. Broadly, the approach to determine interacting 
partners of Lrrc9 can be grouped into either an unbiased approach, where a screen is 
performed to identify suitable partners or by using a candidate approach, wherein 
potential interactions of Lrrc9 with specific proteins are tested based on pre-existing 
information that merits such an investigation. I have described the results of the unbiased 
approach in the following section.  
6.10.1 Unbiased approach to identify partners of Lrrc9 
The rationale behind this approach was to identify the interacting partners of Lrrc9 using 
a yeast two-hybrid screen and then subsequently validate the interaction and to further 
probe the relevance of this interaction in the context of motile cilia.  
A yeast two-hybrid screen was performed using the full-length Lrrc9 as the bait to 
identify potential interactors. A commercial company Hybrigenics carried out the screen 
and tested the bait against a library constructed from 20 hpf zebrafish embryos. 












Table 6.8 Hits obtained from the yeast two-hybrid screen 
Sl. No Hit Category of interaction  
1 Pax6a A 
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Table 6.9 Categories of interactions in a Yeast two-hybrid screen.  
Category Meaning 
A  Very high confidence in the interaction 
B  
  High confidence in the interaction 
C  Good confidence in the interaction 
D 
 Moderate confidence in the interaction 
This category is the most difficult to interpret because it mixes 
two classes of interactions: 
 * False-positive interactions 
 * Interactions hardly detectable by the Y2H technique (low 
representation of the mRNA in the library, prey folding, prey 
toxicity in yeast...) 
 
E 
 Interactions involving highly connected prey domains, 
warning of non-specific interaction. The threshold for high 
connectivity is 10 for screens with Human, Mouse, Drosophila 
and Arabidopsis and 6 for all other organisms. They can be 
classified in different categories: 
  * Prey proteins that are known to be highly connected due to 
their biological function 
  * Proteins with a prey interacting domain that contains a 
known protein interaction motif or a biochemically 
promiscuous motif 
 
F  Experimentally proven technical artifacts  
 




Thus, we can see that the Paired box transcription factor-Pax6a is the best hit 
followed by the protein Snapin. Given the pre-existing literature about the role of Pax6a 
in eye development [189], it is unlikely that it would have a motile ciliary role. Further, 
localization of Lrrc9 is cytoplasmic, while Pax6a is a transcription factor. Hence, I 
reasoned that this interaction might likely be a false-positive one with no relevance in the 
context of motile cilia.  
On the other hand, bioinformatics predicted that Snapin, could interact with 
Kinesin. In this scenario, coupled with previous literature about Snapin’s role as an 
adaptor of dynein [190], it merits a detailed study to validate if Snapin and Lrrc9 interact. 
However, it may also be the case that the interaction turns out to be negative. I have 




The Leucine-rich repeat (LRR) motif is a common entity that is present in a diverse range 
of proteins and several members of this class are evolutionarily conserved. Interestingly, 
proteins containing LRR domains have been found to have diverse functional roles in the 
cell, for example, in signal transduction, and in the immune system. These domains occur 
either exclusively in a protein or can occur along with other domains, for example, like 
the coiled-coil domains and the EF-hand domains [164,165]. Despite their ubiquitous 
presence, precise functional roles for the majority of these proteins are yet to be 
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identified. From existing literature, it has been proposed that proteins with LRR domains 
serve as templates for protein-protein interactions [164].   
 The importance of Lrr proteins in ciliary biology dawned with key studies that 
demonstrated the importance of two Lrr proteins - Lrrc6 and Lrrc50 in conferring ciliary 
motility [35-36,40-41]. Interestingly, both these members were first identified as 
mutations in zebrafish that led to the development of kidney cysts in the zebrafish 
embryo. Soon after, these studies gained further importance when mutations in these 
genes were demonstrated to be the underlying cause of PCD in humans.  These studies 
uncovered the importance of Lrr proteins in ciliary biology and drove home the point that 
zebrafish could be a promising model for identifying relevant genes as well as to 
identifying mechanisms of ciliary dysfunction in the clinical context of PCD. And, as 
discussed in chapter 2, these two proteins have now been recognized to be a part of multi-
protein complexes called as axonemal dynein assembly factors (DNAAF’s) that are 
important for assembly of the dynein complexes that power ciliary motility. 
When we classified our FIGs based on the domains encoded, we observed that 
genes encoding Lrr proteins were greater than two-fold enriched in our collection of 
FIGs. This observation concurs with a previous study by Avidor-Reiss et al. where a 
similar enrichment was observed [152]. Despite this enrichment, very little is known 
regarding the functional attributes of this class of proteins in the motile cilium, prompting 
me to pursue the roles of these proteins in motile cilia. Likewise, as expected, our screen 
also revealed that transcripts of lrrc6 and lrrc50 are upregulated by Foxj1.  
A first-pass MO-mediated knockdown of a few Lrr encoding genes revealed that 
loss of Lrrc9 had the most profound effect on motile cilia, and further analysis revealed 
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several interesting aspects, thus, making a compelling case for lrrc9 as a novel motile 
ciliary gene. Loss of Lrrc9 recapitulated features of ciliary dysfunction such as the 
presence of multiple otoliths, curved appearance of the body, prominent kidney cysts and 
randomization of left-right asymmetry. While these features may be similar to that arising 
due to loss of the other known Lrr proteins – Lrrc6 and Lrrc50, what distinguished the 
loss of Lrrc9 from others (Lrrc6 and Lrrc50) is a drastic reduction in ciliary length. I 
observed a nearly two-fold reduction in the length of cilia lining the pronephric duct upon 
loss of Lrrc9. Likewise, I also observed a reduction in length of KV cilia in lrrc9 
morphants. Taken together, these observations explain the phenotypes observed like the 
presence of cysts in the PND due to dysmotility of cilia lining the PND of the zebrafish 
embryo and randomization of the LRA due to altered beating of KV cilia. This is in 
contrast to a loss of Lrrc6 and Lrrc50 where there is no reduction in ciliary length.       
Another novel finding upon loss of Lrrc9 is the defective ultrastructural 
organization of cilium. Defects in the ciliary architecture of lrrc9 morphants include loss 
of peripheral location of the 9+2 doublets with an ectopic doublet in two-thirds of 
analyzed lrrc9 morphants and a 100% delocalized central pair in the morphant cilia. This 
is another novel finding, since, the most important ultrastructural defects observed upon 
loss of LRRC6 and LRRC50 is the loss of ODA and IDA with no defects to the 9+2 
arrangement (discussed in chapter 2).  
Interestingly, a feature shared by Lrrc9, Lrrc6 and Lrrc50 is with respect to 
intracellular localization. I observed that tagged Lrrc9 localizes to the cytoplasm. 
Similarly, as discussed in chapter 2, previous work revealed that Lrrc6 and Lrrc50 
localize to the cytoplasm, consistent with their roles in the cytoplasmic preassembly of 
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the dynein complexes. In the absence of a specific Lrrc9 antibody, localization was 
determined by expressing and detecting a Myc-tagged version of Lrrc9. Such an 
approach has a potential limitation in that the tag could potentially interfere with the true 
localization of the protein. Shifting the position of the tag and then assaying the 
localization is one option to overcome this limitation. Alternately, a rescue of the 
morphant phenotype by co-injection of MO and RNA expressing the tagged version of 
the protein gives sufficient confidence that the tag does not interfere with the normal 
functions of the protein.  
Another novel finding comes from the analysis of domain structure of Lrrc9 that 
revealed the presence 19 Lrr domains. This presence of large number of Lr repeats in 
Lrrc9 is interesting given that given that Lrrc50 and Lrrc6 have only 6 and 5 Lr repeats 
respectively. At this point, the functional roles of these multiple repeats remain unclear. 
A more detailed structure-function relationship studies will be needed to identify the roles 
of specific Lr repeats in Lrrc9. 
 Yeast two-hybrid analysis identified the paired box transcription factor 6a - Pax6a 
and Snapin, which is an adaptor for dynein in axons, as the interacting partner of Lrrc9. 
Given the role for pax6b in eye development, it is quite unlikely to interact with Lrrc9 in 
the context of cilia. Thus, Snapin remains the only other hit to be validated. It is 
surprising that a yeast two-hybrid screen with the full-length Lrrc9 bait identified only a 
potential single hit. In this context, an option might have been to use smaller sized baits 
(by truncating Lrrc9 based on the domain configurations) and then repeat yeast two- 
hybrid analysis. However, the concern about adopting such an approach would be that of 
specificity. If Lrrc9 is split into smaller baits, it is possible that the interactors identified 
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from such a screen might be those that interact with Lrr domains in general and might not 
be specific to Lrrc9. This is true for the other well-known Lrr proteins with ciliary roles – 
Lrrc6 and Lrrc50 where the roles of specific Lr repeats remain unclear.  
In this context, the candidate-based approach could prove to be a potential method 
to identify possible interacting partners. Upon scanning the literature, I found that loss of 
ciliary genes - COILED-COIL DOMAIN CONTAINING 39 [191], and COILED-COIL 
CONTAINING DOMAIN 40 [192], CCDC39 and CCDC40 led to defects in the 
ultrastructure of cilia. Most noticeable defects included the appearance of ectopic 
doublets, loss of peripheral 9+2 doublets and delocalized central pair. This complex 
defect appears to be similar to that arising due to loss of Lrrc9. In this background, it 
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As mentioned in chapter 3, my thesis hypothesized that identifying the targets of Foxj1 
would lead to the identification of novel genes with potential functions in motile cilia. 
The approaches discussed in chapter 5 and chapter 6, have been used to test and validate 
this hypothesis.   
In chapter 5, a microarray-based approach was adopted to identify the targets of 
Foxj1. This approach uncovered a list of 513 novel FIG’s with conserved human 
orthologs that was found to be upregulated upon overexpression of Foxj1. To test the 
strength of the list of FIG’s, I carried out a thorough, large-scale knockdown screen in a 
vertebrate model- zebrafish. I knocked down approximately 10% of the candidates (50 
genes) from the FIG list to show that knockdown produced cilia-related phenotypes in 
62% of the targets leading us to extrapolate that the list of FIG’s contains between 252 to 
383 novel ciliary genes at 95% confidence interval.    
I used a slightly different approach in chapter 6, where I evaluated the role of Lrr 
encoding genes in motile cilia. Of the candidates tested, loss of lrrc9 led to the 
production to several cilia-related phenotypes in the morphant embryos. I verified that 
lrrc9 transcript is upregulated by Foxj1.  
At the gross morphological level, lrrc9 morphant embryos exhibited defects in 
otoliths, CBA, altered LRA and kidney cysts. Examination of cilia in the KV and PND 
revealed a reduction in ciliary length in the case of lrrc9 morphant embryos. Also, ciliary 
ultrastructure is altered in case of lrrc9 morphant embryos with a loss of 9+2 arrangement 
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of microtubule doublets, the presence of ectopic doublets and delocalization of the central 
pair in the axonemes. Taken together, these findings make a strong case for lrrc9 as a 
potential novel ciliary gene. Furthermore, there are other lrr encoding genes in the list of 
FIGs. Detailed characterization of these candidates will be instrumental in understanding 
the development and function of motile cilia. Also, given the conservation of these genes 
in humans, it would be interesting to check if mutations in these lrr encoding genes lead 
to PCD, as history has shown earlier.  
The experimental findings from chapter 5 and chapter 6 strongly support the 
argument that the list of FIGs represents a unique collection of ciliary genes. While 
chapter 5 looks at a random, broad subset of the FIG list, chapter 6 looks closely at a 
single promising candidate- lrrc9. Together, results from these chapters lend support and 
validity to the hypothesis that identification of targets of Foxj1 would uncover novel 
ciliary genes and thus supports the hypothesis I set out to prove.   
 
7.1 Future experiments 
The following are some of the future experiments that can be done to identify to identify 
molecular functions of Lrrc9. 
i. Testing the interactors of Lrrc9.  
As discussed earlier, co-immunoprecipitation (Co-IP) experiments would be needed to 
verify if Snapin physically interacts with Lrrc9. Tagged versions of Snapin and Lrrc9 can 
be expressed in zebrafish embryos and pull-downs can be done with suitable antibody 
and western blot carried out to check if the partner protein has been pulled out. In all my 
previous attempts, I have observed toxicity and cell death following transfection of lrrc9 
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GFP in 293T cells. However, I have been successful in expressing full-length Lrrc9 
(figure 6.12) by injecting lrrc9myc RNA in zebrafish embryos. Hence, for the Co-IP, 
zebrafish embryos can be used to express the proteins for pull-down. If the interaction 
turns to be positive, then knocking down of snapin and assaying the outcome of this 
knockdown on motile cilia can be done to determine the functional significance of this 
interaction.  
 
ii. Testing of alternate MOs to verify phenotypes 
 In chapter 6, I have successfully designed and tested a splice MO – lrrc9 spMO to 
demonstrate the consequence of loss of Lrrc9. To further validate these observations, 
additional MOs that target lrrc9 would be useful. I have designed an additional splice as 
well as a translation-blocking MO complementary to the region spanning the translational 
start codon to verify if these MOs produce similar phenotypes as lrrc9 spMO.   
 
iii. Generating lrrc9 mutant 
MO-based knockdown is a quick and transient method to achieve loss of lrrc9 function. 
Therefore, a mutant would be required to reliably test the effect of loss of function of 
lrrc9. To generate lrrc9 mutants, the CRISPR methodology can be utilized to create 
indels (insertions-deletions) in lrrc9.  
 
iv. Does loss of Lrrc9 affect localization of other ciliary components? 
By using relevant antibodies, one can test if other ciliary components like ODA, IDA, RS 
and other regulators are affected due to loss of Lrrc9. Unfortunately, the available 
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commercial antibodies work well on human respiratory cilia and does not work on 
zebrafish embryos. Hence, LRRC9 knockdown could be done in human respiratory cilia 
using shRNA, and then assayed for the localization of various ciliary components. 
Following the knockdown of LRRC9, TEM, and other localization studies could be 
carried out to understand the functions of LRRC9. 
 
v. Direct vs indirect targets of Foxj1 
By performing Chromatin immunoprecipitation sequencing, ChIP-Seq, direct vs indirect 
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Supplementary table1. List of Foxj-induced genes (FIGs)  
 
 







ENSDARG00000079361 abcg2b ABCG2 ATP-binding cassette, 
sub-family G 
(WHITE), member 2   
24.797 up 
ENSDARG00000053644 got1l1 GOT1L1 glutamic-oxaloacetic 
transaminase 1-like 1   
23.404 up 
ENSDARG00000006174 lrrc23 LRRC23 leucine rich repeat 
containing 23   
19.650 up 
ENSDARG00000077573 tmprss13b TMPRSS13 transmembrane 




AC104809.3 Protein LOC728763  18.585 up 
ENSDARG00000091592 peli1a PELI1 pellino E3 ubiquitin 
protein ligase 1  
17.739 up 
ENSDARG00000069383 cnga4 CNGA4 cyclic nucleotide gated 
channel alpha 4   
17.607 up 
ENSDARG00000070366 BX005001.2 Dnah7c dynein, axonemal, 
heavy chain 7C  
16.395 up 
ENSDARG00000004204 efhc2 EFHC2 EF-hand domain (C-
terminal) containing 2  
16.245 up 
ENSDARG00000058508 TTC18 TTC18 tetratricopeptide repeat 
domain 18  
16.151 up 
ENSDARG00000054578 arl6ip1 ARL6IP1 ADP-ribosylation 
factor-like 6 
interacting protein 1   
15.535 up 
ENSDARG00000052428 C6H22orf23 C22orf23 chromosome 22 open 
reading frame 23  
15.453 up 
ENSDARG00000055739 ribc1 RIBC1 RIB43A domain with 
coiled-coils 1   
15.078 up 
ENSDARG00000068678 IQCG IQCG IQ motif containing G   14.980 up 
ENSDARG00000097784 C17H6orf18
3 
C6orf183 chromosome 6 open 
reading frame 183   
14.807 up 
ENSDARG00000042391 odf3b ODF3B outer dense fiber of 




DNAAF3 dynein, axonemal, 
assembly factor 3  
14.543 up 
ENSDARG00000016815 casc1 CASC1 cancer susceptibility 




Dnah6 dynein, axonemal, 
heavy chain 6 
14.283 up 
ENSDARG00000042215 pias4b PIAS4 protein inhibitor of 
activated STAT, 4   
14.077 up 
ENSDARG00000041300 lrrc48 LRRC48 leucine rich repeat 
containing 48   
13.645 up 
ENSDARG00000051890 hp HPR haptoglobin-related 
protein 
13.604 up 
ENSDARG00000028973 tekt2 TEKT2 tektin 2 (testicular)   13.588 up 
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ENSDARG00000040478 lrp2bp LRP2BP LRP2 binding protein   13.558 up 
ENSDARG00000053520 C7orf62 C7orf62 chromosome 7 open 




C6orf183 chromosome 6 open 
reading frame  
12.960 up 
ENSDARG00000069435 ccdc147 CCDC147 coiled-coil domain 







ENSDARG00000043470 rsph3 RSPH3 radial spoke 3 
homolog 
(Chlamydomonas)   
12.848 up 
ENSDARG00000005595 adgb ADGB androglobin   12.789 up 
ENSDARG00000032348 CABZ01090
712.1 
THSD4 thrombospondin, type 
I, domain containing 4   
12.736 up 
ENSDARG00000059171 stpg1 STPG1 sperm-tail PG-rich 
repeat containing 1  
12.467 up 
ENSDARG00000058090 wdr65 WDR65 WD repeat domain 65  12.454 up 
ENSDARG00000006292 MAATS1 MAATS1 MYCBP-associated, 
testis expressed 1   
12.437 up 
ENSDARG00000028899 tekt4 TEKT4 tektin 4   12.410 up 
ENSDARG00000017983 rtdr1 RTDR1 rhabdoid tumor 
deletion region gene 1  
12.153 up 
ENSDARG00000062806 ttll9 TTLL9 tubulin tyrosine ligase-
like family, member 9   
12.117 up 
ENSDARG00000068855 CCDC176 
(2 of 2) 
CCDC176 coiled-coil domain 
containing 176   
12.009 up 
ENSDARG00000017720 LRRIQ4 LRRIQ4 leucine-rich repeats 
and IQ motif 
containing 4   
11.846 up 
ENSDARG00000040668 lrtomt LRTOMT leucine rich 
transmembrane and O-
methyltransferase 
domain containing   
11.810 up 
ENSDARG00000054414 spata17 SPATA17 spermatogenesis 
associated 17   
11.228 up 
ENSDARG00000030095 ccdc78 CCDC78 coiled-coil domain 
containing 78  
11.196 up 
ENSDARG00000029859 C8H1orf228 C1orf228 chromosome 1 open 
reading frame 228   
11.107 up 
ENSDARG00000061899 iqub IQUB IQ motif and ubiquitin 
domain containing   
11.106 up 
ENSDARG00000062702 ankmy1 ANKMY1 ankyrin repeat and 
MYND domain 




KIF18B kinesin family member 
18B  
11.095 up 
ENSDARG00000056896 ttc12 TTC12 tetratricopeptide repeat 
domain 12   
11.057 up 
ENSDARG00000078249 unc13d UNC13D unc-13 homolog D (C. 
elegans)  
10.825 up 
ENSDARG00000077179 ccdc83 CCDC83 coiled-coil domain 
containing 83  
10.731 up 
ENSDARG00000042157 ppil6 PPIL6 peptidylprolyl 10.597 up 




(cyclophilin)-like 6  
ENSDARG00000087556 PACRG (2 
of 2) 
PACRG PARK2 co-regulated   10.593 up 
ENSDARG00000090068 C5H9orf117 C9orf117 chromosome 9 open 
reading frame 117   
10.572 up 
ENSDARG00000087210 VWA3A VWA3A von Willebrand factor 
A domain containing 
3A   
10.507 up 
ENSDARG00000000606 dnah7l DNAH6 dynein, axonemal, 




C11orf65 chromosome 11 open 
reading frame 65   
10.309 up 
Dr.41247 LOC798565 RYR1 ryanodine receptor 1 
(skeletal)   
10.272 up 
ENSDARG00000060035 rnf32 RNF32 ring finger protein 32   10.260 up 
ENSDARG00000027710 btbd16 BTBD16 BTB (POZ) domain 
containing 16   
10.258 up 
ENSDARG00000079249 OGDHL OGDHL oxoglutarate 
dehydrogenase-like   
10.204 up 
ENSDARG00000067831 tbata TBATA thymus, brain and 
testes associated   
10.180 up 
ENSDARG00000018605 tekt1 TEKT1 tektin 1   10.154 up 
ENSDARG00000054136 CCDC105 CCDC105 coiled-coil domain 
containing 105   
10.092 up 
ENSDARG00000037553 il1rapl2 IL1RAPL2 interleukin 1 receptor 
accessory protein-like 
2   
10.087 up 
ENSDARG00000086728 CXorf58 CXorf58 chromosome X open 
reading frame 58  
10.029 up 
ENSDARG00000055736 dnah1 DNAH1 dynein, axonemal, 
heavy chain 1   
10.007 up 
ENSDARG00000015476 iqch IQCH IQ motif containing H   9.977 up 
ENSDARG00000017055 zymnd12 ZMYND12 zinc finger, MYND-
type containing 12   
9.941 up 
ENSDARG00000011326 ankrd45 ANKRD45 ankyrin repeat domain 
45   
9.931 up 
ENSDARG00000017023 ak7b AK7 adenylate kinase 7   9.906 up 
ENSDARG00000032885 C11H1orf15
8 
C1orf158 chromosome 1 open 
reading frame 158   
9.842 up 
ENSDARG00000010407 ppp4r4 PPP4R4 protein phosphatase 4, 
regulatory subunit 4  
9.720 up 
ENSDARG00000074265 dzip1l DZIP1L DAZ interacting zinc 
finger protein 1-like   
9.672 up 
ENSDARG00000055128 armc4 ARMC4 armadillo repeat 




C20orf96 chromosome 20 open 
reading frame 96   
9.571 up 
ENSDARG00000088753 C5H4orf22 C4orf22 chromosome 4 open 
reading frame 22   
9.544 up 





TUBA3D tubulin, alpha 3d   9.448 up 
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ENSDARG00000054026 mustn1a MUSTN1 musculoskeletal, 
embryonic nuclear 
protein 1   
9.420 up 
ENSDARG00000055787 dzank1 DZANK1 double zinc ribbon and 
ankyrin repeat 
domains 1   
9.413 up 
ENSDARG00000075984 HSBP1 HSBP1 heat shock factor 
binding protein 1   
9.412 up 
ENSDARG00000069194 mycbpap MYCBPAP MYCBP associated 
protein   
9.412 up 
ENSDARG00000021913 ak9 AK9 adenylate kinase 9   9.323 up 
ENSDARG00000090342 CCDC37 (2 
of 2) 
CCDC37 coiled-coil domain 
containing 37   
9.303 up 
ENSDARG00000039341 capsla CAPS calcyphosine   9.237 up 
ENSDARG00000036412 LRRC71 LRRC71 leucine rich repeat 
containing 71   
9.198 up 
ENSDARG00000031693 KIF9 KIF9 kinesin family member 
9   
9.167 up 
Dr.89298 Dr.89298 DNAH2 dynein, axonemal, 
heavy chain 2   
9.161 up 




binding domain 1   
9.139 up 
ENSDARG00000059855 wdr66 WDR66 WD repeat domain 66   9.103 up 
ENSDARG00000056888 si:dkeyp-
87a6.1 
DNAH8 dynein, axonemal, 
heavy chain 8   
9.036 up 
ENSDARG00000062924 CCDC176 
(1 of 2) 
CCDC176 coiled-coil domain 
containing 176   
9.008 up 
ENSDARG00000038612 pih1d3 PIH1D3 PIH1 domain 
containing 3  
8.947 up 
ENSDARG00000060165 dnah7 DNAH7 dynein, axonemal, 
heavy chain 7  
8.933 up 
ENSDARG00000067646 tmem232 TMEM232 transmembrane protein 
232   
8.917 up 
ENSDARG00000043157 dnajb13 DNAJB13 DnaJ (Hsp40) 
homolog, subfamily B, 
member 13   
8.916 up 
ENSDARG00000058885 TTC29 TTC29 tetratricopeptide repeat 




C15orf26 chromosome 15 open 
reading frame 26   
8.767 up 
ENSDARG00000006491 agpat9l AGPAT9 1-acylglycerol-3-
phosphate O-
acyltransferase 9   
8.724 up 
ENSDARG00000034457 C8H1orf194 C1orf194 chromosome 1 open 
reading frame 194   
8.637 up 
ENSDARG00000044549 C6H21orf58 C21orf58 chromosome 21 open 
reading frame 58   
8.631 up 
ENSDARG00000090484 dnali1 DNALI1 dynein, axonemal, 
light intermediate 
chain 1   
8.552 up 
ENSDARG00000068130 C5H9orf9 C9orf9 chromosome 9 open 
reading frame 9   
8.543 up 
ENSDARG00000058370 ropn1l ROPN1L rhophilin associated 
tail protein 1-like   
8.465 up 
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ENSDARG00000069262 C8H1orf173 C1orf173 chromosome 1 open 
reading frame 173   
8.448 up 
ENSDARG00000052343 spata18 SPATA18 spermatogenesis 
associated 18   
8.433 up 
ENSDARG00000063009 C6H2orf62 C2orf62 chromosome 2 open 
reading frame 62   
8.420 up 
Dr.152821 dnah9l DNAH11 dynein, axonemal, 
heavy chain 11  
8.408 up 
ENSDARG00000087352 AL935046.1 DNAH2 dynein, axonemal, 
heavy chain 2  
8.401 up 
ENSDARG00000021462 daw1 DAW1 dynein assembly factor 
with WDR repeat 
domains 1  
8.386 up 
ENSDARG00000057632 ppp1r42 PPP1R42 protein phosphatase 1, 
regulatory subunit 42  
8.356 up 
ENSDARG00000091471 ECT2L ECT2L epithelial cell 
transforming sequence 
2 oncogene-like   
8.343 up 
ENSDARG00000068122 C5H9orf171 C9orf171 chromosome 9 open 




C6orf165 chromosome 6 open 
reading frame 165  
8.286 up 
ENSDARG00000019135 ankef1a ANKEF1 ankyrin repeat and EF-
hand domain 
containing 1  
8.256 up 
ENSDARG00000075206 C17H8orf74 C8orf74 chromosome 8 open 
reading frame 74   
8.240 up 
ENSDARG00000061149 nrn1lb NRN1L neuritin 1-like   8.200 up 
ENSDARG00000053318 lrrc6 LRRC6 leucine rich repeat 
containing 6   
8.168 up 
ENSDARG00000039491 C20orf26 (1 
of 2) 
C20orf26 chromosome 20 open 
reading frame 26   
8.143 up 
ENSDARG00000004794 ccdc146 CCDC146 coiled-coil domain 
containing 146   
8.125 up 
ENSDARG00000020158 spag6 SPAG6 sperm associated 
antigen 6   
8.111 up 
ENSDARG00000038056 fgfbp2b FGFBP2 fibroblast growth 
factor binding protein 
2  
8.035 up 
ENSDARG00000030961 ak8 AK8 adenylate kinase 8   8.012 up 
ENSDARG00000069723 zbbx ZBBX zinc finger, B-box 
domain containing   
8.003 up 
ENSDARG00000069230 zgc:153738 IQCA1 IQ motif containing 
with AAA domain 1   
7.999 up 
ENSDARG00000042937 EFCAB6 EFCAB6 EF-hand calcium 
binding domain 6  
7.990 up 
ENSDARG00000062978 ccdc151 CCDC151 coiled-coil domain 
containing 151   
7.982 up 
ENSDARG00000058377 ttc6 TTC6 tetratricopeptide repeat 
domain 6   
7.973 up 
ENSDARG00000045683 ccdc87 CCDC87 coiled-coil domain 





readthrough   
7.942 up 
ENSDARG00000035550 ccdc42b CCDC42 coiled-coil domain 7.938 up 
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containing 42   
ENSDARG00000002406 zmynd10 ZMYND10 zinc finger, MYND-
type containing 10   
7.927 up 
ENSDARG00000039152 fbxo36b FBXO36 F-box protein 36   7.904 up 
ENSDARG00000032005 ccdc65 CCDC65 coiled-coil domain 




PCDP1 Primary ciliary 
dyskinesia protein 1  
7.862 up 
ENSDARG00000012030 dnaaf1 DNAAF1 dynein, axonemal, 
assembly factor 1  
7.862 up 
ENSDARG00000017355 rsph9 RSPH9 radial spoke head 9 
homolog 
7.750 up 
ENSDARG00000087144 FAM183B FAM183A family with sequence 
similarity 183, 
member A   
7.710 up 
ENSDARG00000079983 agbl2 AGBL2 ATP/GTP binding 
protein-like 2   
7.630 up 
ENSDARG00000039344 tctex1d1 TCTEX1D1 Tctex1 domain 
containing 1   
7.616 up 
ENSDARG00000075825 dlec1 DLEC1 deleted in lung and 
esophageal cancer 1   
7.563 up 
ENSDARG00000019001 ak7a AK7 adenylate kinase 7  7.503 up 
ENSDARG00000001825 wdr96 WDR96 WD repeat domain 96   7.468 up 
ENSDARG00000091663 DYDC2 DYDC2 DPY30 domain 
containing 2   
7.463 up 
ENSDARG00000044400 wdr78 WDR78 WD repeat domain 78   7.455 up 
ENSDARG00000056630 angptl5 ANGPTL5 angiopoietin-like 5   7.433 up 
ENSDARG00000075917 si:dkeyp-
87a12.1 
C1orf222 chromosome 1 open 
reading frame 222  
7.367 up 
ENSDARG00000088340 spag1b SPAG1 sperm associated 
antigen 1   
7.273 up 
ENSDARG00000014058 rab36 RAB36 RAB36, member RAS 
oncogene family 
7.269 up 
ENSDARG00000042913 spef2 SPEF2 sperm flagellar 2   7.155 up 
ENSDARG00000059236 ptger4a PTGER4 prostaglandin E 
receptor 4 (subtype 
EP4)   
7.131 up 
ENSDARG00000087059 fam213ab FAM213A family with sequence 
similarity 213, 
member A   
7.122 up 
ENSDARG00000007792 dyx1c1 DYX1C1 dyslexia susceptibility 
1 candidate 1   
7.099 up 
ENSDARG00000030463 tppp3 TPPP3 tubulin 
polymerization-
promoting protein 
family member 3   
7.039 up 
ENSDARG00000009311 pvalb6 PVALB parvalbumin   7.037 up 
ENSDARG00000053240 kif6 KIF6 kinesin family member 
6   
6.971 up 
ENSDARG00000069698 lrguk LRGUK leucine-rich repeats 
and guanylate kinase 
domain containing  
6.952 up 
ENSDARG00000012275 katnal2 KATNAL2 katanin p60 subunit A-
like 2   
6.927 up 
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ENSDARG00000062235 lrrc34 LRRC34 leucine rich repeat 
containing 34   
6.912 up 
ENSDARG00000088049 WDR63 WDR63 WD repeat domain 63   6.895 up 
ENSDARG00000008075 illr4 CLEC4M C-type lectin domain 
family 4, member M  
6.881 up 
ENSDARG00000041321 wdr16 WDR16 WD repeat domain 16  6.851 up 
ENSDARG00000042182 drc1 DRC1 dynein regulatory 
complex subunit 1 
homolog 
(Chlamydomonas)   
6.844 up 
ENSDARG00000052512 tsga10 TSGA10 testis specific, 10   6.835 up 
ENSDARG00000041617 nme5 NME5 NME/NM23 family 
member 5   
6.756 up 
ENSDARG00000071806 BX572078.1 SPINK1 serine peptidase 
inhibitor, Kazal type 1   
6.745 up 
ENSDARG00000068103 ccdc19 CCDC19 coiled-coil domain 
containing 19  
6.721 up 
ENSDARG00000069361 spa17 SPA17 sperm autoantigenic 
protein 17   
6.680 up 
ENSDARG00000058950 CSPP1 CSPP1 centrosome and 
spindle pole associated 
protein 1   
6.672 up 
ENSDARG00000038788 DNAI1 (1 of 
2) 
DNAI1 dynein, axonemal, 
intermediate chain 1   
6.620 up 
ENSDARG00000036189 spata4 ASB5 ankyrin repeat and 
SOCS box containing 




ZYG11B zyg-11 family member 
B, cell cycle regulator  
6.553 up 
ENSDARG00000087373 dnah5 DNAH5 dynein, axonemal, 
heavy chain 5   
6.540 up 
ENSDARG00000058140 ttc25 TTC25 tetratricopeptide repeat 




DNAH10 dynein, axonemal, 
heavy chain 10   
6.502 up 
ENSDARG00000062021 CCDC181 CCDC181 coiled-coil domain 
containing 181  
6.494 up 
ENSDARG00000022660 armc2 ARMC2 armadillo repeat 
containing 2   
6.411 up 
ENSDARG00000061377 efcab1 EFCAB1 EF-hand calcium 
binding domain 1   
6.327 up 
ENSDARG00000031600 rd3 RD3 retinal degeneration 3   6.307 up 
ENSDARG00000031248 enkur ENKUR enkurin, TRPC 
channel interacting 
protein   
6.283 up 
ENSDARG00000053455 ccdc103 CCDC103 coiled-coil domain 
containing 103  
6.247 up 
ENSDARG00000063451 CCDC13 CCDC13 coiled-coil domain 
containing 13  
6.236 up 




ENSDARG00000041301 crybb3 CRYBB3 crystallin, beta B3   6.229 up 
ENSDARG00000076484 stab1 STAB1 stabilin 1   6.185 up 
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ENSDARG00000055698 pcnxl2 PCNXL2 pecanex-like 2 
(Drosophila)  
6.166 up 
ENSDARG00000052664 MSLN (1 of 
2) 
MSLN mesothelin   6.116 up 
ENSDARG00000070129 barhl2 BARHL2 BarH-like homeobox 2   6.097 up 
ENSDARG00000053625 anxa2b ANXA2 annexin A2   6.063 up 
ENSDARG00000003414 capslb CAPSL calcyphosine-like   6.062 up 
ENSDARG00000061850 CR847986.1 CAPN6 calpain 6   6.062 up 
ENSDARG00000053828 UBXN11 UBXN11 UBX domain protein 
11   
6.061 up 
ENSDARG00000058486 caps2 CAPS2 calcyphosine 2   6.059 up 
ENSDARG00000010662 fbxo36a FBXO36 F-box protein 36  6.046 up 
ENSDARG00000009743 efhc1 EFHC1 EF-hand domain (C-
terminal) containing 1   
6.011 up 
ENSDARG00000069703 efhb EFHB EF-hand domain 
family, member B   
5.995 up 
ENSDARG00000014081 fam184a FAM184A family with sequence 
similarity 184, 
member A   
5.962 up 
ENSDARG00000070236 DUPD1 (6 
of 12) 
DUPD1 dual specificity 
phosphatase and pro 
isomerase domain 
containing 1   
5.957 up 
ENSDARG00000071360 morn2 MORN2 MORN repeat 
containing 2   
5.929 up 
ENSDARG00000014849 pih1d2 PIH1D2 PIH1 domain 
containing 2  
5.903 up 
ENSDARG00000015010 CCDC114 CCDC114 coiled-coil domain 




C11orf63 chromosome 11 open 
reading frame 63   
5.815 up 
ENSDARG00000042936 fam228a FAM228B family with sequence 
similarity 228, 
member B   
5.779 up 
ENSDARG00000006863 CCDC108 CCDC108 coiled-coil domain 
containing 108   
5.745 up 
ENSDARG00000044561 ccr7 CCR7 chemokine (C-C 
motif) receptor 7   
5.726 up 
ENSDARG00000086355 TTC40 TTC40 tetratricopeptide repeat 
domain 40   
5.716 up 
ENSDARG00000053744 dcdc2b DCDC2B doublecortin domain 
containing 2B  
5.715 up 
ENSDARG00000060567 trpm2 TRPM2 transient receptor 
potential cation 
channel, subfamily M, 
member 2   
5.640 up 
ENSDARG00000036924 TATDN1 TATDN1 TatD DNase domain 
containing 1   
5.629 up 
ENSDARG00000070598 eno4 ENO4 enolase family 
member 4   
5.595 up 
ENSDARG00000063068 syne1b SYNE1 spectrin repeat 
containing, nuclear 
envelope 1   
5.583 up 
ENSDARG00000070868 C23H1orf19 C1orf192 chromosome 1 open 5.555 up 
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2 reading frame 192   
ENSDARG00000041134 dnaaf2 DNAAF2 dynein, axonemal, 
assembly factor 2   
5.549 up 
ENSDARG00000035944 sync SYNC syncoilin, intermediate 








A3   
5.482 up 
ENSDARG00000037174 zgc:113355 NEK3 NIMA-related kinase 3   5.464 up 
ENSDARG00000056007 cyb5d1 CYB5D1 cytochrome b5 domain 
containing 1   
5.429 up 
ENSDARG00000062355 axdnd1 AXDND1 axonemal dynein light 
chain domain 
containing 1   
5.415 up 
ENSDARG00000016161 ccdc170 CCDC170 coiled-coil domain 
containing 170  
5.412 up 
ENSDARG00000010586 tex9 TEX9 testis expressed 9   5.338 up 
ENSDARG00000045705 meig1 MEIG1 meiosis/spermiogenesi
s associated 1  23429 
5.321 up 
ENSDARG00000089020 zgc:158260 FAM47E family with sequence 
similarity 47, member 
E   
5.299 up 
ENSDARG00000057276 iqca1 IQCA1 IQ motif containing 
with AAA domain 1   
5.291 up 
Dr.150723 rnf150a RNF150 ring finger protein 150  5.278 up 
ENSDARG00000000349 C21H11orf7
0 
C11orf70 chromosome 11 open 
reading frame 70  
5.277 up 
ENSDARG00000013375 fem1c FEM1C fem-1 homolog c (C. 
elegans)   
5.271 up 
ENSDARG00000077928 ccdc173 CCDC173 coiled-coil domain 
containing 173   
5.227 up 
ENSDARG00000058940 C8H9orf116 C9orf116 chromosome 9 open 
reading frame 116  
5.205 up 
Dr.113684 npnt NPNT nephronectin  5.147 up 
ENSDARG00000078611 lrriq3 LRRIQ3 leucine-rich repeats 
and IQ motif 
containing 3   
5.133 up 
ENSDARG00000067742 eva1bb EVA1B eva-1 homolog B (C. 
elegans)  
5.051 up 
ENSDARG00000042780 apoba APOB apolipoprotein B   4.998 up 
ENSDARG00000074029 CT573248.1 STX19 syntaxin 19   4.964 up 
ENSDARG00000014233 sept8b SEPT8 septin 8   4.952 up 
ENSDARG00000093734 ASPG (3 of 
3) 
ASPG asparaginase homolog 
(S. cerevisiae)  
4.941 up 
ENSDARG00000076040 arl15a ARL15 ADP-ribosylation 
factor-like 15   
4.931 up 
ENSDARG00000044433 sned1 SNED1 sushi, nidogen and 
EGF-like domains 1  
4.919 up 
ENSDARG00000045638 slc13a1 SLC13A1 solute carrier family 
13 (sodium/sulfate 
symporter), member 1   
4.881 up 
ENSDARG00000041104 CU694368.1 RERG RAS-like, estrogen- 4.879 up 




inhibitor   
ENSDARG00000060112 sybu SYBU syntabulin (syntaxin-
interacting)  
4.877 up 





4   
4.860 up 
ENSDARG00000056764 hydin HYDIN HYDIN, axonemal 
central pair apparatus 
protein   
4.858 up 
ENSDARG00000054023 ttll6 TTLL6 tubulin tyrosine ligase-
like family, member 6   
4.843 up 
ENSDARG00000060280 pde9a PDE9A phosphodiesterase 9A   4.837 up 
ENSDARG00000076395 nme8 NME9 NME/NM23 family 
member 9   
4.828 up 
ENSDARG00000033949 fbxo16 FBXO16 F-box protein 16   4.816 up 
ENSDARG00000032372 CCDC180 CCDC180 coiled-coil domain 
containing 180   
4.799 up 
ENSDARG00000030357 zgc:66313 AMY2B amylase, alpha 2B 
(pancreatic)  
4.724 up 





ENSDARG00000069762 ccdc11 CCDC11 coiled-coil domain 
containing 11  
4.682 up 
ENSDARG00000078871 fam166b FAM166B family with sequence 
similarity 166, 
member B   
4.682 up 
ENSDARG00000022098 opn4a OPN4 opsin 4  4.681 up 
ENSDARG00000021697 morn3 MORN3 MORN repeat 
containing 3   
4.675 up 
ENSDARG00000045909 dynlt1 DYNLT1 dynein, light chain, 
Tctex-type 1   
4.674 up 
ENSDARG00000070526 zc2hc1c ZC2HC1C zinc finger, C2HC-
type containing 1C  
4.667 up 
ENSDARG00000002968 a1cf A1CF APOBEC1 
complementation 
factor   
4.648 up 
ENSDARG00000022007 SPEF1 SPEF1 sperm flagellar 1   4.625 up 
ENSDARG00000057227 si:dkey-
222b8.4 
KIAA0895 KIAA0895   4.609 up 
ENSDARG00000006474 fam154b FAM154B family with sequence 
similarity 154, 




C16orf80 chromosome 16 open 
reading frame 80   
4.550 up 
ENSDARG00000070620 grin2db GRIN2B glutamate receptor, 
ionotropic, N-methyl 
D-aspartate 2B  
4.496 up 
ENSDARG00000061687 atxn1a ATXN1 ataxin 1   4.470 up 
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ENSDARG00000091001 mycbp MYCBP MYC binding protein   4.449 up 
ENSDARG00000016485 CCDC39 CCDC39 coiled-coil domain 
containing 39   
4.445 up 
ENSDARG00000076028 sez6l SEZ6L seizure related 6 
homolog (mouse)-like   
4.418 up 
ENSDARG00000016607 echdc2 ECHDC2 enoyl CoA hydratase 
domain containing 2   
4.380 up 
ENSDARG00000062328 rasgrp2 RASGRP2 RAS guanyl releasing 
protein 2 (calcium and 
DAG-regulated)   
4.378 up 
ENSDARG00000038729 s100z S100Z S100 calcium binding 
protein Z   
4.370 up 
ENSDARG00000044801 wdr38 WDR38 WD repeat domain 38   4.364 up 
ENSDARG00000070666 rhol RHO rhodopsin   4.313 up 
ENSDARG00000017982 cyp39a1 CYP39A1 cytochrome P450, 
family 39, subfamily 
A, polypeptide 1   
4.311 up 
ENSDARG00000086452 CU672227.1 DTHD1 death domain 










ENSDARG00000054352 lrrc9 LRRC9 leucine rich repeat 




CROCC ciliary rootlet coiled-
coil, rootletin   
4.242 up 
ENSDARG00000089057 LRRC56 (1 
of 2) 
LRRC56 leucine rich repeat 
containing 56  
4.231 up 
ENSDARG00000045075 tmem106a TMEM106A transmembrane protein 
106A  
4.226 up 
ENSDARG00000070446 RSPH1 RSPH1 radial spoke head 1 
homolog 
(Chlamydomonas)   
4.223 up 
ENSDARG00000012244 ube2e3 UBE2E3 ubiquitin-conjugating 





metallopeptidase 23B   
4.209 up 
ENSDARG00000062144 shank3a SHANK3 SH3 and multiple 
ankyrin repeat 
domains 3   
4.193 up 
ENSDARG00000068719 gmnc GMNC geminin coiled-coil 
domain containing  
4.189 up 
ENSDARG00000093781 lrriq1 LRRIQ1 leucine-rich repeats 
and IQ motif 
containing 1   
4.149 up 
ENSDARG00000058375 syce2 SYCE2 synaptonemal complex 
central element protein 
2  
4.138 up 
ENSDARG00000090202 RBM11 RBM11 RNA binding motif 
protein 11  
4.116 up 
ENSDARG00000045788 avpr1b AVPR1A arginine vasopressin 
receptor 1A   
4.115 up 
ENSDARG00000018008 mdh1b MDH1B malate dehydrogenase 4.114 up 
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1B, NAD (soluble)  
ENSDARG00000054318 stk33 STK33 serine/threonine kinase 
33   
4.106 up 
ENSDARG00000059910 KNDC1 (1 
of 2) 
KNDC1 kinase non-catalytic C-
lobe domain (KIND) 




RIC8B RIC8 guanine 
nucleotide exchange 
factor B   
4.075 up 
ENSDARG00000053386 wdr27 WDR27 WD repeat domain 27  4.066 up 
ENSDARG00000076271 mtp MTTP microsomal 
triglyceride transfer 




DYNC2H1 dynein, cytoplasmic 2, 
heavy chain 1   
4.023 up 
ENSDARG00000062056 elmod1 ELMOD1 ELMO/CED-12 
domain containing 1   
4.021 up 
ENSDARG00000006981 ccdc113 CCDC113 coiled-coil domain 
containing 113  
4.015 up 
ENSDARG00000020822 rabl5 RABL5 RAB, member RAS 
oncogene family-like 5  
4.001 up 
ENSDARG00000074049 C19H5orf49 C5orf49 chromosome 5 open 
reading frame 49   
3.981 up 
ENSDARG00000069446 dbh DBH dopamine beta-
hydroxylase 
(dopamine beta-
monooxygenase)   
3.979 up 
ENSDARG00000062501 hhipl1 HHIPL1 HHIP-like 1  3.965 up 
ENSDARG00000090725 DYNC2H1 
(2 of 2) 
DYNC2H1 dynein, cytoplasmic 2, 
heavy chain 1  
3.889 up 
ENSDARG00000071637 ASIC1 (2 of 
2) 
ASIC1 acid-sensing (proton-
gated) ion channel 1   
3.881 up 
ENSDARG00000013252 TMC5 TMC5 transmembrane 
channel-like 5  
3.873 up 
ENSDARG00000014866 hprt1l PRTFDC1 phosphoribosyl 
transferase domain 
containing 1   
3.854 up 
ENSDARG00000058280 SPAG17 SPAG17 sperm associated 
antigen 17   
3.850 up 
ENSDARG00000055238 kif17 KIF17 kinesin family member 
17  
3.795 up 
ENSDARG00000020354 lmx1a LMX1A LIM homeobox 
transcription factor 1, 
alpha  
3.794 up 
ENSDARG00000053026 kif19 KIF19 kinesin family member 
19  
3.773 up 
ENSDARG00000095603 grid2ipb GRID2IP glutamate receptor, 




Dr.81747 Dr.81747 GLB1L2 galactosidase, beta 1-
like 2   
3.736 up 
ENSDARG00000051858 ccdc33 CCDC33 coiled-coil domain 
containing 33   
3.735 up 
ENSDARG00000070473 parp6b PARP6 poly (ADP-ribose) 3.711 up 




member 6   
ENSDARG00000068096 atf5a ATF5 activating transcription 
factor 5  
3.689 up 
ENSDARG00000092662 dnaaf3 DNAAF3 dynein, axonemal, 
assembly factor 3   
3.628 up 
ENSDARG00000043550 ENKD1 ENKD1 enkurin domain 
containing 1   
3.621 up 
ENSDARG00000022109 kcnip1a KCNIP1 Kv channel interacting 
protein 1  
3.576 up 
ENSDARG00000053858 crip1 CRIP1 cysteine-rich protein 1 
(intestinal)  
3.572 up 
ENSDARG00000009844 DUSP23 (1 
of 2) 
DUSP23 dual specificity 
phosphatase 23   
3.556 up 
ENSDARG00000062581 nlgn3a NLGN3 neuroligin 3   3.544 up 
ENSDARG00000061697 ca14 CA14 carbonic anhydrase 
XIV   
3.524 up 
ENSDARG00000054186 ncs1b NCS1 neuronal calcium 
sensor 1  
3.521 up 
ENSDARG00000013858 cdc14aa CDC14A cell division cycle 14A   3.505 up 
ENSDARG00000068782 spg20a SPG20 spastic paraplegia 20 
(Troyer syndrome)   
3.496 up 
ENSDARG00000011127 ahsa1l AHSA1 AHA1, activator of 
heat shock 90kDa 
protein ATPase 
homolog 1 (yeast)   
3.490 up 
ENSDARG00000091138 ACTR3 (2 
of 2) 
ACTR3 ARP3 actin-related 
protein 3 homolog 
(yeast)   
3.486 up 
ENSDARG00000045982 PLA2G4C 
(4 of 5) 
PLA2G4C phospholipase A2, 
group IVC (cytosolic, 
calcium-independent)   
3.475 up 
ENSDARG00000010312 cp CP ceruloplasmin 
(ferroxidase)  
3.475 up 
ENSDARG00000012422 col11a2 COL11A2 collagen, type XI, 
alpha 2  
3.454 up 
ENSDARG00000073843 myo9ab MYO9A myosin IXA   3.437 up 
ENSDARG00000025679 comtb LRTOMT leucine rich 
transmembrane and O-
methyltransferase 
domain containing  
3.410 up 
ENSDARG00000014169 SYT2 (1 of 
2) 
SYT2 synaptotagmin II  3.378 up 
ENSDARG00000039385 dlg4b DLG4 discs, large homolog 4 
(Drosophila)   
3.367 up 
ENSDARG00000078954 rxrba RXRB retinoid X receptor, 
beta   
3.360 up 
ENSDARG00000030512 tsnaxip1 TSNAXIP1 translin-associated 
factor X interacting 
protein 1  
3.341 up 
ENSDARG00000040004 PKHD1L1 
(1 of 2) 
PKHD1L1 polycystic kidney and 
hepatic disease 1 
(autosomal recessive)-
like 1  
3.333 up 
ENSDARG00000000516 ankar ANKAR ankyrin and armadillo 3.327 up 
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repeat containing   
ENSDARG00000039824 CCDC89 CCDC89 coiled-coil domain 
containing 89   
3.310 up 
ENSDARG00000078461 pde6c PDE6C phosphodiesterase 6C, 
cGMP-specific, cone, 
alpha prime   
3.303 up 
ENSDARG00000044253 paqr3b PAQR3 progestin and adipoQ 
receptor family 
member III   
3.297 up 
ENSDARG00000024278 adh8b ADH5 alcohol dehydrogenase 
5 (class III), chi 
polypeptide  
3.273 up 
ENSDARG00000020239 lpin1 LPIN1 lipin 1   3.272 up 
ENSDARG00000074923 SLC16A7 SLC16A7 solute carrier family 
16 (monocarboxylate 
transporter), member 7   
3.257 up 
ENSDARG00000093628 s100a11 S100A13 S100 calcium binding 
protein A13  
3.254 up 
ENSDARG00000055754 smc1a SMC1A structural maintenance 
of chromosomes 1A  
3.212 up 
ENSDARG00000038793 ccdc24 CCDC24 coiled-coil domain 
containing 24   
3.206 up 
ENSDARG00000031886 ift140 IFT140 intraflagellar transport 
140 homolog 
(Chlamydomonas)   
3.192 up 
ENSDARG00000059175 cep19 CEP19 centrosomal protein 




APBB2 amyloid beta (A4) 
precursor protein-
binding, family B, 
member 2   
3.189 up 
ENSDARG00000070956 tecra TECR trans-2,3-enoyl-CoA 
reductase   
3.183 up 
ENSDARG00000043236 ccna1 CCNA1 cyclin A1  3.173 up 
ENSDARG00000002666 kcnj1b KCNJ1 potassium inwardly-
rectifying channel, 
subfamily J, member 1   
3.171 up 
ENSDARG00000094516 es1 C21orf33 chromosome 21 open 
reading frame 33   
3.153 up 
ENSDARG00000090557 MFAP4 (6 
of 14) 
MFAP4 microfibrillar-
associated protein 4  
3.133 up 
ENSDARG00000027599 fam221a FAM221A family with sequence 
similarity 221, 
member A   
3.119 up 
ENSDARG00000045626 nek8 NEK8 NIMA-related kinase 8   3.113 up 
ENSDARG00000069726 glis3 GLIS3 GLIS family zinc 
finger 3  
3.110 up 
ENSDARG00000021739 klhl24a KLHL24 kelch-like family 
member 24  
3.093 up 
ENSDARG00000079002 dnai1 DNAI1 dynein, axonemal, 
intermediate chain 1   
3.082 up 
ENSDARG00000010300 traf3ip1 TRAF3IP1 TNF receptor-
associated factor 3 
interacting protein 1  
3.078 up 
ENSDARG00000053517 EML5 EML5 echinoderm 3.071 up 




protein like 5   
ENSDARG00000059939 dab1a DAB1 Dab, reelin signal 
transducer, homolog 1 
(Drosophila)   
3.069 up 
ENSDARG00000043328 fip1l1a FIP1L1 factor interacting with 
PAPOLA and CPSF1   
3.063 up 
ENSDARG00000068939 XAF1 XAF1 XIAP associated factor 
1   
3.046 up 
ENSDARG00000059692 scn12aa SCN2A sodium channel, 
voltage-gated, type II, 
alpha subunit   
3.040 up 




homolog (Drosophila)   
3.021 up 
ENSDARG00000067570 ctsbb CTSB cathepsin B   3.019 up 
ENSDARG00000054973 itsn2b ITSN2 intersectin 2   3.002 up 
ENSDARG00000058200 PLCXD2 PLCXD2 phosphatidylinositol-
specific phospholipase 
C, X domain 
containing 2   
2.994 up 
ENSDARG00000079271 dcxr DCXR dicarbonyl/L-xylulose 
reductase   
2.991 up 
ENSDARG00000041830 tsn TSN translin   2.974 up 
ENSDARG00000088572 CABZ01074
647.1 
ZP1 zona pellucida 
glycoprotein 1 (sperm 
receptor)  
2.971 up 
ENSDARG00000076557 bicc2 BICC1 bicaudal C homolog 1 
(Drosophila)  
2.965 up 
ENSDARG00000042863 clrn1 CLRN1 clarin 1  2.958 up 
ENSDARG00000032959 kcnc1b KCNC1 potassium voltage-
gated channel, Shaw-
related subfamily, 
member 1   
2.946 up 
ENSDARG00000067777 HSPB11 HSPB11 heat shock protein 
family B (small), 
member 11  
2.946 up 
ENSDARG00000089687 C25H17orf1
05 (1 of 2) 
C17orf105 chromosome 17 open 
reading frame 105  
2.942 up 
ENSDARG00000036840 krt15 KRT20 keratin 20   2.938 up 
ENSDARG00000060549 ECEL1 ECEL1 endothelin converting 
enzyme-like 1   
2.933 up 
ENSDARG00000036612 ift27 IFT27 intraflagellar transport 
27 homolog 
(Chlamydomonas)   
2.926 up 
ENSDARG00000079397 cerkl CERKL ceramide kinase-like  2.925 up 
ENSDARG00000005372 camk4 CAMK4 calcium/calmodulin-
dependent protein 
kinase IV  
2.920 up 
ENSDARG00000027512 asic1b ASIC3 acid-sensing (proton-
gated) ion channel 3   
2.916 up 
ENSDARG00000035963 ccdc96 CCDC96 coiled-coil domain 
containing 96  
2.914 up 
ENSDARG00000062477 kiaa1549la KIAA1549L KIAA1549-like   2.913 up 
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ENSDARG00000004158 TMEM63C TMEM63C transmembrane protein 
63C  
2.910 up 
ENSDARG00000025428 socs3a SOCS3 suppressor of cytokine 
signaling 3   
2.907 up 
ENSDARG00000056742 crmp1 CRMP1 collapsin response 
mediator protein 1   
2.898 up 
ENSDARG00000090173 C11orf1 C11orf1 chromosome 11 open 
reading frame 1   
2.898 up 
ENSDARG00000016813 ccdc40 CCDC40 coiled-coil domain 
containing 40  
2.898 up 
ENSDARG00000068255 nanos3 NANOS3 nanos homolog 3 
(Drosophila)   
2.892 up 
ENSDARG00000043847 tmem244 TMEM244 transmembrane protein 
244   
2.887 up 
ENSDARG00000093026 CCDC74B CCDC74A coiled-coil domain 
containing 74A   
2.884 up 
ENSDARG00000094896 RBM33 (2 
of 2) 
RBM33 RNA binding motif 
protein 33  
2.875 up 
ENSDARG00000067692 CDH18 (2 of 
2) 
CDH18 cadherin 18, type 2   2.856 up 
ENSDARG00000017165 slc3a1 SLC3A1 solute carrier family 3 
(amino acid transporter 
heavy chain), member 
1  
2.849 up 
ENSDARG00000054858 TP53BP2 (2 
of 2) 
TP53BP2 tumor protein p53 
binding protein, 2  
2.843 up 
ENSDARG00000077484 B4GALNT3 
(2 of 3) 
B4GALNT3 beta-1,4-N-acetyl-
galactosaminyl 
transferase 3  
2.843 up 
ENSDARG00000069334 AGFG2 AGFG2 ArfGAP with FG 
repeats 2  
2.839 up 
ENSDARG00000055589 s100t S100P S100 calcium binding 
protein P  
2.836 up 
ENSDARG00000090690 NELL2A NELL2 NEL-like 2 (chicken)   2.830 up 
ENSDARG00000086207 grin2da GRIN2D glutamate receptor, 
ionotropic, N-methyl 
D-aspartate 2D   
2.824 up 
ENSDARG00000020693 sesn1 SESN1 sestrin 1   2.821 up 
ENSDARG00000042396 trim35-30 TRIM35 tripartite motif 




WDR64 WD repeat domain 64   2.812 up 
ENSDARG00000073764 CYP27A1 (5 
of 6) 
CYP27A1 cytochrome P450, 
family 27, subfamily 




DYNC2H1 dynein, cytoplasmic 2, 
heavy chain 1   
2.793 up 
ENSDARG00000068726 masp1 MASP1 mannan-binding lectin 
serine peptidase 1 
(C4/C2 activating 
component of Ra-
reactive factor)  
2.791 up 
ENSDARG00000041750 ccdc92 CCDC92 coiled-coil domain 
containing 92   
2.785 up 
Dr.75110 chd4a CHD4 chromodomain 2.785 up 
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helicase DNA binding 
protein 4 
ENSDARG00000034572 gpr143 GPR143 G protein-coupled 
receptor 143  
2.779 up 
ENSDARG00000069504 IL12B (3 of 
3) 
IL12B interleukin 12B 
(natural killer cell 
stimulatory factor 2, 
cytotoxic lymphocyte 
maturation factor 2, 
p40)  
2.765 up 
ENSDARG00000079610 akap9 AKAP9 A kinase (PRKA) 
anchor protein 9   
2.763 up 
ENSDARG00000081322 RNF125 RNF125 ring finger protein 125, 
E3 ubiquitin protein 
ligase   
2.756 up 
ENSDARG00000044634 tbce TBCE tubulin folding 
cofactor E   
2.751 up 
ENSDARG00000044976 zgc:136902 KRT20 keratin 20  2.739 up 
ENSDARG00000059914 sdr42e2 SDR42E2 short chain 
dehydrogenase/reducta
se family 42E, member 
2   
2.739 up 
ENSDARG00000063332 shank3a SHANK3 SH3 and multiple 
ankyrin repeat 
domains 3   
2.738 up 
ENSDARG00000037307 gnpda1 GNPDA1 glucosamine-6-
phosphate deaminase 1   
2.733 up 
ENSDARG00000091116 pkhd1l1 PKHD1L1 polycystic kidney and 
hepatic disease 1 
(autosomal recessive)-
like 1   
2.732 up 
ENSDARG00000001009 CLIC6 CLIC6 chloride intracellular 
channel 6   
2.731 up 
ENSDARG00000059558 tecta TECTA tectorin alpha  2.730 up 
ENSDARG00000031046 nr1h5 NR1H2 nuclear receptor 
subfamily 1, group H, 
member 2 
2.724 up 
ENSDARG00000090343 ACTN2 (2 
of 2) 
ACTN2 actinin, alpha 2  2.715 up 
ENSDARG00000020944 ezra EZR ezrin  2.715 up 
ENSDARG00000022160 ttc23 TTC23 tetratricopeptide repeat 
domain 23   
2.714 up 
ENSDARG00000028396 fkbp5 FKBP5 FK506 binding protein 
5 
2.704 up 
ENSDARG00000053049 AMFR AMFR autocrine motility 
factor receptor, E3 
ubiquitin protein ligase  
2.693 up 
ENSDARG00000015278 plxnc1 PLXNC1 plexin C1  2.692 up 




complex subunit 1   
2.687 up 
ENSDARG00000041595 ces3 CES1 carboxylesterase 1   2.686 up 
ENSDARG00000030215 matn1 MATN1 matrilin 1, cartilage 
matrix protein   
2.685 up 
ENSDARG00000055229 ncs1a NCS1 neuronal calcium 2.677 up 
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sensor 1  
ENSDARG00000086650 si:dkeyp-
27e10.6 
BC030307 cDNA sequence 
BC030307 
2.676 up 
ENSDARG00000087741 asb14 ASB14 ankyrin repeat and 
SOCS box containing 
14   
2.674 up 
ENSDARG00000068030 APOLD1 (3 
of 4) 
APOLD1 apolipoprotein L 
domain containing 1   
2.672 up 
ENSDARG00000069014 nphp4 NPHP4 nephronophthisis 4   2.663 up 
ENSDARG00000062415 ctnnd2a CTNND2 catenin (cadherin-
associated protein), 
delta 2  
2.657 up 
ENSDARG00000027851 zgc:92218 KIAA1407 KIAA1407   2.656 up 




3   
2.645 up 
ENSDARG00000011459 gsna GSN gelsolin   2.635 up 
ENSDARG00000090441 CABZ01085
192.1 
MDGA2 MAM domain 
containing 
glycosylphosphatidylin





scramblase 1   
2.629 up 
ENSDARG00000069423 tmie TMIE transmembrane inner 
ear  
2.623 up 
ENSDARG00000088398 tmem107l TMEM107 transmembrane protein 
107   
2.614 up 
ENSDARG00000068166 dfnb31b DFNB31 deafness, autosomal 
recessive 31   
2.589 up 
ENSDARG00000063269 DUPD1 (3 
of 12) 
DUPD1 dual specificity 
phosphatase and pro 
isomerase domain 
containing 1   
2.570 up 
ENSDARG00000061288 kcnc4 KCNC4 potassium voltage-
gated channel, Shaw-
related subfamily, 
member 4  
2.569 up 
ENSDARG00000006427 fabp2 FABP2 fatty acid binding 
protein 2, intestinal   
2.559 up 
ENSDARG00000013842 tbc1d19 TBC1D19 TBC1 domain family, 
member 19   
2.556 up 
ENSDARG00000073876 ARF4 (2 of 
3) 
ARF4 ADP-ribosylation 
factor 4  
2.552 up 
ENSDARG00000027538 NOXRED1 NOXRED1 NADP-dependent 
oxidoreductase domain 
containing 1   
2.533 up 
ENSDARG00000041215 cetn4 CETN2 centrin, EF-hand 




FFAR2 free fatty acid receptor 
2   
2.520 up 
ENSDARG00000005828 faima FAIM Fas apoptotic 
inhibitory molecule  
2.507 up 
ENSDARG00000069956 pdlim2 PDLIM2 PDZ and LIM domain 2.504 up 
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2 (mystique)  
ENSDARG00000039657 fank1 FANK1 fibronectin type III and 
ankyrin repeat 
domains 1  
2.500 up 
ENSDARG00000077045 scg5 SCG5 secretogranin V (7B2 
protein)  
2.491 up 
ENSDARG00000036337 cers3b CERS3 ceramide synthase 3  2.490 up 
ENSDARG00000087127 TCERG1L TCERG1L transcription 
elongation regulator 1-
like   
2.489 up 
ENSDARG00000086680 tec TEC tec protein tyrosine 
kinase   
2.464 up 





ENSDARG00000071881 arl9 ARL9 ADP-ribosylation 
factor-like 9  
2.462 up 
ENSDARG00000037425 s100a10a S100A10 S100 calcium binding 
protein A10   
2.462 up 
ENSDARG00000012409 rnf207b RNF207 ring finger protein 207   2.461 up 
ENSDARG00000004789 lrp1ba LRP1B low density lipoprotein 
receptor-related 
protein 1B   
2.459 up 
ENSDARG00000029482 ush2a USH2A Usher syndrome 2A 
(autosomal recessive, 
mild)   
2.447 up 
ENSDARG00000040871 gas8 GAS8 growth arrest-specific 
8   
2.444 up 
ENSDARG00000008541 chia.4 OVGP1 oviductal glycoprotein 
1, 120kDa   
2.443 up 
ENSDARG00000040874 add3a ADD3 adducin 3 (gamma)   2.441 up 
ENSDARG00000042990 cyp2p10 CYP2J2 cytochrome P450, 
family 2, subfamily J, 




PRG3 proteoglycan 3  2.428 up 
ENSDARG00000035332 C10H21orf5
9 
C21orf59 chromosome 21 open 
reading frame 59   
2.427 up 
ENSDARG00000018459 msrb2 MSRB2 methionine sulfoxide 
reductase B2   
2.407 up 
ENSDARG00000003181 sult1st4 SULT1C2 sulfotransferase 
family, cytosolic, 1C, 
member 2  
2.404 up 
ENSDARG00000042308 arhgef18b ARHGEF18 Rho/Rac guanine 
nucleotide exchange 




EFCAB4B EF-hand calcium 
binding domain 4B   
2.394 up 
ENSDARG00000013227 glulc GLUL glutamate-ammonia 
ligase   
2.390 up 
Dr.123247 Dr.123247 RCAN1 regulator of 
calcineurin 1   
2.383 up 
ENSDARG00000039411 cep68 CEP68 centrosomal protein 
68kDa   
2.370 up 
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ENSDARG00000019179 lrit1a LRIT1 leucine-rich repeat, 
immunoglobulin-like 
and transmembrane 
domains 1  
2.360 up 
ENSDARG00000042902 lace1b LACE1 lactation elevated 1   2.357 up 
ENSDARG00000069591 DDAH1 DDAH1 dimethylarginine 
dimethylaminohydrola
se 1   
2.351 up 
ENSDARG00000095355 CMA1 (25 
of 29) 
CMA1 chymase 1, mast cell   2.351 up 
ENSDARG00000033610 morn5 MORN5 MORN repeat 
containing 5   
2.349 up 
ENSDARG00000071347 aftphb AFTPH aftiphilin  2.349 up 
ENSDARG00000077554 KLHL33 (3 
of 3) 
KLHL33 kelch-like family 
member 33   
2.347 up 
ENSDARG00000035832 pyyb PYY peptide YY   2.342 up 
ENSDARG00000002255 CABZ01090
303.1 
EPB41L3 erythrocyte membrane 
protein band 4.1-like 3  
2.337 up 
ENSDARG00000008639 kifap3a KIFAP3 kinesin-associated 
protein 3  
2.336 up 
ENSDARG00000033367 rrm2b RRM2B ribonucleotide 
reductase M2 B (TP53 
inducible) 
2.331 up 
ENSDARG00000002037 pfkfb2b PFKFB2 6-phosphofructo-2-
kinase/fructose-2,6-
biphosphatase 2   
2.328 up 
ENSDARG00000086370 apoea APOE apolipoprotein E  2.328 up 
ENSDARG00000013575 rfx2 RFX2 regulatory factor X, 2 
(influences HLA class 
II expression)   
2.326 up 
ENSDARG00000023026 pkp2 PKP2 plakophilin 2 2.320 up 
ENSDARG00000058818 rbm38 RBM38 RNA binding motif 
protein 38  
2.317 up 
ENSDARG00000025974 MAGI3 (1 
of 3) 
MAGI3 membrane associated 
guanylate kinase, WW 
and PDZ domain 
containing 3   
2.317 up 
ENSDARG00000019451 pcsk2 PCSK2 proprotein convertase 
subtilisin/kexin type 2  
2.315 up 
ENSDARG00000004176 ulk4 ULK4 unc-51 like kinase 4  2.314 up 
ENSDARG00000023443 tjp2b TJP2 tight junction protein 2  2.314 up 
ENSDARG00000069951 eef1a1b EEF1A1 eukaryotic translation 
elongation factor 1 
alpha 1  
2.307 up 
ENSDARG00000062630 dnah9l DNAH17 dynein, axonemal, 
heavy chain 17   
2.296 up 
ENSDARG00000026723 syncripl SYNCRIP synaptotagmin 
binding, cytoplasmic 
RNA interacting 
protein   
2.296 up 
ENSDARG00000014623 CMA1 (1 of 
29) 
CMA1 chymase 1, mast cell  2.293 up 
ENSDARG00000055751 fosb FOSB FBJ murine 
osteosarcoma viral 
2.288 up 
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oncogene homolog B   
ENSDARG00000039579 cfd CFD complement factor D 
(adipsin)  
2.287 up 
ENSDARG00000040610 CU571169.1 SLC7A11 solute carrier family 7 
(anionic amino acid 
transporter light chain, 
xc- system), member 
11  
2.277 up 
ENSDARG00000060374 ttll11 TTLL11 tubulin tyrosine ligase-
like family, member 
11   
2.263 up 




ENSDARG00000052923 zgc:113162 TESK2 testis-specific kinase 2   2.260 up 
ENSDARG00000070492 fgf21 FGF21 fibroblast growth 
factor 21   
2.257 up 
ENSDARG00000003835 stom STOM stomatin   2.256 up 
ENSDARG00000059391 gyg1b GYG1 glycogenin 1   2.247 up 
ENSDARG00000002576 cabp5a CABP5 calcium binding 
protein 5  
2.243 up 
ENSDARG00000061602 SSX2IP (2 
of 3) 
SSX2IP synovial sarcoma, X 
breakpoint 2 
interacting protein   
2.241 up 
ENSDARG00000063569 LRRC10B LRRC10B leucine rich repeat 




KIAA1377 KIAA1377   2.230 up 
ENSDARG00000020039 MAD2L1BP MAD2L1BP MAD2L1 binding 




IPCEF1 interaction protein for 
cytohesin exchange 




TTC21A tetratricopeptide repeat 
domain 21A   
2.222 up 
ENSDARG00000053215 me1 ME1 malic enzyme 1, 
NADP(+)-dependent, 
cytosolic   
2.220 up 
ENSDARG00000041734 tbc1d32 TBC1D32 TBC1 domain family, 
member 32   
2.219 up 
ENSDARG00000059911 bbs7 BBS7 Bardet-Biedl 
syndrome 7  
2.211 up 
ENSDARG00000018516 stk38b STK38 serine/threonine kinase 
38  
2.204 up 
ENSDARG00000005913 TGM1 (1 of 
6) 
TGM1 transglutaminase 1  2.202 up 
ENSDARG00000062973 ttll7 TTLL7 tubulin tyrosine ligase-
like family, member 7  
2.196 up 
ENSDARG00000041565 tnfaip1 TNFAIP1 tumor necrosis factor, 
alpha-induced protein 
1 (endothelial)  
2.196 up 
ENSDARG00000070413 C19H18orf2
1 (1 of 2) 
C18orf21 chromosome 18 open 
reading frame 21  
2.193 up 
ENSDARG00000091731 DUPD1 (8 
of 12) 
DUPD1 dual specificity 
phosphatase and pro 
2.193 up 




containing 1   
ENSDARG00000015879 pax8 PAX8 paired box 8   2.189 up 
ENSDARG00000075706 MYRIP (2 
of 2) 
MYRIP myosin VIIA and Rab 
interacting protein   
2.183 up 
ENSDARG00000077730 TRAK1 (2 
of 3) 
TRAK1 trafficking protein, 
kinesin binding 1  
2.182 up 




ENSDARG00000079753 zgc:162576 Plk1s1 polo-like kinase 1 
substrate 1  
2.179 up 
ENSDARG00000032126 scg5 SCG5 secretogranin V (7B2 
protein)   
2.176 up 
ENSDARG00000061757 RABGAP1L RABGAP1L RAB GTPase 
activating protein 1-
like   
2.170 up 
ENSDARG00000003520 tbc1d14 TBC1D14 TBC1 domain family, 
member 14   
2.167 up 
ENSDARG00000012039 ttc26 TTC26 tetratricopeptide repeat 
domain 26  
2.166 up 
ENSDARG00000061818 meox2b MEOX2 mesenchyme 
homeobox 2   
2.166 up 
ENSDARG00000071314 CCDC57 (1 
of 2) 
CCDC57 coiled-coil domain 
containing 57  
2.165 up 
ENSDARG00000069269 wdr35 WDR35 WD repeat domain 35   2.162 up 
ENSDARG00000023861 dnase1l3l DNASE1L3 deoxyribonuclease I-
like 3   
2.162 up 
ENSDARG00000071386 CMA1 (7 of 
29) 
CMA1 chymase 1, mast cell   2.161 up 
ENSDARG00000017554 SLC44A2 (1 
of 2) 
SLC44A2 solute carrier family 
44 (choline 
transporter), member 2   
2.153 up 
Mm.343850 Kcnh6 KCNH6 potassium voltage-
gated channel, 
subfamily H (eag-
related), member 6   
2.148 up 
ENSDARG00000037954 tnnt1 TNNT1 troponin T type 1 
(skeletal, slow)  
2.144 up 
ENSDARG00000087841 ECE2 ECE2 endothelin converting 
enzyme 2   
2.142 up 
ENSDARG00000013415 lmna LMNA lamin A/C   2.142 up 
ENSDARG00000053106 cep44 CEP44 centrosomal protein 
44kDa  
2.137 up 
ENSDARG00000016213 BX088711.1 RDH8 retinol dehydrogenase 
8 (all-trans)  
2.130 up 
ENSDARG00000060169 mns1 MNS1 meiosis-specific 




GBP6 guanylate binding 
protein family, 
member 6   
2.126 up 
ENSDARG00000004633 EPN3 (1 of 
2) 
EPN3 epsin 3  2.124 up 
ENSDARG00000016897 fbxo15 FBXO15 F-box protein 15   2.120 up 
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ENSDARG00000059060 lgalsla LGALSL lectin, galactoside-
binding-like  
2.118 up 
ENSDARG00000068128 PPP1R15B PPP1R15B protein phosphatase 1, 
regulatory subunit 15B   
2.111 up 
ENSDARG00000077982 elf3 ELF3 E74-like factor 3 (ets 
domain transcription 
factor, epithelial-
specific )  
2.108 up 
ENSDARG00000089863 CCDC57 CCDC57 coiled-coil domain 
containing 57  
2.108 up 
ENSDARG00000038590 ptprsb PTPRS protein tyrosine 
phosphatase, receptor 
type, S   
2.105 up 
ENSDARG00000033251 osbpl3a OSBPL3 oxysterol binding 
protein-like 3   
2.105 up 
ENSDARG00000026086 C6H3orf67 C3orf67 chromosome 3 open 
reading frame 67  
2.105 up 
ENSDARG00000007175 recql RECQL RecQ protein-like 
(DNA helicase Q1-
like)   
2.101 up 
ENSDARG00000090722 C20H6orf58 
(1 of 2) 
C6orf58 chromosome 6 open 
reading frame 58   
2.099 up 
Mm.44158 Slc14a2 SLC14A2  solute carrier family 
14 (urea transporter), 
member 2 
2.098 up 
ENSDARG00000043093 MPEG1 (1 
of 3) 
MPEG1 macrophage expressed 
1  
2.087 up 
ENSDARG00000062221 ARAP1 (1 
of 4) 
ARAP1 ArfGAP with RhoGAP 
domain, ankyrin repeat 
and PH domain 1   
2.078 up 
ENSDARG00000042387 PTPDC1 (1 
of 3) 




Dr.77174 c3a C3 complement 
component 3  
2.067 up 
ENSDARG00000038012 FAM83F (2 
of 2) 
FAM83F family with sequence 
similarity 83, member 
F  
2.067 up 
ENSDARG00000056922 ltbp1 LTBP2 latent transforming 
growth factor beta 
binding protein 2  
2.065 up 
ENSDARG00000087474 ccr6a CCR6 chemokine (C-C 
motif) receptor 6   
2.064 up 
ENSDARG00000052427 CCDC64B CCDC64B coiled-coil domain 
containing 64B  
2.060 up 
ENSDARG00000022525 mchr1b MCHR1 melanin-concentrating 
hormone receptor 1  
2.058 up 
ENSDARG00000018508 zdhhc8b ZDHHC8 zinc finger, DHHC-
type containing 8  
2.055 up 
ENSDARG00000070412 mtmr7b MTMR7 myotubularin related 
protein 7   
2.052 up 
ENSDARG00000062799 baiap2a BAIAP2 BAI1-associated 2.051 up 
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protein 2  
ENSDARG00000007753 cpne2 CPNE2 copine II   2.050 up 
ENSDARG00000003251 zbtb22b ZBTB22 zinc finger and BTB 
domain containing 22  
2.041 up 
ENSDARG00000027875 SLC44A4 SLC44A4 solute carrier family 
44, member 4   
2.036 up 
ENSDARG00000037476 sorbs3 SORBS3 sorbin and SH3 
domain containing 3   
2.035 up 




ENSDARG00000038283 wnt6a WNT6 wingless-type MMTV 
integration site family, 
member 6  
2.035 up 
ENSDARG00000067549 ADAMTS12 ADAMTS12 ADAM 
metallopeptidase with 
thrombospondin type 1 
motif, 12   
2.033 up 
ENSDARG00000063054 shank3b SHANK3 SH3 and multiple 
ankyrin repeat 
domains 3  
2.033 up 
ENSDARG00000016691 cd9b CD9 CD9 molecule   2.032 up 
ENSDARG00000074852 si:dkeyp-
67e6.5 
MYO15B myosin XVB 
pseudogene   
2.030 up 
ENSDARG00000059682 slc43a3a SLC43A3 solute carrier family 
43, member 3   
2.029 up 
ENSDARG00000090543 tmem138 TMEM138 transmembrane protein 
138   
2.027 up 
ENSDARG00000062350 synm SYNM synemin, intermediate 
filament protein   
2.020 up 
ENSDARG00000038812 e2f5 E2F5 E2F transcription 
factor 5, p130-binding 
2.016 up 
ENSDARG00000055715 capn8 CAPN8 calpain 8  2.012 up 
ENSDARG00000005320 nipsnap1 NIPSNAP1 nipsnap homolog 1 (C. 
elegans)  
2.009 up 
ENSDARG00000045442 cpb1 CPB1 carboxypeptidase B1 
(tissue)   
2.008 up 








ENSDARG00000039352 pald1b PALD1 phosphatase domain 
containing, paladin 1  
2.000 up 
ENSDARG00000090052 BX470211.1 N/A N/A 4.179 up 
ENSDARG00000059545 foxj1a FOXJ1 forkhead box J1 13.905 up 




Supplementary table 2. List of genes previously identified to have cilia-related role that 





Gene Description (Vertebrate Ortholog) Reference 
BBS7 Bardet-Biedl syndrome 7 [Source:HGNC 
Symbol;Acc:18758] 
Yen et al., Hum Mol Genet. 2005 
DNAI1 dynein, axonemal, intermediate chain 1 
[Source:HGNC Symbol;Acc:2954] 
Zariwala et al., Am J Respir Crit Care 
Med, 2006 
DNAI1 dynein, axonemal, intermediate chain 1 
[Source:HGNC Symbol;Acc:2954] 
Zariwala et al., Am J Respir Crit Care 
Med, 2006 
DNAAF3 dynein, axonemal, assembly factor 3 
[Source:HGNC Symbol;Acc:30492] 
Mitchison et al., Nat Genetics, 2012 
DNAAF3 dynein, axonemal, assembly factor 3 
[Source:HGNC Symbol;Acc:30492] 
Mitchison et al., Nat Genetics, 2012 
DNAH5 dynein, axonemal, heavy chain 5 
[Source:HGNC Symbol;Acc:2950] 
Olbrich et al., Nature Genet., 2002 
HYDIN HYDIN, axonemal central pair apparatus 
protein [Source:HGNC 
Symbol;Acc:19368] 
Lechtreck et al., JCB, 2008 
DNAH11 dynein, axonemal, heavy chain 11 
[Source:HGNC Symbol;Acc:2942] 
Schwabe GC et al., Hum Mutat, 2008 
DNAAF2 dynein, axonemal, assembly factor 2 
[Source:HGNC Symbol;Acc:20188] 
Omran et al., Nature, 2008 
RSPH4A radial spoke head 4 homolog A 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:21558] 
Castleman et al., Am J Hum Genet, 
2009 
RSPH9 radial spoke head 9 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:21057] 
Castleman et al., Am J Hum Genet, 
2009 
DNAAF1 dynein, axonemal, assembly factor 1 
[Source:HGNC Symbol;Acc:30539] 
Loges et al., Am J Hum Genet, 2009 
CCDC39 coiled-coil domain containing 39 
[Source:HGNC Symbol;Acc:25244] 
Merveille et al., 2010 
CCDC40 coiled-coil domain containing 40 
[Source:HGNC Symbol;Acc:26090] 
Becker-Heck et al., 2010 
CCDC103 coiled-coil domain containing 103 
[Source:HGNC Symbol;Acc:32700] 
Panizzi JR et al., Nat Genet, 2012 
LRRC6 leucine rich repeat containing 6 
[Source:HGNC Symbol;Acc:16725] 
Kott et al., Am J Hum Genet, 2012 
CCDC114 coiled-coil domain containing 114 
[Source:HGNC Symbol;Acc:26560] 
Knowles MR et al., Am J Hum 
Genet, 2013 and Onoufriadis A et al., 
Am J Hum Genet, 2013 
DRC1 dynein regulatory complex subunit 1 
homolog (Chlamydomonas) 
[Source:HGNC Symbol;Acc:24245] 
Wirschell M et al., Nat Genet, 2013 
ZMYND10 zinc finger, MYND-type containing 10 
[Source:HGNC Symbol;Acc:19412] 
Zariwala et al., Am J Hum Genet, 
2013 and Moore et al., Am J Hum 
Genet, 2013 
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ARMC4 armadillo repeat containing 4 
[Source:HGNC Symbol;Acc:25583] 
Hjeij R et al., Am J Hum Genet, 2013 
and Onoufriadis A et al., J Med 
Genet, 2014 
RSPH1 radial spoke head 1 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:12371] 
Kott et al., Am J Hum Genet, 2013 
DYX1C1 dyslexia susceptibility 1 candidate 1 
[Source:HGNC Symbol;Acc:21493] 
Chandrasekar G et al., Plos One, 
2013 and Tarkar A et al., Nat Genet, 
2013 
C21orf59 chromosome 21 open reading frame 59 
[Source:HGNC Symbol;Acc:1301] 
Austin-Tse C et al., Am J Hum 
Genet, 2013 
CCDC65 coiled-coil domain containing 65 
[Source:HGNC Symbol;Acc:29937] 
Horani A et al., Plos One, 2013 and 
Austin-Tse C et al., Am J Hum 
Genet, 2013 
SPAG1 sperm associated antigen 1 [Source:HGNC 
Symbol;Acc:11212] 
Knowles et al., Am J Hum Genet, 
2013 
GLIS3 GLIS family zinc finger 3 [Source:HGNC 
Symbol;Acc:28510] 
Hashimoto et al., Plos One, 2009 
TMEM138 transmembrane protein 138 
[Source:HGNC Symbol;Acc:26944] 
Lee et al., Science, 2012 
CSPP1 centrosome and spindle pole associated 
protein 1 [Source:HGNC 
Symbol;Acc:26193] 
Patzke et al., Mol Biol Cell, 2010 
NPHP4 nephronophthisis 4 [Source:HGNC 
Symbol;Acc:19104] 
Jauregui et al., J Cell Biol, 2008 
NEK8 NIMA-related kinase 8 [Source:HGNC 
Symbol;Acc:13387] 
Smith et al., J Am Soc Nephrol, 2006 
BICC1 bicaudal C homolog 1 (Drosophila) 
[Source:HGNC Symbol;Acc:19351] 
Maisonneuve et al., Development, 
2009 
USH2A Usher syndrome 2A (autosomal recessive, 
mild) [Source:HGNC Symbol;Acc:12601] 
Liu et al., Proc Natl Acad Sci, 2007 
IFT80 intraflagellar transport 80 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:29262] 
Beales et al., Nat Genet, 2007 
DYNC2H1 dynein, cytoplasmic 2, heavy chain 1 
[Source:HGNC Symbol;Acc:2962] 
Merrill et al., Am J Hum Genet, 2009 
DYNC2H1 dynein, cytoplasmic 2, heavy chain 1 
[Source:HGNC Symbol;Acc:2962] 
Merrill et al., Am J Hum Genet, 2009 
DYNC2H1 dynein, cytoplasmic 2, heavy chain 1 
[Source:HGNC Symbol;Acc:2962] 
Merrill et al., Am J Hum Genet, 2009 
WDR35 WD repeat domain 35 [Source:HGNC 
Symbol;Acc:29250] 
Mill et al., Am J of Hum Gen, 2011 
IFT140 intraflagellar transport 140 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:29077] 
Absalon et al., Mol Biol Cell, 2008 
IFT172 intraflagellar transport 172 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:30391] 
Gorivodsky et al., Dev Biol, 2009 
AK7 adenylate kinase 7 [Source:HGNC 
Symbol;Acc:20091] 
Fernandez-Gonzalez et al., Am J 
Respir Cell Mol Biol, 2009 
AK7 adenylate kinase 7 [Source:HGNC 
Symbol;Acc:20091] 
Fernandez-Gonzalez et al., Am J 
Respir Cell Mol Biol, 2009 
ARL6IP1 ADP-ribosylation factor-like 6 interacting 
protein 1 [Source:HGNC 
Tu et al., Plos One, 2012 




C2orf62 chromosome 2 open reading frame 62 
[Source:HGNC Symbol;Acc:25062] 
Bontems F et al., Plos One, 2014 
CCDC151 coiled-coil domain containing 151 
[Source:HGNC Symbol;Acc:28303] 
Jerber J et al., Hum Mol Genet, 2014 
CDC14A cell division cycle 14A [Source:HGNC 
Symbol;Acc:1718] 
Clément et al., Dev Dyn, 2012 
CETN2 centrin, EF-hand protein, 2 [Source:HGNC 
Symbol;Acc:1867] 
Delaval et al., Cell Cycle, 2011 
CROCC ciliary rootlet coiled-coil, rootletin 
[Source:HGNC Symbol;Acc:21299] 
Conroy PC et al., Cell Cycle, 2012 
DNAH1 dynein, axonemal, heavy chain 1 
[Source:HGNC Symbol;Acc:2940] 
Neesen J et al., Hum Mol Genet, 
2001 
DNAJB13 DnaJ (Hsp40) homolog, subfamily B, 
member 13 [Source:HGNC 
Symbol;Acc:30718] 
Yang et al., JCB, 2008 
DYNLT1 dynein, light chain, Tctex-type 1 
[Source:HGNC Symbol;Acc:11697] 
Palmer et al., Eur J Cell Biol, 2011 
DZIP1L DAZ interacting zinc finger protein 1-like 
[Source:HGNC Symbol;Acc:26551] 
Glazer et al., Dev Biol, 2010 
EFHC1 EF-hand domain (C-terminal) containing 1 
[Source:HGNC Symbol;Acc:16406] 
Suzuki et al., Hum Mol Genet, 2009 
GAS8 growth arrest-specific 8 [Source:HGNC 
Symbol;Acc:4166] 
Colantonio et al., Nature, 2009 
IFT27 intraflagellar transport 27 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:18626] 
Qin et al., Curr Biol. 2007 
IFT88 intraflagellar transport 88 homolog 
(Chlamydomonas) [Source:HGNC 
Symbol;Acc:20606] 
Pazour et al., JCB, 2000 
IQUB IQ motif and ubiquitin domain containing 
[Source:HGNC Symbol;Acc:21995] 
Lai et al., Mol Biol Cell, 2011 
KIF17 kinesin family member 17 [Source:HGNC 
Symbol;Acc:19167] 
Insinna et al., Dev Biol, 2008 
KIF19 kinesin family member 19 [Source:HGNC 
Symbol;Acc:26735] 
Niwa et al., Dev Cell, 2012 
MCHR1 melanin-concentrating hormone receptor 1 
[Source:HGNC Symbol;Acc:4479] 
Conductier et al., Front Endocrinol, 
2013 
NEK3 NIMA-related kinase 3 [Source:HGNC 
Symbol;Acc:7746] 
Chang et al., J Cell Sci, 2009 
NME5 NME/NM23 family member 5 
[Source:HGNC Symbol;Acc:7853] 
Vogel et al., Vet Pathol, 2011 
PACRG PARK2 co-regulated [Source:HGNC 
Symbol;Acc:19152] 
Wilson et al., Hum Mol Gen, 2010 
PCDP1 Primary ciliary dyskinesia protein 1 
[Source:UniProtKB/Swiss-
Prot;Acc:Q4G0U5] 
Lee et al., Mol Cell Biol. 2008 
PIH1D3 PIH1 domain containing 3 [Source:HGNC 
Symbol;Acc:28570] 
Dong et al., J Cell Biol, 2014 
PTPDC1 protein tyrosine phosphatase domain 
containing 1 [Source:HGNC 
Symbol;Acc:30184] 
Lai et al., Mol Biol Cell, 2011 
RABL5 RAB, member RAS oncogene family-like 
5 [Source:HGNC Symbol;Acc:21895] 
Adhiambo et al., JCS, 2009 
 Appendices  
 
224 
RFX2 regulatory factor X, 2 (influences HLA 
class II expression) [Source:HGNC 
Symbol;Acc:9983] 
Yu et al., Nat Genet, 2008 
RILPL2 Rab interacting lysosomal protein-like 2 
[Source:HGNC Symbol;Acc:28787] 
Schaub et al., Mol Biol Cell, 2013 
SPAG17 sperm associated antigen 17 
[Source:HGNC Symbol;Acc:26620] 
Teves et al., Am J Respir Cell Mol 
Biol., 2013 
SPAG6 sperm associated antigen 6 [Source:HGNC 
Symbol;Acc:11215] 
Sapiro et al., Mol Cell Biol, 2002 
SPEF2 sperm flagellar 2 [Source:HGNC 
Symbol;Acc:26293] 
Sironen, et al., 2011 
SSX2IP synovial sarcoma, X breakpoint 2 
interacting protein [Source:HGNC 
Symbol;Acc:16509] 
Klinger et al., Mol Biol Cell, 2014 
and Hori et al., EMBO Rep, 2014 
TBC1D32 TBC1 domain family, member 32 
[Source:HGNC Symbol;Acc:21485] 
Ko et al., Dev Cell, 2010 
TEKT2 tektin 2 (testicular) [Source:HGNC 
Symbol;Acc:11725] 
Tanaka et al., Mol. Cell Biol., 2004 
TEKT4 tektin 4 [Source:HGNC 
Symbol;Acc:31012] 
Roy et al., FASEB J, 2007 
TMEM107 transmembrane protein 107 
[Source:HGNC Symbol;Acc:28128] 
Christopher et al., Dev Biol, 2012 
TRAF3IP1 TNF receptor-associated factor 3 
interacting protein 1 [Source:HGNC 
Symbol;Acc:17861] 
Kunitomo et al., Genes Cells, 2008 
TTC25 tetratricopeptide repeat domain 25 
[Source:HGNC Symbol;Acc:25280] 
Hayes et al., Dev Biol, 2007 
TTC26 tetratricopeptide repeat domain 26 
[Source:HGNC Symbol;Acc:21882] 
Zhang Q et al., Mol Biol Cell., 2012 
TTC29 tetratricopeptide repeat domain 29 
[Source:HGNC Symbol;Acc:29936] 
Chung et al., eLIFE, 2014 
TTLL6 tubulin tyrosine ligase-like family, 
member 6 [Source:HGNC 
Symbol;Acc:26664] 
Suryavanshi et al., Curr Biol, 2010 
TTLL9 tubulin tyrosine ligase-like family, 
member 9 [Source:HGNC 
Symbol;Acc:16118] 
Kubo et al., Curr Biol, 2010 
ULK4 unc-51 like kinase 4 [Source:HGNC 
Symbol;Acc:15784] 
Vogel et al., Vet Pathol, 2011 
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Supplementary table 3. Quantitative PCR verification of upregulation of FIGs. 
  Zebrafish qPCR (FoxJ1++/WT) 
Gene Symbol/Name Fold-change 
Standard 
Error p-value (T-test) 
aftphb 9.45 3.19 3.85E-02 
ak9 37.93 7.52 8.10E-03 
arhgef18b 9.16 1.31 4.18E-03 
bx470211.1 3.26 0.82 1.99E-02 
c18h15orf26 34.80 3.85 1.55E-03 
c20h6orf165 31.14 10.45 3.17E-02 
c24h11orf65 80.03 19.38 4.78E-03 
c6h3orf67 35.54 9.42 1.75E-02 
ccdc78 19.69 1.62 7.01E-04 
ces3 3.72 0.61 1.03E-02 
chia.4 4.52 1.17 2.89E-02 
clic6 8.87 1.14 3.11E-03 
cma1 (1 of 29) 28.53 7.75 3.54E-02 
cp 5.68 1.43 2.32E-02 
ct573248.1 9.58 2.20 1.49E-02 
dlec1 32.71 4.51 2.96E-03 
dr.81747 14.93 1.40 5.00E-03 
ect2l 74.58 15.99 9.64E-03 
fank1 16.90 3.30 8.54E-03 
fgfbp2b 19.03 2.86 4.02E-03 
hhipl1 13.97 1.50 1.62E-03 
il1rapl2 24.47 7.95 1.59E-02 
illr4 13.62 2.26 5.70E-03 
iqcg 82.20 19.03 1.18E-02 
kcnip1a 43.31 13.23 2.47E-02 
kif6 15.30 1.03 4.00E-04 
lace1b 7.72 1.27 6.57E-03 
lrtomt 27.66 4.95 6.27E-03 
magi3 (1 of 3) 4.46 0.71 8.27E-03 
masp1 9.59 0.77 4.01E-03 
mns1 5.39 0.80 5.84E-03 
mustn1a 28.96 4.58 4.40E-03 
plcxd2 19.18 5.22 8.81E-03 
s100a10a 8.88 2.26 1.99E-02 
scg5 7.69 0.60 7.81E-04 
si:ch211-195b15.7 91.41 24.67 1.76E-02 
si:ch211-71m22.1 10.91 2.90 2.09E-02 
si:ch211-95g8.1 68.26 9.28 2.71E-03 
si:ch73-242m19.1 38.69 1.42 5.83E-05 
si:dkey-26i13.8 29.81 2.71 8.86E-04 
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si:dkeyp-67e6.5 4.86 0.71 6.13E-03 
slc43a3a 7.18 0.81 2.34E-03 
spa17 26.75 8.72 2.09E-02 
tmc5 12.48 1.65 3.04E-03 
tp53bp2 (2 of 2) 13.93 2.91 1.06E-02 
trak1 (2 of 3) 7.23 1.29 8.42E-03 
ttll7 4.75 0.89 1.22E-02 
wdr27 54.18 26.13 4.88E-02 
zbbx 26.56 7.64 2.21E-02 
zgc:153738 22.13 2.58 1.91E-03 
actb1 1.374534874 0.083947523 0.003315511 
rplp0 1.00 0.00 1.00E+00 
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aftphb CG045_MO3 intron 2 - exon 3 0.75 
ak9 CG010_MO1 exon 2 - intron 2 0.75 
arhgef18b CG014_MO4 exon 3 - intron 3 1 
bx470211.1 CG063_MO3 intron 2 - exon 3 0.5 
c18h15orf26 CG021_MO1 exon 1 - intron 1 1 
c20h6orf165 CG005_MO1 exon 1 - intron 1 1 
c24h11orf65 CG025_MO4 intron 1 - exon 2 0.75 
c6h3orf67 CG006_MO1 exon 7 - intron 7 1 
ccdc78 CG030_MO1 exon 2 - intron 2 0.75 
ces3 CG057_MO4 intron 3 - exon 4 0.5 
chia.4 CG013_MO1 exon 4 - intron 4 1 
clic6 CG043_MO2 exon 1 - intron 1 0.5 
cma1 (1 of 29) CG031_MO2 exon 1 - intron 1 0.75 
cp CG009_MO3 exon 17 - intron 17 1 
ct573248.1 CG035_MO1 Start mo 0.375 
dlec1 CG017_MO1 exon 2 - intron 2 1 
dr.81747 CG018_MO2 exon 1 - intron 1 1 
ect2l CG039_MO4 exon 3 - intron 3 1 
fank1 CG049_MO1 exon 2 - intron 2 1 
fgfbp2b CG003_MO1 Start mo 0.75-1 
hhipl1 CG034_MO2 intron 1 - exon 2 0.375 
il1rapl2 CG061_MO1 exon 4 - intron 4 1 
illr4 CG056_MO1 exon 3 - intron 3 0.75 
iqcg CG004_MO1 exon 3 - intron 3 1 
kcnip1a CG011_MO2 exon 3 - intron 3 0.25 
kif6 CG042_MO1 exon 5 - intron 5 0.05 
lace1b CG041_MO3 exon 2 - intron 2 0.75 
lrtomt CG058_MO1 exon 2 - intron 2 1 
magi3 (1 of 3) CG055_MO1 exon 13 - intron 13 1 
masp1 CG052_MO1 exon 2 - intron 2 1 
mns1 CG033_MO3 intron 2 - exon 3 0.5 
mustn1a CG062_MO1 exon 2 - intron 2 0.25-0.375 
plcxd2 CG020_MO1 exon 1 - intron 1 0.55 
s100a10a CG032_MO1 exon 2 - intron 2 0.375 
scg5 CG027_MO1 exon 2 - intron 2 0.166 
si:ch211-195b15.7 CG044_MO4 intron 3 - exon 4 0.25 
si:ch211-71m22.1 CG024_MO3 intron 1 - exon 2 0.5 
si:ch211-95g8.1 CG053_MO1 exon 6 - intron 6 0.375 
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si:ch73-242m19.1 CG038_MO1 exon 32 - intron 32 0.75 
si:dkey-26i13.8 CG048_MO1 exon 2 - intron 2 0.75 
si:dkeyp-67e6.5 CG008_MO1 exon 29 - intron 29 0.75 
slc43a3a CG040_MO3 intron 1 - exon 2 0.166 
spa17 CG007_MO1 exon 2 - intron 2 0.25 
tmc5 CG022_MO2 intron 5 - exon 6 0.125-0.166 
tp53bp2 (2 of 2) CG054_MO1 exon 1 - intron 1 1 
trak1 (2 of 3) CG059_MO1 exon 3 - intron 3 1 
ttll7 CG028_MO1 exon 3 - intron 3 1 
wdr27 CG016_MO1 exon 2 - intron 2 1 
zbbx CG001_MO2 exon 4 - intron 4 0.25 
zgc:153738 CG012_MO2 exon 2 - intron 2 1 
lrrc9 lrrc9 SpMO1 exon 2 - intron 2 0.25 
control mo Control_MO n/a 0.25 
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Supplementary table 5. Effect of morpholino on FIG transcripts 
 
Gene Symbol/Name Effect on transcript 
aftphb deletion of 52bp of exon 3 or deletion of whole of exon 3 
ak9 inclusion of whole of intron 2 
arhgef18b deletion of whole of exon 3 
bx470211.1 complete loss of transcript 
c18h15orf26 inclusion of whole of intron 1 
c20h6orf165 inclusion of 132bp of intron 1, inclusion of whole of intron 1 or deletion of 23bp of 
exon 1 
c24h11orf65 inclusion of whole of intron 1 
c6h3orf67 inclusion of whole of intron 7 
ccdc78 inclusion of whole of intron 2  
ces3 deletion of whole of exon 4 
chia.4 deletion of whole of exon 5 
clic6 complete loss of transcript 
cma1 (1 of 29) complete loss of transcript 
cp inclusion of whole of intron 17 
ct573248.1 n/a 
dlec1 inclusion of whole of intron 2 or deletion of 87bp of exon 2 
dr.81747 complete loss of transcript 
ect2l deletion of 33bp of exon 3 
fank1 complete loss of transcript 
fgfbp2b n/a 
hhipl1 complete loss of transcript 
il1rapl2 inclusion of 29bp of intron 4 
illr4 complete loss of transcript 
iqcg complete loss of transcript 
kcnip1a inclusion of whole of intron 3 
kif6 inclusion of whole of intron 5 
lace1b inclusion of whole of both introns 1 and 2 
lrtomt complete loss of transcript 
magi3 (1 of 3) deletion of 14bp of exon 13 
masp1 deletion of 20bp of exon 2 
mns1 inclusion of whole of intron 2 or deletion of whole of exon 3 
mustn1a deletion of 16bp of exon 2 
plcxd2 inclusion of whole of intron 1 
s100a10a inclusion of whole of intron 1 
scg5 inclusion of whole of intron 2 or inclusion of whole of both introns 1 and 2 
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si:ch211-195b15.7 inclusion of whole of intron 3, inclusion of whole of both introns 2 and 3 or deletion 
of whole of both exons 3 and 4 
si:ch211-71m22.1 inclusion of whole of intron 1 
si:ch211-95g8.1 inclusion of 23bp of intron 6 
si:ch73-242m19.1 deletion of 36bp of exon 32 
si:dkey-26i13.8 deletion of whole of exon 2 
si:dkeyp-67e6.5 deletion of 18bp of exon 29 or deletion of whole of exon 29 
slc43a3a inclusion of 118bp of intron 2 and deletion of whole of exon 2 
spa17 inclusion of 149bp of intron 2 
tmc5 inclusion of whole of intron 5 
tp53bp2 (2 of 2) inclusion of 31bp of intron 1 
trak1 (2 of 3) inclusion of 28 bp of intron 3 or inclusion of whole of intron 3 
ttll7 complete loss of transcript 
wdr27 inclusion of whole of intron 2 or deletion of 107bp of exon 2 
zbbx inclusion of whole of intron 4 
zgc:153738 inclusion of whole of intron 2 
lrrc9   
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Supplementary table 6. Otolith defects observed upon knockdown of FIGs 
    Otolith Formation 











88 1 10 99 11.11 5.08E-03 
ak9 CG010_
MO1 
75 0 89 164 54.27 9.75E-40 
arhgef18b CG014_
MO4 





69 6 14 89 22.47 8.07E-08 
c18h15orf26 CG021_
MO1 
152 0 12 163 7.36 7.30E-02 
c20h6orf165 CG005_
MO1 
n/a n/a n/a n/a n/a n/a 
c24h11orf65 CG025_
MO4 
207 0 28 235 11.91 1.11E-04 
c6h3orf67 CG006_
MO1 
94 3 36 133 29.32 2.31E-14 
ccdc78 CG030_
MO1 
n/a n/a n/a n/a n/a n/a 
ces3 CG057_
MO4 
85 2 20 107 20.56 1.33E-07 
chia.4 (ovgp1) CG013_
MO1 
n/a n/a n/a n/a n/a n/a 
clic6 CG043_
MO2 
133 8 54 195 31.79 1.46E-19 
cma1 CG031_
MO2 
54 0 30 84 35.71 9.89E-15 
cp CG009_
MO3 





n/a n/a n/a n/a n/a n/a 
dlec1 CG017_
MO1 





32 2 94 127 75.59 1.14E-57 
ect2l CG039_
MO4 
95 93 25 213 55.40 1.17E-46 
fank1 CG049_
MO1 
n/a n/a n/a n/a n/a n/a 
fgfbp2b CG003_
MO1 
114 0 11 125 8.80 2.78E-02 
hhipl1 CG034_
MO2 
90 0 8 98 8.16 5.81E-02 
il1rapl2 CG061_
MO1 
n/a n/a n/a n/a n/a n/a 
illr4 CG056_
MO1 
n/a n/a n/a n/a n/a n/a 





55 1 29 85 35.29 1.38E-14 
kcnip1a CG011_
MO2 
47 6 18 71 33.80 2.83E-12 
kif6 CG042_
MO1 
n/a n/a n/a n/a n/a n/a 
lace1b CG041_
MO3 
69 0 11 80 13.75 1.11E-03 
lrtomt CG058_
MO1 
n/a n/a n/a n/a n/a n/a 
magi3 CG055_
MO1 
72 11 108 191 62.30 3.91E-53 
masp1 CG052_
MO1 
n/a n/a n/a n/a n/a n/a 
mns1 CG033_
MO3 
89 3 23 115 22.61 4.43E-09 
mustn1a CG062_
MO1 
78 0 56 134 41.79 3.23E-24 
plcxd2 CG020_
MO1 
85 3 25 113 24.78 2.75E-10 
s100a10a CG032_
MO1 
n/a n/a n/a n/a n/a n/a 
scg5 CG027_
MO1 



























n/a n/a n/a n/a n/a n/a 
slc43a3a CG040_
MO3 
164 0 37 201 18.41 9.62E-09 
spa17 CG007_
MO1 
61 0 32 93 34.41 7.74E-15 
tmc5 CG022_
MO2 
85 0 25 110 22.73 6.20E-09 
tp53bp2 CG054_
MO1 
91 0 59 150 39.33 1.61E-23 
trak1 CG059_
MO1 
n/a n/a n/a n/a n/a n/a 
ttll7 CG028_
MO1 
n/a n/a n/a n/a n/a n/a 
wdr27 CG016_
MO1 
n/a n/a n/a n/a n/a n/a 
zbbx CG001_
MO2 





n/a n/a n/a n/a n/a n/a 





351 1 32 384 8.59 5.11E-03 
Wild-type n/a 331 0 12 343 3.50 1.00E+00 
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Supplementary table 7. CBA observed upon knockdown of FIGs  
  Curved Body Axis 






aftphb 2 98 100 98.00 1.25E-91 
ak9 11 195 206 94.66 7.40E-128 
arhgef18b 104 79 183 43.17 9.67E-39 
bx470211.1 (n/a) 29 89 89 100.00 5.26E-65 
c18h15orf26 64 79 143 55.24 4.12E-47 
c20h6orf165 n/a n/a n/a n/a n/a 
c24h11orf65 178 74 252 29.37 7.97E-28 
c6h3orf67 5 114 119 95.80 6.41E-97 
ccdc78 n/a n/a n/a n/a n/a 
ces3 0 116 116 100.00 1.26E-105 
chia.4 (ovgp1) n/a n/a n/a n/a n/a 
clic6 5 125 130 96.15 7.73E-103 
cma1 23 81 104 77.88 1.41E-63 
cp 2 107 109 98.17 5.80E-97 
ct573248.1 (stx19) n/a n/a n/a n/a n/a 
dlec1 n/a n/a n/a n/a n/a 
dr.81747 (glb1l2) 0 139 139 100.00 7.57E-118 
ect2l 59 109 168 64.88 9.44E-63 
fank1 n/a n/a n/a n/a n/a 
fgfbp2b 105 19 123 15.45 2.44E-10 
hhipl1 55 35 90 38.89 1.41E-24 
il1rapl2 n/a n/a n/a n/a n/a 
illr4 n/a n/a n/a n/a n/a 
iqcg 81 3 84 3.57 3.18E-02 
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kcnip1a 0 105 105 100.00 2.69E-99 
kif6 n/a n/a n/a n/a n/a 
lace1b 48 77 125 61.60 9.06E-51 
lrtomt n/a n/a n/a n/a n/a 
magi3 20 172 192 89.58 2.18E-110 
masp1 n/a n/a n/a n/a n/a 
mns1 18 159 177 89.83 1.84E-106 
mustn1a 8 119 127 93.70 2.72E-96 
plcxd2 65 76 141 53.90 2.30E-45 
s100a10a n/a n/a n/a n/a n/a 
scg5 2 123 125 98.40 6.98E-106 
si:ch211-195b15.7 
(ric8b) 
52 128 130 98.46 1.05E-73 
si:ch211-71m22.1 
(plscr1) 
17 152 169 89.94 3.53E-104 
si:ch211-95g8.1 
(ac104809.3) 
7 124 131 94.66 5.40E-100 
si:ch73-242m19.1 
(c6orf183) 
n/a n/a n/a n/a n/a 
si:dkey-26i13.8 
(kif18b) 
52 147 199 73.87 1.24E-81 
si:dkeyp-67e6.5 
(myo15b) 
n/a n/a n/a n/a n/a 
slc43a3a 82 116 198 58.59 7.92E-59 
spa17 26 59 85 69.41 2.35E-48 
tmc5 30 90 120 75.00 4.66E-65 
tp53bp2 20 114 134 85.07 1.16E-83 
trak1 n/a n/a n/a n/a n/a 
ttll7 n/a n/a n/a n/a n/a 
wdr27 n/a n/a n/a n/a n/a 
zbbx 4 116 120 97.11 2.90E-99 
zgc:153738 (iqca1) n/a n/a n/a n/a n/a 
Control_MO 357 7 364 1.92 7.57E-02 
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WT 309 1 310 0.32 1.00E+00 
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Supplementary table 8. Hydrocephalus observed upon knockdown of FIGs 
  Hydrocephalus 
Gene  Normal Swollen Total Embryos 
Scored 
Defects (%) P-value 
(Fisher's Exact 
Test) 
aftphb 81 19 100 19.00 5.60E-13 
ak9 173 33 206 16.02 1.31E-14 
arhgef18b 172 11 183 6.01 1.52E-05 
bx470211.1 (n/a) 21 68 89 76.40 1.89E-58 
c18h15orf26 84 59 133 44.36 1.18E-34 
c20h6orf165 n/a n/a n/a n/a n/a 
c24h11orf65 244 8 252 3.17 1.54E-03 
c6h3orf67 61 18 79 22.78 6.32E-14 
ccdc78 n/a n/a n/a n/a n/a 
ces3 37 79 116 68.10 1.05E-57 
chia.4 (ovgp1) n/a n/a n/a n/a n/a 
clic6 78 52 130 40.00 4.57E-32 
cma1 63 41 104 39.42 2.03E-28 
cp 92 17 109 15.60 4.27E-11 
ct573248.1 
(stx19) 
n/a n/a n/a n/a n/a 
dlec1 n/a n/a n/a n/a n/a 
dr.81747 (glb1l2) 119 20 139 14.39 2.39E-11 
ect2l 155 13 168 7.74 9.14E-07 
fank1 n/a n/a n/a n/a n/a 
fgfbp2b 122 1 123 0.81 2.84E-01 
hhipl1 26 64 90 71.11 2.24E-53 
il1rapl2 n/a n/a n/a n/a n/a 
illr4 n/a n/a n/a n/a n/a 
iqcg 84 0 84 0.00 1.00E+00 
kcnip1a 57 48 105 45.71 9.73E-34 
kif6 n/a n/a n/a n/a n/a 
lace1b 97 28 125 22.40 6.30E-17 
lrtomt n/a n/a n/a n/a n/a 
magi3 95 125 220 56.82 5.32E-61 
masp1 n/a n/a n/a n/a n/a 
mns1 156 31 187 16.58 1.29E-14 
mustn1a 127 0 127 0.00 1.00E+00 
plcxd2 23 118 141 83.69 9.71E-86 
s100a10a n/a n/a n/a n/a n/a 
scg5 73 74 147 50.34 2.95E-44 





33 82 115 71.30 4.30E-61 
si:ch211-71m22.1 
(plscr1) 
96 73 169 43.20 3.04E-39 
si:ch211-95g8.1 
(ac104809.3) 
102 27 129 20.93 5.27E-16 
si:ch73-242m19.1 
(c6orf183) 
n/a n/a n/a n/a n/a 
si:dkey-26i13.8 
(kif18b) 
186 33 219 15.07 5.01E-14 
si:dkeyp-67e6.5 
(myo15b) 
n/a n/a n/a n/a n/a 
slc43a3a 129 69 198 34.85 9.96E-33 
spa17 64 26 90 28.89 5.96E-19 
tmc5 83 37 120 30.83 3.04E-23 
tp53bp2 115 25 140 17.86 4.24E-14 
trak1 n/a n/a n/a n/a n/a 
ttll7 n/a n/a n/a n/a n/a 
wdr27 n/a n/a n/a n/a n/a 
zbbx 8 112 120 93.33 1.50E-94 
zgc:153738 
(iqca1) 
n/a n/a n/a n/a n/a 
Control_MO 362 2 364 0.55 5.02E-01 
WT 310 0 310 0.00 1.00E+00 
 
 
 Appendices  
 
239 
Supplementary table 9. Kidney cyst observed upon knockdown of FIGs 
Gene Name  Normal Kidney Cysts Total 
Embryos 
Scored 
Defects (%) P-value 
(Fisher's 
Exact Test) 
aftphb 67 0 67 0 1 
ak9 75 0 75 0 1 
arhgef18b 118 0 118 0 1 
bx470211.1 
(n/a) 
67 8 75 10.66666667 5.88142E-05 
c18h15orf26 80 0 80 0 1 
c20h6orf165 n/a n/a n/a n/a n/a 
c24h11orf65 101 0 101 0 1 
c6h3orf67 94 1 95 1.052631579 0.358490566 
ccdc78 n/a n/a n/a n/a n/a 
ces3 60 0 60 0 1 
chia.4 (ovgp1) n/a n/a n/a n/a n/a 
clic6 110 0 110 0 1 
cma1 78 0 78 0 1 
cp 74 0 74 0 1 
ct573248.1 
(stx19) 
n/a n/a n/a n/a n/a 
dlec1 n/a n/a n/a n/a n/a 
dr.81747 
(glb1l2) 
37 66 103 64.0776699 6.22109E-37 
ect2l 110 2 112 1.785714286 0.1568865 
fank1 n/a n/a n/a n/a n/a 
fgfbp2b 96 0 96 0 1 
hhipl1 68 0 68 0 1 
il1rapl2 n/a n/a n/a n/a n/a 
illr4 n/a n/a n/a n/a n/a 
iqcg 63 0 63 0 1 
kcnip1a 78 0 78 0 1 
kif6 n/a n/a n/a n/a n/a 
lace1b 99 2 101 1.98019802 0.138034714 
lrtomt n/a n/a n/a n/a n/a 
magi3 74 0 74 0 1 
masp1 n/a n/a n/a n/a n/a 
mns1 101 9 110 8.181818182 0.000181377 
mustn1a 83 1 84 1.19047619 0.330708661 
plcxd2 157 2 159 1.257861635 0.232800801 
s100a10a n/a n/a n/a n/a n/a 
scg5 78 3 81 3.703703704 0.032763404 
si:ch211- 63 0 63 0 1 
























n/a n/a n/a n/a n/a 
slc43a3a 90 10 65 15.38461538 3.61141E-05 
spa17 84 0 84 0 1 
tmc5 50 44 94 46.80851064 4.49002E-24 
tp53bp2 27 40 67 59.70149254 1.12493E-27 
trak1 n/a n/a n/a n/a n/a 
ttll7 n/a n/a n/a n/a n/a 
wdr27 n/a n/a n/a n/a n/a 
zbbx 103 0 103 0 1 
zgc:153738 
(iqca1) 
n/a n/a n/a n/a n/a 
Control_MO 209 0 209 0 1 
WT 170 0 115 0 1 
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Supplementary table 10. LRA observed upon knockdown of FIGs 
 
  Left/Right Asymmetry (lefty2 expression) 
Gene  Left 
(Normal) 











aftphb 21 17 7 0 45 53.33 3.24E-14 
ak9 13 14 7 0 34 61.76 1.57E-14 
arhgef18b 30 18 5 17 70 57.14 2.98E-22 
bx470211.
1 (n/a) 
27 12 5 9 53 49.06 5.10E-14 
c18h15orf
26 
37 4 1 0 42 11.90 3.48E-01 
c20h6orf1
65 
n/a n/a n/a n/a n/a n/a n/a 
c24h11orf
65 
37 6 3 2 48 22.92 8.24E-04 
c6h3orf67 55 6 1 4 66 16.67 9.76E-03 
ccdc78 n/a n/a n/a n/a n/a n/a n/a 
ces3 40 10 8 0 58 31.03 5.16E-07 
chia.4 
(ovgp1) 
n/a n/a n/a n/a n/a n/a n/a 
clic6 25 12 3 4 44 43.18 6.67E-10 
cma1 29 8 3 10 50 42.00 2.13E-10 
cp 25 14 3 4 46 45.65 3.33E-11 
ct573248.
1 (stx19) 
n/a n/a n/a n/a n/a n/a n/a 
dlec1 n/a n/a n/a n/a n/a n/a n/a 
dr.81747 
(glb1l2) 
17 27 3 0 47 63.83 8.17E-20 
ect2l 38 15 6 0 59 35.59 6.57E-09 
fank1 n/a n/a n/a n/a n/a n/a n/a 
fgfbp2b 54 9 6 1 70 22.86 9.64E-05 
hhipl1 23 2 6 5 36 36.11 1.95E-06 
il1rapl2 n/a n/a n/a n/a n/a n/a n/a 
illr4 n/a n/a n/a n/a n/a n/a n/a 
iqcg 58 3 5 0 66 12.12 1.33E-01 
kcnip1a 28 17 27 3 75 62.67 2.16E-27 
kif6 n/a n/a n/a n/a n/a n/a n/a 
lace1b 19 12 6 1 38 50.00 3.05E-11 
lrtomt n/a n/a n/a n/a n/a n/a n/a 
magi3 43 21 6 18 88 51.14 9.64E-22 
masp1 n/a n/a n/a n/a n/a n/a n/a 
mns1 29 23 4 0 56 48.21 3.42E-14 
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mustn1a 33 29 7 0 69 52.17 6.89E-19 
plcxd2 39 14 0 24 77 49.35 1.28E-18 
s100a10a n/a n/a n/a n/a n/a n/a n/a 

























n/a n/a n/a n/a n/a n/a n/a 
slc43a3a 22 15 1 0 38 42.11 1.57E-08 
spa17 23 6 3 25 57 59.65 1.63E-20 
tmc5 16 9 4 5 34 52.94 2.58E-11 
tp53bp2 34 27 1 28 90 62.22 7.05E-31 
trak1 n/a n/a n/a n/a n/a n/a n/a 
ttll7 n/a n/a n/a n/a n/a n/a n/a 
wdr27 n/a n/a n/a n/a n/a n/a n/a 
zbbx 17 10 3 3 33 48.48 1.32E-09 
zgc:15373
8 (iqca1) 
n/a n/a n/a n/a n/a n/a n/a 
Control_ 
MO 
213 3 3 7 226 5.75 6.28E-01 
WT 451 24 4 5 484 6.82 1.00E+00 
 
